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ABSTRACT 
 
 
C—H activation (the cleavage of carbon-hydrogen bonds) reactions are emerging as a powerful new 
approach for complex molecule synthesis.  The development of reactions that are selective, catalytic, mild, and 
efficient have the potential to significantly streamline the synthesis of organic molecules used in medicine, 
biological studies, materials chemistry, and other fields.  This work describes both the development of the first 
general, linear allylic C—H amination reaction, as well as applications of a biomimetic non-heme iron catalyst 
towards generating diverse oxidation products and exploring biological pathways. 
 Linear allylic amines are a common motif found in many organic molecules; however, their synthesis 
involves a lengthy, multi-step sequence that exposes the substrate to a variety of different reaction conditions 
(oxidative, reductive, nucleophilic).  Methods that directly transform alpha olefins into linear allylic amines via C—
H activation would therefore represent a potentially useful synthetic transformation.  Through the use of two 
different palladium-catalyzed approaches, electrophile activation and nucleophile activation with catalytic 
Cr(salen)Cl and Brønsted base, respectively, good yields and high selectivities for the E linear aminated product 
could be obtained.  The method was demonstrated for a large number of diverse substrates, and allylic amination is 
preferred in the presence of other potentially reactive functional groups (alcohols, epoxides, aryl triflates).  This 
reaction was also applied to the synthesis of a deoxynegamycin analogue; comparison of the route enabled by direct 
C—H amination to the previously reported route revealed a significant decrease in step count and an overall increase 
in synthetic efficiency. 
 C—H activation has other potential application beyond synthesis of known compounds; it can also be used 
to diversify natural products or pharmacophores.  Nature utilizes this strategy routinely to generate libraries of 
different oxidized products.  This work describes a small molecule enzyme mimic (“FePDP”) that demonstrates 
mixed hydroxylase/desaturase aliphatic C—H oxidation activity (in the presence of carboxylic acid directing 
groups) on a picrotoxinin derivative.  Additionally, this biomimetic catalyst is used to explore oxidations of taxanes, 
the core structure found in the anti-cancer agent paclitaxel.  Hydrogen-abstraction/ring contraction suggested a new 
late-stage, P450-mediated biosynthetic hypothesis for the formation of A-ring nortaxane natural products, and 
demonstrated evidence of radical intermediates for this class of stereoretentive non-heme iron catalysts.  The FePDP 
catalyst was also used to access potentially useful taxane derivatives by stereoselectively installing oxidation at C2, 
which is critical for paclitaxel’s primary mode of action.   
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CHAPTER 1: CATALYTIC INTERMOLECULAR LINEAR ALLYLIC C—H AMINATION VIA 
HETEROBIMETALLIC CATALYSIS1 
1.1 INTRODUCTION 
The past hundred years have witnessed tremendous advancements in both organic methodology and total 
synthesis.  With the synthetic conquest of such molecular giants such as amphotericin2 and brevetoxin A,3 it 
becomes increasingly apparent that the complexity of the target defines the time and resources needed, rather than 
the likelihood of success in reaching the target compound.  This has, in part, nourished a general desire to develop 
new reactions (synthetic methods) that increase the efficiency with which molecules are made through two major 
strategies.  First, the development of reactions that initiate powerful bond formations can reduce synthetic steps, by 
skipping intermediates and accessing the desired functional group(s) directly.  Second, highly selective reactions 
(stereo-, regio-, site-) have allowed these reactions to be applied to complex molecules (many functional groups) at 
late stages in a synthesis, thus eliminating traditional protecting group manipulations.  Transition metals have played 
a key role in the development of reactions meeting these two criteria, while demonstrating an exceptional increase in 
synthetic efficiency.4  Amination is one area of research that has the potential to benefit from transition metal 
chemistry.  Nitrogen has traditionally been installed through oxygenated intermediates, leading to relatively lengthy 
synthetic sequences.  In particular, direct installation of nitrogen via C—H bond activation can eliminate the need 
for more complex, pre-oxidized fragments.   
 This introduction will focus primarily on previous technologies to access linear (primary) allylic amines; 
the last comprehensive review specifically covering this transformation was published over 25 years ago.5  
However, a more general review on allylic amination by Johannsen and Jørgensen provides an excellent model for 
organizing the large number of transformations by reaction type.6 The three major categories that will be used herein 
are: (1) substitution reactions, (2) metal-catalyzed substitution reactions, and (3) direct C-H to C-N bond 
conversions from terminal olefins.  Although numerous and interesting methods exist for accessing branched allylic 
amines (especially enantioselectively, 7 using transition metal-allyl complexes), examples of this type will be 
mentioned only for their relevance to the development of oxidative, palladium(II) catalyzed allylic aminations. 
1.1.1 Non-metal substitution reactions 
 Substitution reactions feature the exchange of a protected nitrogen source with an electrophilic allylic 
functional group, such as an alcohol or other leaving group derived from the alcohol.  An allylic alcohol is most 
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commonly accessed from the requisite alcohol or olefin, which is oxidized to the aldehyde.  The aldehyde can then 
be alkylated with a Wittig or Horner-Wadsworth-Emmons reaction, followed by a 1,2 reduction of the ester to the 
corresponding alcohol.  This overall sequence requires series of oxidation state changes, by subjecting the substrate 
to oxidative, nucleophilic, and reducing conditions (Figure 1.1). 
Figure 1.1. Common synthetic route to linear allylic amines. 
 
Note that nitrogen still must be installed in addition to this lengthy sequence, usually after conversion of the 
alcohol into a leaving group.  Although displacement with ammonia would be ideal for accessing allylic amines, the 
resulting products are generally more nucleophilic than ammonia, leading to multiple additions of electrophile.8  
One of the first solutions to the over-alkylation problem was the use of a phthalimide salt as the nucleophile, which 
blocked subsequent additions (Gabriel amine synthesis).9  The phthalimide can then be removed under reducing or 
hydrolysis conditions, liberating the free amine.  Azide nucleophiles have also received a great deal of use, primarily 
due to their ability to be easily reduced.  Unfortunately, both the toxicity and potential instability may discourage 
azide use on large scale.  The Mitsunobu10 reaction represented a major advancement in oxygen functionalization 
due to both its use as a mild esterification reaction, and as a simple method for the stereochemical inversion of 
alcohols.  However, the Mitsunobu reaction can also be useful for directly converting alcohols into nitrogen 
functionality.  Although sterically dense branched allylic amines can be difficult to access using this method11 
(owing to SN2’ attack), linear allylic amines can be synthesized from the allylic alcohol with phthalimide, azide, or 
other slightly acidic nitrogen surrogates.  One advantage of this method is that a large number of nitrogen 
nucleophiles with different protecting groups can be used.  Disadvantages of this method are that it still requires the 
linear allylic alcohol intermediate as a starting point, and in some cases, purification of the products away from the 
toxic azodicarboxylate source (and its reduction products) can be challenging. 
 Although not specifically a substitution reaction, one additional method of allylic amine synthesis bears 
mention.  Aldehydes can be reacted with complex vinyl phosphonium salts (Schweizer reaction) to generate 
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phthalimide protected allylic amines in good yield (43-95%).12  Although this process eliminates the reduction step 
described earlier for substitution reactions, a multi-step sequence is required to prepare the Wittig reagent.  Although 
the olefin geometry is generally high for aryl or α,β-unsaturated aldehydes, unbiased 3-phenylpropanal produced the 
product in 60% yield with only a 3:1 E/Z ratio. 
1.1.2 Pd-catalyzed substitution reactions 
Figure 1.2. Pd(0)-catalyzed amination reactions for the synthesis of linear allylic amines. 
 
 Transition metal-catalyzed reactions have been developed to synthesize linear allylic amines via linear 
allylic esters or, in some rare cases, alcohols.  Since the discovery of palladium-catalyzed substitution reactions,13 
the use of palladium in synthesis has grown dramatically.  Tsuji reported that π-allyl palladium chloride dimers 
could be functionalized with soft carbon nucleophiles, such as malonates.14  The first reports of allylic amination via 
a π-allyl intermediate from allylic acetates with Pd(0) came from reactions exploring the polymerization of 
butadiene.  Takahashi and coworkers reported the incorporation of nitrogen nucleophiles onto dimerized butadiene, 
although the identity/structure of the products was not known.15  Later, Walker and coworkers used amine bases to 
accelerate the polymerization of butadiene with Pd/PPh3 in acetic acid solvent (Figure 1.2, 1).16  They found that 
secondary amine bases, such as diethylamine, instead led to different products with incorporation of the amine base.  
Trost later developed a catalytic system that converted branched or linear allylic acetates into linear (E) allylic 
amines; the bis-protected para-methoxybenzyl nitrogen product can then be easily deprotected under oxidative 
conditions to furnish the free amine (Figure 1.2, 2).17  Other nucleophiles have also been developed for the synthesis 
of allylic amines, such as the sodium salt of bis(tert-butoxycarbonyl)imide, although lower linear/branched and E/Z 
ratios were reported (Figure 1.2, 3).18   
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Åkermark, Hegedus, and Zetterberg conducted a mechanistic investigation into the origin of the 
regioselectivity observed for palladium catalyzed amination reactions.19  A palladium π-allyl chloride dimer was 
either treated with silver tetrafluoroborate and one equivalent of triphenylphosphine, or an excess of 
triphenylphosphine.   
Figure 1.3. Regioselectivities for Pd(0)-catalyzed allylic aminations. 
 
Both of these new species were then reacted with N,N-dimethylamine, and the regioselectivities were 
examined.  The presumably cationic conditions generated linear amine products (Figure 1.3, 1), while addition of 
excess phosphine ligand gave rise to exclusively branched product (Figure 1.3, 2).  The authors rationalize this 
outcome by suggesting that attack on the cationic π-allyl complex is governed by sterics, while the presence of 
bulky ligands (such as two triphenylphosphines) on palladium favors the formation of a σ-complex with palladium 
on the least crowded carbon.  An SN2’ attack on this σ-complex would then generate the observed branched amine 
product.   
 Although allylic carboxylates and halides make excellent starting materials for Pd(0) catalyzed substitution 
reactions, a number of researchers have investigated amination reactions that utilize the allylic alcohol directly using 
Lewis acid activation.  For example, anilines are competent nucleophiles for Pd(0) catalyzed substitution, if catalytic 
amounts of Ti(O-iPr)4 and molecular sieves are added to the reaction mixture (Figure 1.4, 1).20  Although generally 
high yielding, linear/branched selectivities are frequently low and multiple allylations are difficult to avoid for 
arylamines that lack steric bulk.  Special ligands have made it possible to run the reaction Lewis acid-free with high 
linear/branched ratios, albeit with lower E/Z ratios (Figure 1.4, 2).21   
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Figure 1.4. Pd-catalyzed linear allylic amine synthesis from allylic alcohols. 
 
 Other metal-allyl species have been used to access branched allylic amines,22 but relatively few exhibit 
preference for linear allylic amines.  Terminal allylic halides can be reacted with aniline or morpholine to yield 
allylic amines using a mixture of copper(II) perchlorate and copper metal.23  Unfortunately, low linear/branched 
ratios and occasionally competing diallylation limit this method’s usefulness.   
1.1.3 Direct C—H amination 
 Although transition metal π-allyl complexes have added to the toolbox of allylic amine synthesis, their 
dependence on allylic leaving groups doesn’t lend a substantial advantage over simple substitution methods for the 
synthesis of linear allylic amines, but a substantial improvement in efficiency could be made by directly converting 
C—H bonds into C—N bonds.  Several recent reviews on advances in C—H amination nicely summarize these 
methods; only methods that generate  allylic amine products will be mentioned below.24 
Figure 1.5. Ene reactions with terminal olefins. 
 
In general, nitroso and azo ene reactions favor an electron-rich double bond, making terminal olefins a 
challenging substrate class for this process.  Ene-type reactions that give high selectivity for allylic amines involve 
the reaction of an olefin with an electron-deficient enophile, such as an azo- or nitroso species.  They have been 
extensively reviewed;25 only selected examples pertaining to reactions of mono-substituted olefins will be 
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considered in more detail.  Nevertheless, numerous examples exist of systems capable of forming linear allylic 
amines with high levels of regioselectivity, although solvent quantities of substrate give the best yields (based on 
oxidant).  Bis(2,2,2-trichloroethyl)azodicarboxylate reacts cleanly with acetate protected hex-5-en-1-ol to give only 
the linear product, in 85% yield (5.7:1 E/Z), which was deprotected under reducing conditions.26  A similar reaction 
can be carried out with DEAD (diethylazodicarboxylate) by adding stoichiometric tin(IV)chloride and excess olefin 
to realize the hydrazine product in 87% yield (Figure 1.5, 1).27  The resulting hydrazine could then be deprotected to 
reveal the ethyl carbamate with sodium/liquid ammonia.  Acyl nitroso enophiles are capable of reaction with solvent 
quantities of olefins such as 1-octene (89% yield, E/Z unreported), forming easily reducible hydroxylamine 
products.28  Nitroso-metal complexes of iron, molybdenum, or copper (either pre-formed or created in-situ) have 
also shown promise for allylic amination, although internal double bonds are predictably more reactive.29  One of 
the more exciting examples of catalytic activity employing a limiting amount of terminal olefin was reported by 
Nicholas.30  With excess tert-butylhydroxy carbamate, 10% copper(I)chloride, and hydrogen peroxide, 1-octene 
could be transformed into the linear allylic hydroxylamine (E/Z unreported, Figure 1.5, 2).  It was also demonstrated 
that the addition of P(OEt3) under similar conditions could catalyze the in-situ reduction of the hydroxylamine with 
concurrent oxidation of copper(I) to copper(II).  Although regioselectivities are outstanding for most of these ene 
processes, the use of solvent quantities of substrate and limited demonstration of scope detract from the high E/Z and 
linear/branched selectivities.   
An extremely powerful C-H to C-N bond transformation that has already seen strategic use in synthesis is 
the metal-catalyzed nitrene insertion reaction.31  State-of-the-art nitrene reactions generally involve the use of 
hypervalent iminoiodinanes, and transition metals such as iron, manganese, or ruthenium.  While iron and 
manganese systems have typically utilized porphyrin-type ligands to stabilize the metal center, carboxylate ligands 
on rhodium catalysts have been much more amenable to steric and electronic modification.  Rh-stabilized nitrenes 
react selectively with tertiary, benzylic, or allylic C-H bonds. Earlier classes of catalysts were fairly intolerant of 
double bonds, owing to high levels of competing aziridination (Figure 1.6, 1), although newer ligands and nitrogen 
sources have overcome many of these chemoselectivity issues (Figure 1.6, 2).32  No examples of this method that 
generate linear allylic amines exist, but branched allylic amines can in some cases be realized either by intra- or 
intermolecular systems, occasionally with levels of enantio-33 or diasteroselectivity.34    
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Figure 1.6.  Metal-catalyzed nitrene insertion reactions. 
 
 Cross-metathesis approaches to linear allylic amines deserve mention because they can generate the same 
linear allylic amine products from terminal olefins.35  Excess Boc-protected allylamine could be coupled with 
methyl but-3-enoate in 31% yield (>10:1 E/Z) using the Grubbs catalyst.36  Although this method proved to be 
superior to previous Wittig olefination routes used to access the same products, the low yield and use of excess 
nitrogen-containing partner were clear disadvantages.  Addition of 10% Lewis acidic alkyl or aryl boranes led to 
improvements in both the yield and coupling partner scope, with relatively high E/Z ratios for some olefin 
combinations.37 
A two-step, stoichiometric Pd(II) π-allyl process has been known for some time to produce allylic amine 
products, although it was never rendered catalytic. One inherent difficulty to solving this problem is the electronic 
demands on the palladium metal center for each individual step in the catalytic cycle.  For example, the C-H 
cleavage step requires a highly electrophilic Pd species that is stabilized by weakly coordinating ligands, such as 
sulfoxides or acetone.  Alternatively, the functionalization step requires a metal with donating, stabilizing ligands to 
promote functionalization (such as phosphines).  Although only one example of an oxidative palladium(II) 
amination reaction proceeding through a π-allyl intermediate had been previously reported by Larock,38 several 
pertinent Pd(0) systems demonstrated the possibility of functionalizing this intermediate.  Trost has demonstrated 
that a palladium allyl species generated from ring opening of vinyl epoxides in the presence of N-tosylisocyanate 
can form oxazolidinones in high yields and good diasteroselectivities.39   
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Based on these precedents, our group developed the first catalytic, stereoselective C-H allylic amination; 
good diastereoselectivities and yields of oxazolidinones were obtained for the reaction of homo-allylic N-
tosylcarbamates (a weak nitrogen nucleophile) containing a tethered olefin (Figure 1.7).40  Key features of this 
reaction were the use of [1,2-bis(phenylsulfinyl)ethane]Pd(OAc)2 1 to promote allylic C-H cleavage instead of 
aminopalladation, and renewable, catalytic amounts of acetate base brought in with the catalyst that promotes 
functionalization.  The use of N-tosylcarbamates as nucleophiles in oxidative palladium(II) systems has been shown 
to be general, being a suitable replacement for acetic acid in a PdCl2/O2 system developed by Kaneda.41 Although 
several systems use high-pressure oxygen as the oxidant, the lack of demonstrated substrate scope, olefin 
isomerization, and the requirement for excess substrate limit application of this method for synthesis.42  
 
1.2 RESULTS AND DISCUSSION 
 With the success of the intramolecular reaction established, the feasibility of extending this reactivity to an 
intermolecular manifold was explored.  Under the previous amination conditions, no product was detected by 
reacting allyl cyclohexane and a “free” N-tosylcarbamate (Table 1.1, entry 1), prompting the search for additives 
that would promote reactivity.  It had been previously shown that addition of Lewis acids could accelerate the rate of 
acetate functionalization from a palladium π-allyl dimer, prompting an examination of these additives.43   
Figure 1.7.  First catalytic, stereoselective allylic C—H amination reaction. 
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Table 1.1. Development of the intermolecular LAA reaction. 
aAverage of 2 runs at 0.3 mmol. b Determined by GC analysis of the crude reaction 
mixture (unless otherwise stated). c THF (0.66M). d TBME (0.66M). eOther metal 
complexes gave <2% GC yield: Ni(II)(TPP), Fe(III)(TPP)Cl, Ru(II)(TPP), 
Cu(II)(TPP), Co(II)(p-MeO-TPP) Fe(III)PthCl, Mn(III)PthCl, Si(IV)PthCl2 ( TPP = 
tetraphenylporphyrin, Pth = phthalocyanine).  fDetermined by 1H NMR analysis of 
the crude reaction mixture. Salen = N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediamine. 
Catalytic Cr(salen)Cl (6 mol %) was found to be the most effective Lewis acid promoter of allylic 
amination, generating the product with both excellent E/Z and linear/branched ratio (Table 1.1, entry 3).44  Tert-
butylmethyl ether was found to be a superior solvent to THF, further increasing the product yield (Table 1.1, entry 
7). The amount of Cr(salen)Cl was also optimized, giving the best results between 4-8 mol%; higher loadings led to 
higher conversions and lower product yields (Figure 1.8)  Next, the roles of both metals and their corresponding 
ligands were examined.  Independent exclusion of either 1 or Cr(salen)Cl led to no reactivity (Table 1.1, entries 2 & 
1, respectively), indicating that both metals were required to effect product formation.  Although the bis-sulfoxide 
ligand was not required for reactivity, diminished yields were observed (Table 1.1, entry 4); this contrasts with the 
salen ligand framework on Cr, as chromium(III) chloride was completely ineffective at forming product (Table 1.1, 
entry 5)  Several other Lewis acid catalysts were explored, all of which afforded lower product yields (Table 1.1, 
entries 6-10). Many other catalysts screened by GC produced no useful amount of allylic amination products. 45  The 
intramolecular amination system required a carbamate tether to the olefin; the intermolecular system could now 
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incorporate a variety of different carbamates that offer diverse protection group removal strategies.  An inquiry into 
the nucleophile scope revealed that along with methyl N-tosylcarbamate, other nucleophiles such as the  
Table 1.2.  Intermolecular Allylic C—H amination substrate 
scope. 
 
a Average of 2 runs at 0.3 mmol. Products were isolated as one regio- and olefin 
isomer (1H NMR).b mixture of 7:1 L:B and 17:1 E:Z (1H NMR). 
carboxybenzyl (Cbz, Table 1.1, entry 11) also furnished products in good yield. Other useful carbamates such as the 
Fmoc and tert-butoxycarbonyl nucleophiles may require additional optimization (Table 1.1, entries 12 & 13) .  
Figure 1.8. Kinetic profiles using various loadings of 2 to form allylic amination product 4 from allyl cyclohexane. 
  
Standard conditions were used, and values were determined by GC.  See experimental section for details. 
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The substrate scope is illustrated in Table 1.2.  Substrates possessing substitution in the homoallylic and 
bishomoallyic position underwent functionalization with excellent levels of stereo- and regioselectivity (Table 1.2, 
entries 1-7).  Product 6 maps onto a bovine plasma SSAO inhibitor.46  1,4 difunctionalized allylic amines are also 
useful products that can be accessed using this methodology (Figure 1.9).  The mildness of these weakly acidic 
conditions is demonstrated by tripeptide isostere47 15 which was isolated as a single diastereomer, indicating no 
epimerization of the stereocenter that is both allylic and adjacent to a carbonyl.    Oxygen and nitrogen functionality 
is also tolerated in this position, 
giving rise to products that resemble 
antibiotics.48  These products were 
isolated with the same high levels of 
enantiomeric enrichment found in 
their respective starting materials, 
indicating the configuration of the 
adjacent stereocenter is preserved.  
Both linear/branched and E/Z ratios 
remained >20:1 for these substrates. 
The ability to incorporate isotopically 
labeled nitrogen functionality onto 
organic frameworks has the potential to improve the study of biological processes.  However, installation of the 
label early on in a synthetic 
sequence both limits the 
diversity of compounds that can 
be accessed, and requires a large 
amount of label source to reach 
the labeled synthetic target at the end of the synthesis.  A late-stage linear allylic amination (LAA) approach could 
potentially overcome these challenges; an example of this process is shown in Figure 1.10.   
Figure 1.9.  Streamlined synthesis of chiral 1,4-difunctionalized allylic 
amines.a 
 
a Average of 2 runs at 0.3 mmol. Standard conditions were used (see Table 2). 
Figure 1.10. Orthogonal deprotection of 15N-labeled allylic carbamate. 
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 The direct installation of allylic nitrogen from a terminal olefin can be a very powerful way to increase the 
efficiency of a synthetic route.  To illustrate this point, an unsaturated analogue of the antibiotic deoxynegamycin 
was targeted for synthesis (Figure 1.11). 
The previous route to this target 
involved 11 total steps from a 
commercially available amino 
acid, most of which were either 
protection/deprotection or 
oxidation state changes.49  The 
result is a seven-step sequence to 
access the needed allylic azide, 
which is eventually reduced.  A 
direct C-H to C-N bond forming 
route also begins with a 
commercially available amino acid, except that the allylic nitrogen functionality is installed in only two steps.  Four 
additional steps, including coupling of the hydrazine fragment and global deprotection furnished the desired target in 
only six steps, with almost double the previous yield (22%).   
 We had hypothesized based on previous work with catalyst 1, that the first mechanism step involved an 
allylic C—H cleavage event to form a palladium π-allyl intermediate.  Preliminary studies had suggested the 
intermediacy of a palladium π-allyl intermediate; a trapping study led to the isolation of the well-characterized 
chloride dimer in 66% yield (Figure 1.12).  Although a π-allyl intermediate was formed in the presence of the 
nitrogen nucleophile, additional studies were needed to validate the intermediate’s competency for product 
formation.  An independently synthesized palladium π-allyl acetate dimer was subjected to reaction conditions 
mimicking that of the catalytic reaction (same molarity relative to palladium).  Although the yield was greatly 
depressed (25% vs 59% catalytic), the E/Z and linear/branched selectivities matched the catalytic reaction.  The 
remainder of the mass appeared to be acetate products, which are observed under the catalytic reaction as well.  
Repeating the functionalization experiment without Cr(salen)Cl or benzoquinone generated no amount of detectable 
product, indicating that that both of these components are necessary for functionalization.  Also in support of this 
Figure 1.11.  Streamlined synthesis of a deoxynegamycin analog. 
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Cr/BQ effect were studies indicating that 2,6-dimethylbenzoquinone gave very low yields of product, presumably 
due to its inability to bind one or 
both of the catalytic metals (due to 
steric hinderance).  One other 
mechanistic hypothesis was tested: 
the intermediacy of an initially 
formed allylic acetate product that 
is subsequently displaced with 
nitrogen. To test this hypothesis, 
independently synthesized 
branched allylic acetates gave only 
trace amination products with different selectivities  (Figure 1.13). Interestingly, a 1:1 mixture of branched and 
linear allylic acetates was observed, indicating acetate isomerization is rapid.  The experiments were also performed 
with the addition of a terminal olefin substrate, thereby generating potential reaction intermediates in the catalytic 
cycle.  Although acetate isomerization was decreased, no other significant changes were noted.   
1.3 CONCLUSION 
 The use of catalyst 1 and Cr(salen)Cl 2 has resulted in the development of the first general, intermolecular 
linear allylic C—H amination reaction.  The method operates on a wide variety of readily accessible terminal olefin 
Figure 1.12. Stoichiometric Studies To Evaluate the Role of (salen)CrCl 
2. 
 
adecene (1 equiv.), 1 (1 equiv.), MeOC(O)NHTs (2 equiv.), THF (0.66M), 45oC, 4h; NBu4Cl 
(4 equiv.), acetone (0.8M), 45oC, 1h. b 2 (0.6 equiv.), BQ (20 equiv.), MeOC(O)NHTs (20 
equiv.), TBME (0.066M /Pd), 45oC, 1h; 21 (1 equiv. Pd), 45oC, 1h. 
Figure 1.13. Investigating the competency of acetate intermediates under the reaction conditions.  
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starting materials, and generates synthetically useful yields of product.  The utility of this transformation was 
demonstrated by streamlining the synthesis of a deoxynegamycin analogue, and incorporating 15N into the reaction 
products.  Additionally, the use of Cr(salen)Cl as a catalytic additive has inspired the generation of a new 
intramolecular C—H amination reaction.50 
 
1.4 EXPERIMENTAL SECTION 
General Information. The following commercially obtained reagents for the allylic amination reaction were used 
as received: Pd(OAc)2 (Strem Chemicals and Johnson-Matthey Chemicals); (+)-(S,S)-Cr(salen)Cl (Strem 
Chemicals). Solvents tetrahydrofuran (THF) and methylene chloride (CH2Cl2) were purified prior to use by passage 
through a bed of activated alumina (Glass Contour, Laguna Beach, California). All allylic amination reactions were 
run under air with no precautions taken to exclude moisture. All other reactions were run over a stream of N2 gas 
unless otherwise stated.  All products were filtered through glass wool plug prior to obtaining a final weight.  
Achiral gas chromatographic (GC) analyses were performed on Agilent Technologies 6890N Series instrument 
equipped with FID detectors using a HP-5 (5%-Phenyl)-methylpolysiloxane column (30m, 0.32mm, 0.25mm). 
Chiral GC analysis was performed on an Agilent 5890 Series instrument equipped with FID detectors using a J&W 
cyclodex-b column (30 m, 0.25 mm, 0.25 mm). Chiral HPLC analysis was performed on an Agilent 1100 Series 
instrument (see individual compounds for conditons).  Thin-layer chromatography (TLC) was conducted with E. 
Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with UV, potassium permanganate, and ceric 
ammonium molybdate staining. Flash column chromatography was performed as described by Still et al.51 using EM 
reagent silica gel 60 (230-400 mesh). 1H NMR spectra were recorded on a Varian Unity-400 (400 MHz) or Varian 
Unity-500 (500 MHz) spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 7.26 
ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p = quintet, m = multiplet, b = broad, app = 
apparent; coupling constant(s) in Hz; integration.  Proton-decoupled 13C NMR spectra were recorded on a Varian 
Unity-400 (100 MHz) or Varian Unity-500 (125 MHz) spectrometer and are reported in ppm using solvent as an 
internal standard (CDCl3 at 77.0 ppm). 15N NMR were recorded on a Varian Unity 600 (61 Hz)  spectrometer and 
are reported in ppm relative to NH3(l) as an external standard.  IR spectra were recorded as thin films on NaCl plates 
on a Mattson Galaxy Series FTIR 5000 and are reported in frequency of absorption (cm-1). High-resolution mass 
spectra were obtained at the University of Illinois Mass Spectrometry Laboratory. Optical rotations were measured 
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using a 1 mL cell with a 1 dm path length on a Perkin-Elmer 341 polarimeter. Optical rotations were obtained with a 
sodium lamp and are reported as follows: [α]λT°C (c = g/100 mL, solvent). 
Nitrogen Nucleophile Synthesis. 
Methyltosyl carbamate: To a 500 mL round bottom flask was added methanol (200 mL) and a stir bar.  
The flask was placed in an ice bath, and p-toluenesulfonylisocyanate (20 mL, 0.131 mol, 1.0 equiv) 
was added dropwise, and the reaction allowed to warm to room temperature. After stirring 1 h, removal of the 
solvent in vacuo produced a colorless syrup that crystallized spontaneously into white plates.  Recrystallization from 
ether-pentane provided the pure product (25.8 g, 113 mmol, 86% yield).   
 1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 8.5 Hz, 2H), 7.86 (bs, 1H), 7.34 (d, J = 8.0 Hz, 2H), 3.69 (s, 
3H), 2.44 (s, 3H).  This procedure was adapted from Uehara, et. al.,52 and the data is in agreement with that reported 
previously. 
Benzyltosyl carbamate: To a 1 L round bottom flask was added benzyl alcohol (9.9 mL, 
95.0 mmol, 1.0 equiv), dichloromethane (200 mL), and a stir bar.  The mixture was cooled 
to 0°C with an ice bath, p-toluenesulfonylisocyanate (15.2 mL, 99.8 mmol, 1.05 equiv) 
was added dropwise, and the reaction stirred for 2 h at rt.  After removal of solvent under reduced pressure, the 
product was crystallized as white plates from 5:1 ether/CH2Cl2. 
 1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 8.5 Hz, 2H), 7.44 (bs, 1H), 7.34 (m, 3H), 7.30 (d, J = 8.0 Hz, 
2H), 7.25 (m, 2H), 5.09 (s, 3H), 2.44 (s, 3H).  This data is in agreement with that reported previously.53 
(9H-fluoren-9-yl)methyl tosylcarbamate: This compound was prepared in the same 
manner as benzyltosyl carbamate. 
 1H NMR (500 MHz, acetone-d6) δ 7.87 (d, J = 8.5 Hz, 2H), 7.84 (d, J = 7.5 
Hz, 2H), 7.63 (d, J = 7.5 Hz, 2H), 7.42 (d, J = 8.0 Hz, 2H), 7.39 (t, J = 7.5 Hz, 2H), 7.26 
(t, J = 7.5 Hz, 2H), 4.37 (d, J = 7.5 Hz, 2H), 4.19 (t, J = 6.5 Hz, 1H), 2.43 (s, 3H). This data is in agreement with 
that reported previously.54 
15N Methyltosyl carbamate:55 Ammonium chloride (1.00 g, 18.7 mmol, 1.0 equiv, Cambridge 
Isotope Labs, 99.7% 15N) was added to a 250 mL round bottom flask, followed by p-
toluenesulfonyl chloride (7.130 g, 37.4 mmol, 2.0 equiv), water (110 mL), and a stir bar.  The heterogeneous 
mixture was gently heated to ~50°C, and KHCO3 (1.33 g, 112.2 mmol, 6.0 equiv) was added.  The reaction was 
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heated to reflux for 8 hr, and became homogenous.  Upon cooling, white crystals began forming, and the reaction 
mixture was cooled further in an ice bath.  The slurry was filtered on a fritted glass funnel to collect the product, 
washed with ice cold water (2 x 3 mL), and air-dried for 2 h.  The filtrate was partially evaporated, and filtered again 
to obtain a second crop.  Further drying overnight with P2O5 afforded the sulfonamide as a crystalline solid (1.83 g, 
10.7 mmol, 57% yield).   
 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.5 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 4.80 (bd, JN-H = 80.0 Hz, 
2H), 2.43 (s, 3H). 15N NMR (60.8 MHz, THF-d8) δ 90.1. 
 A 25 mL round bottom flask was charged with 15N labeled p-toluenesulfonamide (648 mg, 3.8 mmol, 1.0 
equiv), a stir bar, acetonitrile (4 mL), and Et3N (1.39 mL, 10.0 mmol, 2.6 equiv).  With stirring, methyl 
chloroformate (0.443 mL, 6.0 mmol, 1.6 equiv) was added dropwise, and the resulting solution stirred at 25°C for 8 
hr. The solvent was removed at reduced pressure, and the residue dissolved in 30 mL EtOAc, diluted with 30 mL 
NaHCO3, and the layers separated.  The aqueous fraction was poured onto a beaker of ice, and conc. HCl was added 
dropwise until the pH reached < 2 (pH paper).  This solution was filtered to collect the product, washed with ice 
cold water (2 x 1 mL), and the filtrate concentrated to obtain a second crop.  The crude crystals were recrystallized 
from boiling water, and dried over P2O5 for 3 days at 1.0 torr to yield white needles (183.5 mg, 0.77 mmol, 26% 
yield).  The 1H NMR spectrum matched that for the unlabeled compound. 
Independent Synthesis of Allylic Amination Standards. 
Methyl 1-cylochexylallyl(tosyl)carbamate & (E)-Methyl 3-cyclohexylallyl(tosyl)carbamate: 
Cyclohexanecarboxaldehyde (336.5 mg, 3.0 mmol, 1.0 equiv) in dry ether (10 mL) was cannulated into a 100 mL, 
flame-dried round bottom flask containing a stirring solution of vinylmagnesiumbromide (1.0M in THF) and 30 mL 
ether at -78°C.  After 2 hr at this temperature, saturated aqueous NH4Cl (10 mL) was added, and the solution was 
allowed to warm to room temperature.  The mixture was washed with ether (3x50 mL) & brine (50 mL), the organic 
layers combined and dried with MgSO4, filtered through celite, and concentrated by rotatory evaporation.  The light 
yellow liquid was used without further purification.  
 1H NMR (500 MHz, CDCl3) δ 5.86 (ddd, J = 17.2, 10.6, 6.8 Hz, 1H), 5.20 (app dt, J = 17.2, 6.8 Hz, 1H), 
5.14 (d, J = 10.4, 6.8 Hz, 1H), 3.85 (app t, J = 6.4 Hz, 1H), 1.87-1.6 (m, 6H), 1.3-0.9 (m, 5H).  This data is in 
agreement with the literature.56 
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 The yellow liquid above (420.7 mg, 3.0 mmol, 1.0 equiv) was subjected to the same Mitsunobu conditions 
as the Z isomer.  Both linear (E) and branched product (~1:1 ratio) were obtained as a colorless oil (627.2 mg, 1.8 
mmol, 60% for 2 steps) 1H NMR (500 MHz, CDCl3, branched) δ 7.79 (d, J = 8.5 Hz, 2H), 7.28 (d, J = 8.0 Hz, 
2H), 6.14 (dt, J = 17.5, 9.5 Hz, 1H), 5.30 (d, J = 17.5 Hz, 1H), 5.25 (dd, J = 10.0, 2.0 Hz, 1H), 4.58 (t, J = 10.5 Hz, 
1H), 3.64 (s, 3H), 2.42 (s, 3H), 1.65-1.8 (m, 6H), 1.02-1.28 (m, 5H); 1H NMR (500 MHz, CDCl3, linear E) 7.83 (d, J 
= 7.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H) 5.74 (dt, J = 15.5, 6.5 Hz, 1H), 5.46 (dtd, J = 15.5, 6.5, 1.0 Hz, 1H), 4.40 (d, 
J = 6.5 Hz, 2H), 3.68 (s, 3H), 2.43 (s, 3H), 1.97 (m, 1H), 1.65-1.82 (m, 5H), 0.85-1.28 (m, 5H); HRMS (CI, CH4) 
m/z calc’d for C18H26NO4S [M+H]+: 352.1583, found 352.1583. 
 (Z)-Methyl 3-cyclohexylallyl(tosyl)carbamate: This procedure was adapted from 
Denis, et. al.57  To a flame-dried 50 mL round bottom flask (under argon) containing a 
stir bar was added 5 mL dry THF and cyclohexylacetylene (500 mg, 4.62 mmol, 1.0 
equiv).  The solvent was cooled to -78°C, n-BuLi (9 mL, 1M in hexanes) was added dropwise, and the solution 
stirred 2 h at -78°C.  After warming to 0°C with an ice bath, paraformaldehyde prills (552 mg, 18.4 mmol, 4.0 
equiv) were added while the reaction was under a N2 funnel.  After stirring 5 min at 0°C, the solution was stirred an 
additional 2.5 h at room temperature, quenched with sat. NH4Cl (5 mL), extracted twice with Et2O (20 mL), the 
combined organic layers dried with MgSO4, filtered on celite, and evaporated at 30°C, 20 torr.  The crude product 
was then subjected to flash chromatography (25% EtOAc/hexanes, 50x170 mm SiO2) to give a light yellow liquid 
(380.9 mg, 2.8 mmol, 60% yield).   
 This procedure was adopted from Midland, et. al.58  The alcohol prepared above (380.9 mg, 2.8 mmol, 1.0 
equiv) was added to a 25 mL round bottom flask with stir bar.  Pentane (5 mL), 2,6-lutidine (0.05 mL), and Lindlar 
catalyst (10 mg) were added.  The flask was purged twice with H2, fitted with a H2 balloon, and allowed to stir until 
GC indicated >99% conversion of the starting alkyne.  The solution was filtered through celite, and evaporated to 
dryness, affording the crude alcohol (393 mg, 2.8 mmol, >99% yield).  
 1H NMR (500 MHz, CDCl3) δ 5.49 (dt, J = 10.8 Hz, 7.0 Hz, 1H), 5.39 (app t, J = 9.5 Hz, 1H), 4.20 (d, J = 
6.5 Hz, 2H), 2.66 (bm, 1H), 2.29 (m, 1H), 1.58-1.77 (m, 5H), 1.39-1.06 (m, 5H).  This data is in agreement with the 
literature.59 
 The crude alcohol was transferred to a 100 mL round bottom flask with stir bar.  The flask was placed 
under N2, charged with THF (30 mL), Ph3P (944 mg, 3.6 mmol, 1.3 equiv) and methyl N-tosylcarbamate (825 mg, 
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3.6 mmol, 1.3 equiv).  Diisopropylazodicarboxylate (0.71 mL, 3.6 mmol, 1.3 equiv) was added dropwise, and the 
solution stirred for 9 h at room temperature.  After flash chromatography (12% EtOAc/hexanes, 50x170 mm SiO2) 
and evaporation of solvent, a colorless oil 3 was obtained (756.6 mg, 2.2 mmol, 77% yield).  GC analysis indicated 
the Z/E ratio was 28:1. 
 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.5 Hz, 2H), 5.43 (dt, J = 10.0, 1 Hz, 
1H), 5.33 (dtd, J = 11.0, 6.5, 0.5 Hz, 1H), 4.53 (d, J = 6.5, 1.5 Hz, 2H), 3.68 (s, 3H), 2.46 (m, 1H), 2.43 (s, 3H), 1.70 
(m, 5H), 1.08-1.34 (m, 5H); 13C NMR: (125 MHz, CDCl3) δ 152.7, 144.4, 139.9, 136.5, 129.3, 128.4, 122.3, 53.7, 
44.2, 36.4, 33.0, 25.9, 25.7, 21.6; IR (film, cm-1): 3012, 2930, 2852, 1736, 1598, 1495, 1447, 1362, 1269, 1167, 
1090, 909; HRMS (CI, CH4) m/z calc’d for C18H26NO4S [M+H]+: 352.15825, found 352.15831. 
Lewis Acid Screening 
General GC screening procedure (entries 1-9). To a ½ dram vial was sequentially added Pd(bis-sulfoxide)(OAc)2 
(5.0 mg, 0.01 mmol, 0.1 equiv), benzoquinone (21.6 mg, 0.2 mmol, 2.0 equiv), methyltosyl carbamate (45.9 mg, 0.2 
mmol, 2.0 equiv), lewis acid (0.006 mmol, 0.06 equiv), and a stir bar.  To a separate ½ dram vial was added allyl 
cyclohexane (12.4 mg, 0.016 mL, 0.10 mmol, 1.0 equiv), and nitrobenzene (4.11 µL, 0.04 mmol, 0.4 equiv, via 
autopipet).  Solvent (152 µL, via syringe) was added, 
the vial capped, mixed with a vortex stirrer, sampled 
to establish an initial ratio of starting material to 
PhNO2, and transferred to the vial containing solid 
reagents.  No effort was made to exclude moisture or 
air.  The mixed vial was then fitted with a PTFE cap 
and placed in an oil bath at 45°C for 72 hr.  Every 24 
hr, the vial was removed from the oil bath, allowed to 
cool (~5 min), and sampled by removing 10-20 µL 
with a Pasteur pipet.  This sample was then passed 
through a silica plug with ether into a GC vial for 
further analysis. 
Determination of response factor.  An 
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approximately equimolar mixture of allylcyclohexane and pure linear(E) N-tosylcarbamate product was found by 1H 
NMR (CDCl3, 20 s pulse delay) to contain a 0.9078:1 ratio of alkene to amination product (olefin peaks integrated).  
The average ratio of the two compounds was 0.39113 by GC analysis, giving a response factor of 0.431.   
 
 Entry 1: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (5.0 mg, 0.01 mmol, 0.1 equiv), benzoquinone (21.6 mg, 0.2 
mmol, 2.0 equiv), (+)-(S,S)-Cr(salen)Cl (3.8 mg, 0.006 mmol, 0.06 equiv), and methyltosyl carbamate (45.9 mg, 0.2 
mmol, 2.0 equiv) were used. TBME (0.150 mL) was used as solvent.   
Entry 2: Conditions were the same as entry 1, except that Fe(phthalocyanine)Cl (3.6 mg, 0.006 mmol, 0.06 equiv) 
was used. 
Entry 3: Conditions were the same as entry 1, except that Si(phthalocyanine)Cl2 (3.7 mg, 0.006 mmol, 0.06 equiv) 
was used. 
Entry 4: Conditions were the same as entry 1, except that Mn(phthalocyanine)Cl (3.6 mg, 0.006 mmol, 0.06 equiv) 
was used. 
Entry 5: Conditions were the same as entry 1, except that Ni(TPP) (4.0 mg, 0.006 mmol, 0.06 equiv) was used. 
Entry 6: Conditions were the same as entry 1, except that Fe(TPP)Cl (4.2 mg, 0.006 mmol, 0.06 equiv) was used. 
Entry 7: Conditions were the same as entry 1, except that Ru(TPP) (4.3 mg, 0.006 mmol, 0.06 equiv) was used. 
Entry 8: Conditions were the same as entry 1, except that Co(p-MeO-TPP) (4.8 mg, 0.006 mmol, 0.06 equiv) was 
used. 
Entry 9: Conditions were the same as entry 1, except that Cu(TPP) (4.1 mg, 0.006 mmol, 0.06 equiv) was used. 
Optimization of the Allylic Amination Reaction 
General optimization procedure (Table 1.1 entries 1-6).  A one dram borosilicate vial was charged with 38.9 mg 
(96%, 0.3 mmol, 1.0 equiv) of allyl cyclohexane, and the sides of the vial were washed with 0.45 mL solvent via 
syringe. Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.1 equiv, all entries except 2 and 4), (+)-
(S,S)-Cr(salen)Cl (11.4 mg, 0.018 mmol, 0.06 equiv, entries 2-4), benzoquinone (64.8 mg, 0.6 mmol, 2.0 equiv), and 
methyltosyl carbamate (137.4 mg, 0.6 mmol, 2.0 equiv, entries 1-6), and a stir bar were sequentially added, taking 
care to avoid spilling on the vial sides.   
 The vial was capped, suspended in an oil bath at 45°C for 72 h, sampled for GC analysis, and then 
transferred to a 125 mL separatory funnel with diethyl ether (25 mL).  The ether layer was washed 6-7 times with a 
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5% aqueous solution of K2CO3 (8 mL each) until the aqueous layer became a sherry color, and the combined 
aqueous fractions back-extracted with ether (2x80 mL).  Organic layers were then combined, dried over MgSO4, 
filtered through a 1:1 mixture of silica gel/Celite to remove Cr(III), and evaporated at 35°C (~25 torr) to give a dark 
brown oil.  A small aliquot of this mixture was added to an NMR tube, and diluted with CDCl3.  After analysis, the 
sample was returned to the crude mixture, and the solvent removed.  Flash chromatography (SiO2, 10 x 160 mm, 7% 
EtOAc/hexanes, load with 0.5 mL CH2Cl2) resulted in the isolation of an orange-yellow oil containing the allylic 
amination product.   
Table 1.1, Entry 1: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.1 equiv), benzoquinone (64.8 
mg, 0.6 mmol, 2.0 equiv), and methyltosyl carbamate (137.4 mg, 0.6 mmol, 2.0 equiv) were used.  THF (0.45 mL) 
was used as solvent.  Run 1: (<1% yield; run 2: <1% yield). Average: 0% yield 
Table 1.1, Entry 2: (+)-(S,S)-Cr(salen)Cl (11.4 mg, 0.018 mmol, 0.06 equiv), benzoquinone (64.8 mg, 0.6 mmol, 
2.0 equiv), and methyltosyl carbamate (137.4 mg, 0.6 mmol, 2.0 equiv) were used. THF (0.45 mL) was used as 
solvent.  Run 1: (<1% yield); run 2: (<1% yield). Average: 0% yield 
Table 1.1, Entry 3: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.1 equiv), (+)-(S,S)-
Cr(salen)Cl (11.4 mg, 0.018 mmol, 0.06 equiv), benzoquinone (64.8 mg, 0.6 mmol, 2.0 equiv), and methyltosyl 
carbamate (137.4 mg, 0.6 mmol, 2.0 equiv) were used. THF (0.45 mL) was used as solvent.  Run 1: (39% yield 
[>100:1 L/B, 64:1 E/Z]); run 2: (46% yield [>100:1 L/B, 65:1 E/Z]).  Average: 43%, >100:1 L/B, 65:1 E/Z 
Table 1.1, Entry 4: Pd](OAc)2 (6.7 mg, 0.03 mmol, 0.1 equiv), benzoquinone (64.8 mg, 0.6 mmol, 2.0 equiv), and 
methyltosyl carbamate (137.4 mg, 0.6 mmol, 2.0 equiv) were used. THF (0.45 mL) was used as solvent.  Run 1: 
(17.9 mg, 0.05 mmol, 17% yield [>100:1 L/B, 69:1 E/Z]); run 2: (17.9 mg, 0.05 mmol, 17% yield [>100:1 L/B, 
>100:1 E/Z]).  Average: 17% yield, >100:1 L/B, >100:1 E/Z 
Table 1.1, Entry 5: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.1 equiv), CrCl3•3THF (6.7 
mg, 0.018 mmol, 0.06 equiv), benzoquinone (64.8 mg, 0.6 mmol, 2.0 equiv), and methyltosyl carbamate (137.4 mg, 
0.6 mmol, 2.0 equiv) were used. THF (0.45 mL) was used as solvent.  Run 1: (<1% yield); run 2: (<1% yield).  
Average: 0% yield 
Table 1.1, Entry 6: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.1 equiv), benzoquinone (64.8 
mg, 0.6 mmol, 2.0 equiv), Cr(TPP)Cl (12.4 mg, 0.018 mmol, 0.06 equiv), and methyltosyl carbamate (137.4 mg, 0.6 
mmol, 2.0 equiv) were used. THF (0.45 mL) was used as solvent.  Run 1: (25.3 mg, 0.07 mmol, 24% yield [>100:1 
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L/B, 69:1 E/Z]); run 2: (29.5 mg, 0.08 mmol, 27% yield [>100:1 L/B, 73:1 E/Z]).  Average: 25% yield, >100:1 
L/B, 71:1 E/Z 
Table 1.1, Entry 7: See below. 
Table 1.1, Entry 8: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.1 equiv), (+)-(S,S)-
Al(salen)Cl (10.9 mg, 0.018 mmol, 0.06 equiv), benzoquinone (64.8 mg, 0.6 mmol, 2.0 equiv), and methyltosyl 
carbamate (137.4 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure (see below).  TBME (0.45 
mL) was used as solvent.  Run 1: (22.3 mg, 0.063 mmol, 21% yield [>100:1 L/B, 80:1 E/Z]); run 2: (20.6 mg, 0.059 
mmol, 20% yield [>100:1 L/B, 72:1 E/Z]).  Average: 21%, >100:1 L/B, 76:1 E/Z. 
Table 1.1, Entry 9: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.1 equiv), (+)-(S,S)-
Co(salen)OAc (15.2 mg, 0.018 mmol, 0.06 equiv), benzoquinone (64.8 mg, 0.6 mmol, 2.0 equiv), and methyltosyl 
carbamate (137.4 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure (see below).  TBME (0.45 
mL) was used as solvent.  Run 1: (17.5 mg, 0.050 mmol, 17% yield [>100:1 L/B, 93:1 E/Z]); run 2: (18.1 mg, 0.51 
mmol, 17% yield [>100:1 L/B, 88:1 E/Z]).  Average: 17%, >100:1 L/B, 91:1 E/Z. 
Table 1.1, Entry 10: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.1 equiv), (+)-(R,R)-
Mn(salen)Cl (11.4 mg, 0.018 mmol, 0.06 equiv), benzoquinone (64.8 mg, 0.6 mmol, 2.0 equiv), and methyltosyl 
carbamate (137.4 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure (see below).  TBME (0.45 
mL) was used as solvent.  Run 1: (43.8 mg, 0.12 mmol, 42% yield[>100:1 L/B, 80:1 E/Z]); run 2: (49.0 mg, 0.14 
mmol, 46% yield [>100:1 L/B, 75:1 E/Z]).  Average: 44%, >100:1 L/B, 78:1 E/Z. 
 (E)-Methyl 3-cyclohexylallyl(tosyl)carbamate [4a]:  1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.4 Hz, 
2H), 7.28 (d, J = 8.0 Hz, 2H), 5.57 (dd, J = 15.2, 6.4 Hz, 1H), 5.45 (ddd, J = 15.2, 6.4, 1.2 Hz, 1H), 4.41 (d, 6.0 Hz, 
2H), 3.68 (s, 3H), 2.43 (s, 3H), 1.98 (m, 1H), 1.58-1.74 (m, 5H), 1.02-1.31 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 
152.7, 144.4, 141.7, 136.5, 129.2, 128.6, 121.7, 53.7, 48.8, 40.3, 32.5, 26.1, 25.9, 21.6; IR (film, cm-1): 2924, 2851, 
1737, 1597, 1446, 1360, 1277, 1238, 1170, 1089, 972; HRMS (CI, CH4) m/z calc’d for C18H26NO4S [M+H]+: 
352.15825, found 352.15859.  Note that this data was in full agreement with the independently synthesized linear 
(E) product. 
(E)-benzyl 3-cyclohexylallyl(tosyl)carbamate [4b]: Allyl cyclohexane (38.8 mg, 96% 
pure, 0.3 mmol, 1.0 equiv) and benzyl tosylcarbamate (183.2 mg, 0.6 mmol, 2.0 equiv) 
were reacted following the general procedure.  Purification by flash chromatography (5% EtOAc/hexanes) produced 
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a light orange oil that crystallized at 5°C overnight.  Run 1 (80.5 mg, 0.19 mmol, 63% yield); run 2 (84.2 mg 0.20 
mmol, 66% yield). The E/Z isomer ratio was >20:1 by 1H NMR integration of allylic protons for both experiments, 
and the branched isomer was not observed. Average yield: 65%. 
 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 8.0 Hz, 2H), 7.31 (m, 3H), 7.20 (m, 4H), 5.72 (dd, J = 6.5 Hz, 
1H), 5.47 (dtd J = 15.5, 6.5, 1.5 Hz, 1H), 5.08 (s, 2H), 4.43 (d, J = 6.5, 2H), 2.40 (s, 3H), 1.96 (m, 1H), 1.68 (m, 
5H), 1.24 (m, 2H), 1.16 (m, 1H), 1.06 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 152.1, 144.3, 141.6, 136.4, 134.6, 
129.1, 128.5 (2 peaks), 128.3, 121.7, 68.8, 48.7, 40.2, 32.5, 26.1, 25.9, 21.6; IR (film, cm-1): 3067, 3034, 2923, 
2851, 1731, 1597, 1448, 1359, 1263, 1170, 972; HRMS (ESI) m/z calc’d for C24H30NO4S [M+H]+: 428.1896, found 
428.1907. 
(E)-tert-butyl 3-cyclohexylallyl(tosyl)carbamate [4c]: Allyl cyclohexane (38.8 mg, 
96% pure, 0.3 mmol, 1.0 equiv) and commercially available BocNHTs (162.8 mg, 0.6 
mmol, 2.0 equiv) were reacted according to the general procedure, and the workup was performed with ether.  Flash 
chromatography (gradient 1->3->5% EtOAc/hexanes) isolated a colorless oil.  Run 1 (52.3 mg, 0.13 mmol, 44% 
yield); run 2 (45.3 mg, 0.12 mmol, 38% yield); run 3 (45.9 mg, 0.12 mmol, 39% yield).  The linear/branched and 
E/Z ratio exceeded 20:1 by 1H NMR in all three experiments.  Average yield: 40%. 
1HNMR (500 MHz, CDCl3) δ   7.85 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 8.0, 2H), 5.70 (dd, J = 15.2, 6.4 Hz, 1H), 5.49 
(dtd, J = 15.6, 6.4, 1.2 Hz, 1H), 4.37 (d, J = 6.4 Hz, 2H), 2.43 (s, 3H), 1.98 (m, 1H), 1.67 (m, 5H), 1.33 (s, 9H), 
1.32-1.03 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 150.7, 143.9, 141.2, 137.3, 129.1, 128.1, 122.1, 83.9, 48.4, 40.4, 
32.6, 27.9, 26.1, 25.9, 21.6; IR (film, cm-1): 3042, 2979, 2927, 2849, 1737, 1598, 1495, 1450, 1367, 1284, 1256, 
1162, 1090, 1045, 1020, 971, 912, 852, 814, 770, 723, 672; HRMS (ESI) m/z calc’d for C21H32NO4S [M+H]+: 
394.2052, found 394.2058. 
(E)-(9H-fluoren-9-yl)methyl 3-cyclohexylallyl(tosyl)carbamate [4d]: 
Allyl cyclohexane (38.8 mg, 96% pure, 0.3 mmol, 1.0 equiv) and 
FmocNHTs (236 mg, 0.6 mmol, 2.0 equiv) were reacted according to the 
general procedure, and the workup was performed with ether.  Flash chromatography (gradient 5->15% 
EtOAc/hexanes) isolated a light yellow oil which produced white needles after crystallization from ether/pentane.  
Run 1 (67.9 mg, 0.13 mmol, 39% yield); run 2 (63.8 mg, 0.12 mmol, 41% yield).  The linear (Z) and branched 
products were not observed by 1H NMR.  Average yield: 40%. 
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 1H NMR (400 MHz, CDCl3) δ  7.79 (d, J = 8.0 Hz, 2H), 7.75 (d, J = 7.6 Hz, 2H), 7.49 (d, J = 7.6 Hz, 2H), 
7.40 (t, J = 7.2 Hz, 2H), 7.28 (td, J = 7.2, 1.2 Hz, 2H), 7.26 (d, J = 8.4 Hz, 2H), 5.64 (dd, J = 15.6, 6.8 Hz, 1H), 5.31 
(dtd, J = 15.2, 6.8, 1.2 Hz, 1H), 4.44 (d, J = 6.0 Hz, 2H), 4.32 (d, J = 6.4 Hz, 2H), 4.15 (t, J = 6.4 Hz, 1H), 2.42 (s, 
3H), 1.92 (m, 1H), 1.73 (m, 5H), 1.31-1.01 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 152.2, 144.5, 143.2, 141.6, 
141.3, 136.4, 129.3, 128.5, 127.9, 127.2, 124.8, 121.6, 120.0, 68.7, 48.8, 46.7, 40.3, 32.5, 26.1, 26.0, 21.6; IR (film, 
cm-1): 3054, 2929, 2851, 1958, 1898, 1736, 1597, 1450, 1389, 1357, 1317, 1273, 1273, 1235, 1187, 1171, 1132, 
1089, 971, 814, 741; HRMS (ESI) m/z calc’d for C31H34NO4S [M+H]+: 516.2209, found 516.2207. 
Methyl cinnamyl(tosyl)carbamate [5]: Allylbenzene (35.5 mg, 0.3 mmol, 1.0 equiv) 
was reacted following the general procedure, and the workup was performed with 
ether.  Flash chromatography (gradient 5  10% EtOAc/hexanes) yielded a light yellow oil.  Run 1 (57.8 mg, 0.17 
mmol, 56% yield); run 2 (61.5 mg, 0.17 mmol, 59% yield).  No branched product was observed, and the E/Z isomer 
ratio was >20:1 by 1H NMR.  Average yield: 58%. 
 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8.5 Hz, 2H), 7.37 (d, J = 9.0 Hz, 2H), 7.34 (t, J = 7.5 Hz, 2H), 
7.26 (m, 3H), 6.67 (d, J = 16.0 Hz, 1H), 6.24 (dt, J = 16.0, 6.5 Hz, 1H), 4.62 (d, J = 6.5, 2H), 3.72 (s, 3H), 2.4 (s, 
3H); 13C NMR (125 MHz, CDCl3) 152.7, 144.6, 136.4, 136.2, 134.1, 129.3, 128.6, 128.5, 128.0, 126.6, 123.7, 53.9, 
48.8, 21.6; IR (film, cm-1): 3035, 2957, 1738, 1597, 1444, 1359, 1170; HRMS (ESI) m/z calc’d for C18H19NO4S 
[M+H]+: 346.1113, found 346.1125. 
(E)-methyl 3-(benzo[d][1,3]dioxol-5-yl)allyl(tosyl)carbamate [6]: Safrole (48.7 
mg, 0.30 mmol, 1.0 equiv) was reacted following the general procedure.   
Purification by flash chromatography (gradient 25->50% EtOAc/hexanes) provided a pale yellow oil that 
crystallized on standing overnight.  Run 1 (81.9 mg, 0.21 mmol,  70% yield); run 2 (84.5 mg, 0.22 mmol, 73% 
yield).  The branched and Z olefin isomers were not observed by 1H NMR for both experiments.  Average yield: 
72%. 
 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.5 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 6.91 (d, J = 1.5 Hz, 1H), 
6.82 (dd, J = 8.0, 1.5 Hz, 1H), 6.76 (d, J = 8.0 Hz, 1H), 6.59 (d, J = 16.0 Hz, 1H), 6.06 (dt, J = 15.5, 6.5 Hz, 1H), 
5.97 (s, 2H), 4.59 (dd, J = 6.5, 1.5 Hz, 2H), 3.71 (s, 3H), 2.42 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 152.7, 148.0, 
147.5, 144.6, 136.4, 133.8, 130.7, 129.3, 128.5, 121.9, 121.5, 108.3, 105.7, 101.1, 53.9, 48.8, 21.6; IR (film, cm-1): 
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2956, 1737, 1597, 1491, 1446, 1358, 1252, 1252, 1169, 1039; HRMS (ESI) m/z calc’d for C19H19NO6NaS [M+Na]+: 
412.0831, found 412.0836. 
Methyl dec-2-enyl(tosyl)carbamate [7]: n-Dec-1-ene (42.1 mg, 0.3 mmol, 1.0 
equiv) was reacted as described in the general procedure, and worked up with ether.  
Flash chromatography (5% EtOAc/hexanes) led to a brown-orange oil.  Run 1 (62.0 mg, 0.16 mmol, 56% yield, 
mixture of 6.5:1 L/B, 16:1 E/Z); run 2 (67.8 mg, 0.18 mmol, 61% yield, mixture of 7:1 L/B, 18:1 E/Z).  Average 
yield: 59%, 7:1 L/B, 17:1 E/Z. 
 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 6.5 Hz, 2H), 7.39 (d, J = 8.5 Hz, 2H), 5.78 (dd, J = 15.0, 7.0 Hz, 
1H), 5.51 (ddd, J = 15.5, 6.5, 1.5 Hz, 1H), 4.40 (dd, J = 6.5, 0.5 Hz, 2H), 3.69 (s, 3H), 2.43 (s, 3H), 2.04 (q, J = 6.5 
Hz, 2H), 1.37 (m, 10H), 0.88 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 152.7, 144.4, 136.6, 136.0, 129.2, 
128.5, 124.2, 53.7, 48.7, 32.2, 31.8, 29.1 (2 peaks), 29.0, 22.6, 21.6, 14.1; IR (film, cm-1): 2956, 2929, 2856, 1737, 
1443, 1361, 1267, 1171; HRMS (ESI) m/z calc’d for C19H30NO4S [M+H]+: 368.1904, found 368.1896. 
Diagnostic peaks for the branched isomer: 1H NMR (500 MHz, CDCl3) δ 6.09 (ddd, J = 17.5, 10.5, 7.5 Hz, 1H), 
5.26 (dt, J = 18.5, 1.5 Hz, 1H), 5.19 (dt, J = 10.0, 1.0 Hz, 1H), 4.96 (q, J = 7.5 Hz, 1H); Z isomer: δ 4.51 (d, J = 7.0 
Hz, 2H). 
 (R)-tert-butyl(2-methylhex-5-enyloxy)diphenylsilane [(-)-8a]: (R)-(+)-2-Methyl-5-
hexene-1-ol60 (342 mg of a 36% solution in ether, 1.0 mmol, 1.0 equiv, [α]D26 = +11.7°, 
c = 3.03, CHCl3) was added to a flame-dried 25 mL round bottom flask containing a stir bar, and then diluted with 
dichloromethane (7 mL).  The reaction mixture was cooled to 0°C with an ice bath.  Imidazole (204.0 mg, 3.0 mmol, 
3.0 equiv), DMAP (11.2 mg, 0.1 mmol, 0.1 equiv), and TBDPSCl (0.267 mL, 1.05 mmol, 1.05 equiv) were 
sequentially added with stirring.  After 4 hr at 25°C, 4Å MS beads and an additional equivalent of TBDPSCl was 
added.  The reaction was quenched with saturated potassium carbonate (3 mL), diluted with dichloromethane (30 
mL), and the layers separated.  The aqueous layer was washed with dicholormethane (3x20 mL), the organic layers 
combined, dried over MgSO4, filtered through celite, and evaporated.  Flash chromatography (1% EtOAc/pentane) 
supplied a colorless oil (369.9 mg, 1.05 mmol, >99% yield).  
 1H NMR (500 MHz, CDCl3) δ 7.66 (d, J = 6.5 Hz, 4H), 7.36-7.44 (m, 6H), 5.79 (ddt, J = 17.0, 13.5, 6.5 
Hz, 1H), 4.98 (app d, J = 17.0 Hz, 1H), 4.92 (app d, 12.5 Hz, 1H), 3.51 (dd, J = 9.5, 7.0 Hz, 1H), 3.45 (dd, J = 10.0, 
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6.5 Hz, 1H), 1.99-2.11 (m, 2H), 1.68 (m, J = 6.0 Hz, 1H), 1.54 (m, 1H), 1.20 (m, 1H), 0.92 (d, J = 6.5 Hz, 3H). This 
data is in agreement with that reported previously.61 
(R,E)-methyl6-(tert-butyldiphenylsilyloxy)-5-methylhex-2-enyl (tosyl) 
carbamate [(+)-8: The starting material (-)-8a, (105.8 mg, 0.3 mmol, 1.0 
equiv) was reacted following the standard procedure, using Et2O for the workup. Flash chromatography (7.5% 
EtOAc/hexanes) yielded a faint yellow oil.  Run 1 (100.1 mg, 0.17 mmol, 58% yield); run 2 (95.6 mg, 0.16 mmol, 
55% yield).  The branched isomer was not observed, and E/Z isomer ratio was >20:1 by 1H NMR for both 
experiments.  Average yield: 57%. 
 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.5 Hz, 2H), 7.66 (dd, J = 6.0, 1.5 Hz, 4H), 7.36-7.44 (m, 6H), 
7.31 (d, J = 8.0 Hz, 2H), 5.73 (dt, J = 15.5, 7.5 Hz, 1H), 5.53 (dt, J = 15.5, 6.5 Hz, 1H), 4.39 (d, J = 6.5 Hz, 2H), 
3.66 (s, 3H), 3.48 (d, J = 6.5 Hz, 2H), 2.41 (s, 3H), 2.28 (dt, J = 12.5, 5.0 Hz, 1H), 1.89 (app dt, J = 14.0, 7.5 Hz, 
1H), 1.76 (m, 1H), 1.06 (s, 9H), 0.89 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 152.7, 144.4, 136.5, 135.5, 
134.0, 133.8 (2 peaks), 129.5, 129.2, 128.4, 127.6, 125.7, 68.2, 53.7, 48.6, 35.9, 35.8, 26.8, 21.6, 19.3, 16.3; IR 
(film, cm-1): 3072, 2877, 1738, 1597, 1443, 1361, 1169, 1106; HRMS (ESI) m/z calc’d for C32H42NO5SSi [M+H]+: 
580.2553, found 580.2533; [α]D26 = +2.3° (c = 1.0, CHCl3). 
(S)-2-(1-(4-methoxybenzyloxy)hex-5-en-2-yl)isoindoline-1,3-dione [(+)-9a]: Cu(I)Br 
(59 mg, 0.41 mmol, 0.1 equiv) and a stir bar were added to a flame-dried 25 mL round 
bottom flask under nitrogen.  THF (6.8 mL) was added, and the flask was cooled to -40°C in the dark.  Allyl 
magnesium bromide in THF (12.3 mL, 12.3 mmol, 3.0 equiv) was added dropwise, and the reaction allowed to stir 
for 10 min. (S)-(+)-p-methoxybenzyl glycidol (synthesized from commercial (S)-glycidol62, >98% ee, Aldrich) 
(800.0 mg, 4.1 mmol, 1.0 equiv) in 2 mL THF was cannulated into the solution from a separate 25 mL pear-shaped 
flask, with rinsing (2 x 1 mL).  The reaction mixture was stirred 2.5 hr in the dark at -40°C, quenched by addition of 
10 mL saturated aqueous NH4Cl, and then allowed to warm to room temperature with vigorous stirring.  The 
solution was transferred to a separatory funnel, diluted with 20 mL ether + 20 mL H2O.  The ether layer was 
separated, and the aqueous layer washed 2 x 25 mL ether.  Ether layers were combined and washed with 30 mL 
water, followed by 30 mL brine.  After drying over magnesium sulfate, filtration through celite, solvent removal, 
and flash chromatography (20% EtOAc/hexanes), a colorless oil was obtained (449.5 mg).   
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 The oil above (486 mg, 2.1 mmol, 1.0 equiv) was weighed into a 50 mL flame-dried round bottom flask 
equipped with a stir bar.  THF (23 mL), triphenylphosphine (708 mg, 2.7 mmol, 1.3 equiv) and phthalimide (397 
mg, 2.7 mmol, 1.3 equiv) were added sequentially with stirring.  DIAD (0.53 mL, 2.7 mmol, 1.3 equiv) was added 
dropwise until a yellow color persisted.  The reaction was stirred for 12 hr at room temperature, the solvent removed 
in vacuo, and the crude mixture submitted directly to flash chromatography (20% EtOAc/hexanes) to yield a 
colorless oil (689.2 mg, 1.4 mmol, 67% yield, 2 steps).   
 1H NMR (500 MHz, CDCl3) δ 7.80 (dd, J = 5.0, 3.0 Hz, 2H), 7.69 (dd, 5.0, 3.0 Hz), 7.14 (d, J = 9.0 Hz, 
2H), 6.76 (d, J = 9.0 Hz, 2H), 5.75 (ddd, 15.5, 10.0, 7.0 Hz, 1H), 4.96 (dd, J = 15.5, 1.5 Hz, 1H), 4.91 (dd, J = 10.0, 
1.5 Hz, 1H), 4.52 (m, 1H), 4.46 (d, J = 12.0 Hz, 1H), 4.37 (d, J = 11.5 Hz, 1H), 3.97 (app t, J = 9.5 Hz, 1H), 3.75 (s, 
3H), 3.66 (dd, J = 10.0, 5.0 Hz, 1H), 2.18 (m, 1H), 2.05 (q, J = 6.5 Hz, 2H), 1.77 (m, 1H); 13C NMR (125 MHz, 
CDCl3) δ 168.5, 159.0, 137.1, 133.7, 131.8, 130.0, 129.1, 123.0, 115.3, 113.6, 72.3, 69.2, 55.1, 50.7, 30.4, 27.8; IR 
(film, cm-1): 3073, 2999, 2933, 2884, 1774, 1709, 1653, 1613, 1586, 1513, 1467, 1375, 1248, 1090, 1034, 821, 722; 
HRMS (ESI) m/z calc’d for C22H23NNaO4 [M+Na]+: 388.1525, found 388.1522; [α]D26 = +32.5° (c = 1.0, CHCl3). 
(S,E)-methyl 5-(1,3-dioxoisoindolin-2-yl)-6-(4-methoxybenzyloxy)hex-2-
enyl(tosyl)carbamate [(+)-9]: Olefin (+)-9a (109.6 mg, 0.3 mmol, 1.0 equiv) 
was reacted following the standard procedure.  Flash chromatography (40% EtOAc/hexanes) afforded an 
orange-yellow, viscous foam.  Run 1 (119.8 mg, 0.20 mmol, 67% yield); run 2 (112.8 mg, 0.19 mmol, 63% yield).  
The linear to branched ratio was >20:1 by 1H NMR, and the Z isomer was not observed.  Average yield: 65%. 
 1H NMR (500 MHz, CDCl3) δ 7.79 (dd, J = 9.0, 3.0 Hz, 2H), 7.76 (d, J = 8.5 Hz, 2H), 7.69 (dd, J = 5.5, 3.0 
Hz, 2H), 7.28 (d, J = 8.5 Hz, 2H), 7.15 (d, J = 6.5 Hz, 2H), 6.78 (d, J = 8.5 Hz, 2H), 5.66 (dt, J = 15.5, 6.5 Hz, 1H), 
5.57 (dt, J = 15.5, 6.0 Hz, 1H), 4.55 (m, 1H), 4.47 (d, J = 11.5 Hz, 1H), 4.38 (d, J = 11.5 Hz, 1H), 4.27 (doublet of 
AB q, Δν = 32.5 Hz, JAB = 16.0 Hz, J = 6.0 Hz, 2H), 3.96 (app t, J = 10.0 Hz, 1H), 3.76 (s, 3H), 3.69 (dd, J = 10.0, 
5.5 Hz, 1H), 3.58 (s, 3H), 2.76 (ddd, J = 14.0, 9.5, 7.5, 1H), 2.54 (dt, J = 14.5, 5.5 Hz, 1H), 2.42 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 168.5, 159.1, 152.5, 144.5, 136.3, 133.8, 131.8, 130.3, 129.9, 129.3 (2 peaks), 129.2, 128.4, 
128.0, 123.1, 113.7, 72.4, 68.8, 55.2, 53.7, 50.6, 48.1, 31.9, 21.6; IR (film, cm-1): 3060, 2957, 2863, 1773, 1738, 
1709, 1612, 1514, 1444, 1361, 1247, 1171, 1089; HRMS (ESI) m/z calc’d for C31H33N2O8S [M+H]+: 593.1958, 
found 593.1964; [α]D26 = +10.9° (c = 1.0, CHCl3). 
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 (R)-tert-butyl(1-(4-methoxybenzyloxy)pent-4-en-2-yloxy)dimethylsilane [(+)-10a]: This 
compound was prepared as described previously63 from commercially available (S)-glycidol 
(>98% ee by GC). 
 1H NMR (500 MHz, CDCl3) δ 7.25 (d,  J = 9.0 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 5.81 (ddt, J  = 17.0, 10.0, 
7.5 Hz, 1H), 5.05 (app d, J = 17.5 Hz, 1H), 5.02 (app d, J = 10.0 Hz, 1H), 3.85 (p, J = 6.0 Hz), 3.81 (s, 3H), 3.35 
(m, 2H), 2.33 (m, 1H), 2.21 (m, 1H), 0.87 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H); [α]D26 = +2.5° (c = 1.0, CHCl3). 
Literature value for (ent)-10a: [α]D22 = -25° (c = 1.1, CHCl3). 
(R,E)-methyl 4-(tert-butyldimethylsilyloxy)-5-(4-methoxybenzyloxy) pent-2-
enyl(tosyl)carbamate [(+)-10]: Olefin (+)-10a (100.9 mg, 0.3 mmol, 1.0 equiv) 
was reacted according to the general procedure.  Flash chromatography (10% EtOAc/hexanes) provided an orange 
oil. Run 1 (82.1 mg, 0.15 mmol, 49% yield) run 2 (90.4 mg, 0.16 mmol, 55% yield). The E/Z isomer ratio was >20:1 
by 1H NMR integration of allylic protons.  Average yield: 52%, >99% ee. 
 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.0 Hz, 2H), 7.25 (d, J = 8.5 Hz, 2H), 7.24 (d, J = 8.5 Hz, 2H), 
6.86 (d, J = 9.0 Hz, 2H), 5.80 (q, J = 2.5 Hz, 2H), 4.47 (d, J = 2.5 Hz, 2H), 4.45 (d, J = 3.0 Hz, 2H), 4.33 (app t, J = 
5.5 Hz, 1H), 3.80 (s, 3H), 3.66 (s, 3H), 3.37 (m, 2H), 2.41 (s, 3H), 0.87 (s, 9H), 0.05 (s, 3H), 0.03 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 159.0, 152.6, 144.5, 136.3, 134.9, 130.3, 129.2, 129.1, 128.5, 125.1, 113.7, 74.4, 72.9, 71.6, 
55.2, 53.7, 47.9, 25.8, 21.6, 18.2, -4.8; IR (film, cm-1): 3035, 2999, 2957, 2856, 1732, 1613, 1514, 1444, 1361, 1253, 
1119, 1035, 970, 833; HRMS (ESI) m/z calc’d for C28H42NO7SSi [M+H]+: 564.2451, found 564.2461. [α]D26 = 
+5.1° (c = 1.0, CHCl3). 
Determination of enantiomeric purity.  Racemic material was independently synthesized using an analogous route 
from rac-glycidol. The TBS ether was deprotected with TBAF to form the free alcohol, and both enantiomers were 
separated by chiral HPLC (Welco-I, 75% hexanes/20% CH2Cl2/5% CH3CN, 0.9 mL/min @ 30°C), tR = 14.1, 15.5 
min.  Major enantiomer for 10, tR = 15.5 min. 
(R)-tert-butyl(1-(4-methoxybenzyloxy)hex-5-en-2-yloxy)dimethylsilane [(+)-11a]: 
This compound was prepared as described previously.64 
 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.8 Hz, 2H), 6.87 (d, J = 8.8 Hz, 2H), 5.81 (ddt, J = 16.8, 12.8, 
6.4 Hz, 1H), 5.01 (dq, J = 17.2, 1.6 Hz, 1H), 4.93 (app dq, J = 10.4, 1.2 Hz, 1H), 4.45 (s, 2H), 3.81 (s, 4H), 3.38 (dd, 
J = 9.6, 5.6 Hz, 1H), 3.33 (dd, J = 9.6, 5.6 Hz, 1H), 2.1 (m, 2H), 1.6 (m, 1H), 1.54 (m, 1H), 0.87 (s, 9H), 0.06 (s, 
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3H), 0.05 (s, 3H); [α]D26 = +15.7° (c = 1.17, CHCl3). Literature value for (ent)-11a: [α]D20 = -14.1° (c = 1.17, 
CHCl3). 
(R,E)-methyl 5-(tert-butyldimethylsilyloxy)-6-(4-methoxybenzyloxy)hex-
2-enyl(tosyl)carbamate [(+)-11]: Olefin (+)-11a (105.2 mg, 0.3 mmol, 1.0 
equiv) was reacted according to the general procedure.  Flash chromatography (gradient 10->30% EtOAc/hexanes) 
fashioned a pale aqua liquid.  Run 1 (110.5 mg, 0.19 mmol, 64% yield); run 2 (112.6 mg, 0.19 mmol, 65% yield). 
The E/Z isomer ratio was >20:1 by 1H NMR for both experiments, as were the linear/branched ratios.  Average 
yield: 65%. 
 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 9.0 Hz, 2H), 
6.87 (d, J = 8.5 Hz, 2H), 5.78 (dt, J = 15.0, 7.5 Hz 1H), 5.58 (dt, J = 15.5, 6.0 Hz, 1H), 4.44 (s, 2H), 4.39 (d, J = 6.5 
Hz, 2H), 3.85 (p, J = 5.5 Hz, 1H), 3.80 (s, 3H), 3.67 (s, 3H),  3.34 (m, 2H), 2.42 (s, 3H), 2.34 (dt, J = 14.0, 6.0 Hz, 
1H), 2.22 (app dt, J = 13.5, 7.0 Hz, 1H), 0.87 (s, 9H), 0.04 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 159.0, 152.6, 
144.4, 136.4, 131.6, 130.4, 129.2 (2 peaks), 128.4, 126.9, 113.6, 73.6, 72.9, 70.9, 55.2, 53.7, 48.5, 37.6, 25.8, 21.6, 
18.1, -4.6, -4.8; IR (film, cm-1): 3004, 2956, 2855, 1738, 1613, 1514, 1366, 1245, 1172, 834, 776, 675; HRMS (ESI) 
m/z calc’d for C29H44NO7SSi [M+H]+: 578.2608, found 578.2603; [α]D26 = +4.0° (c = 1.0, CHCl3). 
(R)-4-((R)-1-(benzyloxy)but-3-enyl)-2,2-dimethyl-1,3-dioxolane [(+)-12a]: This compound was prepared as 
described previously65 from (Z)-2-butene-1,4-diol. 
1H NMR (500 MHz, CDCl3) δ 7.25-7.37 (m, 5H), 5.87 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H), 5.11 
(app d, J = 17.5 Hz, 1H), 5.06 (app d, J = 10.0 Hz, 1H), 4.72 (d, J = 12.0 Hz, 1H), 4.66 (d, J = 
11.5 Hz, 1H), 4.21 (q, J = 6.5 Hz, 1H), 3.98 (dd, J = 8.0, 6.0 Hz, 1H), 3.71 (t, J = 7.0 Hz, 1H), 3.51 (m, 1H), 2.31 
(m, 1H), 2.32 (m, 1H), 1.43 (s, 3H), 1.37 (s, 3H); [α]D23 = -15.8° (c = 1.1, CHCl3). Literature value: [α]D23 = -15.6° 
(c = 1.1, CHCl3). 
 (S,E)-methyl 4-(tert-butyldimethylsilyloxy)-5-(4-methoxybenzyloxy)pent-2-
enyl(tosyl)carbamate [(+)-12]: Compound (+)-12a (78.7 mg, 0.3 mmol, 1.0 
equiv) was reacted following the general procedure; flash chromatography 
(gradient 10->25->50% EtOAc/hexanes) gave rise to a sticky orange oil.  Run 1 (90.7 mg, 0.19 mmol, 62% yield); 
run 2 (93.7 mg, 0.19 mmol, 64%).  No branched product or Z olefin isomers were observed by 1H NMR.  Average 
yield: 63%. 
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 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8.0 Hz, 2H), 7.26-7.33 (m, 7H), 5.86 (dt, J = 15.5, 5.0 Hz, 1H), 
5.66 (dd, J = 15.5, 7.5 Hz, 1H), 4.66 (d, J = 12.0 Hz, 1H), 4.48 (m, 3H), 4.20 (q, J = 6.5 Hz, 1H), 3.94 (dd, J = 8.5, 
6.5 Hz, 1H), 3.88 (app t, J = 7.0 Hz, 1H), 3.72 (dd, J = 8.5, 6.5 Hz, 1H), 3.69 (3H, s), 2.42 (s, 3H), 1.38 (s, 3H), 1.35 
(s, 3H); 13C NMR (125 MHz, CDCl3) 152.5, 144.7, 138.0, 136.2, 130.3, 129.9, 129.3, 128.4, 128.3, 127.7, 127.5, 
109.7, 79.5, 70.3, 65.6, 53.9, 47.9, 26.4, 25.3, 21.6; IR (film, cm-1): 2993, 2924, 2869, 1738, 1598, 1496, 1444, 
1365, 1248, 1220, 1171, 1090, 1072, 968; LRMS (FD+)  368.2(100), 230.1(90.8), 212.2(19.8), 198.2 (12.7), 155.1 
(47.3); [α]D26 = +15.8° (c = 1.0, CHCl3). 
Observed MS fragments: 
 
(S)-N-methoxy-N,2-dimethylpent-4-enamide [(+)-13a]: (S)-2-Methyl-4-pentenoic acid66 (163.1 mg, 1.4 mmol, 1.0 
equiv) was added to a 100 mL round bottom flask with stir bar.  Dichloromethane (7.2 mL, 
0.2M) was added, and the solution cooled to 0°C in an ice bath.  1,1’-Carbonyldiimidazole 
(279 mg, 1.7 mmol, 1.2 equiv), and the reaction stirred at 0°C for 30 min.  (MeO)MeNH•HCl 
(351 mg, 3.6 mmol, 2.5 equiv) was added portionwise, and the reaction mixture was allowed to reach room 
temperature overnight.  The slurry of white salts was then filtered through a glass wool plug, washed with 1M HCl, 
and brine.  Drying the organic layer over MgSO4 and removal of the solvent gave a light yellow oil that was 
subjected to flash chromatography (25% EtOAc/hexanes).  The purified product was a colorless oil with a pungent 
fruit odor (148.4 mg, 0.94 mmol, 66% yield, 94% ee). 
 1H NMR (500 MHz, CDCl3) δ 5.76 (ddd, J = 17.0, 10.0, 7.0 Hz, 1H), 5.38 (dd, J =  16.5, 2.0 Hz, 1H), 5.01 
(dd, J = 10.5, 1Hz, 1H), 3.69 (s, 3H), 3.19 (s, 3H), 2.95 (bs, 1H), 2.42 (dt, J = 14.0, 7.0 Hz, 1H), 2.21 (dt, J = 14.0, 
6.5 Hz, 1H), 1.12 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 177.28, 136.2, 116.4, 61.5, 37.8. 35.1, 32.2, 
17.0; IR (film, cm-1): 3485 (b), 3077, 2980, 2930, 1664, 1462, 1416, 1386, 1312, 1179, 1117, 1085, 996, 916; 
HRMS (ESI) m/z calc’d for C8H16NNaO2 [M+H]+: 158.1181, found 158.1181; [α]D26 = +24.5° (c = 1.0, CHCl3).    
 Determination of enantiomeric purity. (rac)-13a (synthesized from commercially available 2-methyl-4-
pentenoic acid) was separated by chiral GC (45°C isothermal); tR = 75.4, 77.3 min.  Major enantiomer for (+)-13a, 
tR = 77.7 min. 
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(S,E)-methyl 5-(methoxy(methyl)amino)-4-methyl-5-oxopent-2-
enyl(tosyl)carbamate [(-)-13]: Compound (+)-13a (47.2 mg, 0.3 mmol, 1.0 equiv) 
was subjected to amination conditions as outlined in standard procedure.  Flash 
chromatography led to the isolation of a faint yellow-orange oil.  Run 1 (63.3 mg, 0.16 mmol, 55% yield); run 2 
(60.6 mg, 0.16 mmol, 53% yield).  Branched and Z olefin isomers were not observed by 1H NMR of the purified 
material.  Average yield: 54%. 
 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 5.91 (dd, J = 15.6, 7.6 Hz, 
1H), 5.65 (dt, J = 15.6, 6.0 Hz, 1H), 4.43 (d, J = 6.4 Hz, 2H), 3.70 (s, 3H), 3.69 (s, 3H), 3.64 (bs, 1H), 3.19 (s, 3H), 
2.43 (s, 3H), 1.21 (d, J = 6.8 Hz, 3H); 13C NMR (400 MHz, CDCl3) δ 174.9, 152.6, 144.5, 136.2, 134.9, 129.3, 
128.5, 125.5, 61.5, 53.7, 48.2, 38.2, 32.2, 21.6, 17.2; IR (film, cm-1): 3630, 3487, 2965, 1738, 1667, 1597, 1463, 
1372, 1172, 1089, 992; HRMS (ESI) m/z calc’d for C17H25N2O6S [M+H]+: 385.1433, found 385.1432; [α]D26 = -7.2° 
(c = 1.0, CHCl3). 
 (R)-tert-butyl 3-(benzyloxycarbonylamino)hex-5-enoate [(+)-14a]: This compound was prepared as described 
previously67 in >99% ee.  
1H NMR (500 MHz, CDCl3) δ 7.29-7.37 (m, 5H), 5.76 (m, 1H), 5.28 (bd, J = 8.5 Hz, 
1H), 5.09 (m, 4H), 4.03 (bm, J = 6.0 Hz, 1H), 2.45 (d, J = 5.5 Hz, 2H), 2.32 (m, 2H), 
1.43 (s, 9H); [α]D25 = +1.5° (c = 1.0, CH2Cl2). Literature value: [α]D25 = +1.8° (c = 1.0, 
CH2Cl2). 
Determination of enantiomeric purity. An analogous synthesis of ent-14a allowed a racemic mixture to be 
prepared and separated by chiral HPLC (Daicel Chiralpak AS, 7% iPrOH/93% hexanes, 1.0 mL/min @ 30°C), tR 
= 5.2, 5.7 min).  Major enantiomer for (+)-14a, tR = 5.7 min. 
 (S,E)-tert-butyl 3-(benzyloxycarbonylamino)-6-(N-(methoxycarbonyl)-
4-methylphenylsulfonamido)hex-4-enoate [(+)-14]: The starting material 
(+)-14a, (95.8 mg, 0.3 mmol, 1.0 equiv) was reacted following the standard procedure.  Flash chromatography (40% 
EtOAc/hexanes) isolated   an orange tacky oil. Run 1 (91.3 mg, 0.17 mmol, 56% yield) run 2 (86.2 mg, 0.16 mmol, 
53% yield). The branched and Z olefin isomers were not observed by 1H NMR for both experiments.  Average 
yield: 55%, 99% ee. 
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 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.5 Hz, 2H), 7.31 (m, 7H), 5.79 (dd, J = 16.0, 5.5 Hz, 1H), 5.72 
(dt, J = 15.3, 5.5 Hz, 1H), 5.55 (broad d, J = 8.0 Hz, 1H), 5.11 (m, 2H), 4.57 (m, 1H), 4.43 (d, J = 5.5 Hz, 2H), 3.66 
(s, 3H), 2.56 (app qd, J = 15.5, 5.0 Hz, 2H), 2.41 (s, 3H), 1.41 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 170.2, 155.5, 
152.5, 144.6, 136.3, 136.1, 133.5, 129.3, 128.5 (2 peaks), 128.1, 128.0, 125.8, 81.5, 66.7, 53.8, 49.0, 47.7, 40.1, 
27.9, 21.6; IR (film, cm-1): 3383, 2959, 1721, 1597, 1514, 1447, 1367, 1169, 1027; HRMS (ESI) m/z calc’d for 
C27H35N2O8S [M+H]+: 547.2114, found 547.2112; [α]D26 = +9.4° (c = 1.0, CHCl3). 
 Determination of enantiomeric purity.  An analogous synthesis of ent-14 allowed a racemic mixture to 
be prepared and separated by chiral HPLC (Welco-I, 75% hexanes/20% CH2Cl2/5% CH3CN), 0.9 mL/min @ 30°C, 
tR = 9.1, 10.3 min).  Major enantiomer for (+)-14, tR = 9.1 min. 
(S,E)-tert-butyl 6-(N-(benzyloxycarbonyl)-4-methylphenylsulfonamido)-3-
(benzyloxycarbonylamino)hex-4-enoate [(+)-14b]: The starting material 
(+)-14a, (95.8 mg, 0.3 mmol, 1.0 equiv) and benzyl tosylcarbamate (183.2 mg, 0.6 mmol) were reacted following 
the standard procedure.  Flash chromatography (30% EtOAc/hexanes) gave an orange tacky oil that was recolumned  
3X (20% EtOAc/hexanes) to give a colorless oil.  Run 1 (118.3 mg, 0.19 mmol, 63% yield); run 2 on 1.57 mmol 
scale (602.1 mg, 0.97 mmol, 62% yield). The branched and Z olefin isomers were not observed by 1H NMR for both 
experiments.  Average yield: 63%. 
 1H NMR (500 MHz, CDCl3) δ 7.70 (d, J  = 8.0 Hz, 2H), 7.31-7.35 (m, 8H), 7.18 (m, 4H), 5.75 (m, 2H), 
5.47 (bd, J = 9.5 Hz, 1H), 5.10 (m, 4H), 4.56 (bs, 1H), 4.45 (d, J = 4.5 Hz, 2H), 2.53 (dd, J = 15.3, 4.8 Hz, 1H) 2.47 
(dd, J = 15.3, 4.5 Hz, 1H), 2.38 (s, 3H), 1.41 (s, 9H);  13C NMR (125 MHz, CDCl3) δ 170.1, 155.4, 151.9, 144.4, 
136.4, 136.2, 134.5, 133.7, 129.3, 128.5 (4 peaks), 128.4, 128.1, 128.0, 125.8, 81.5, 68.9, 66.7, 49.1, 47.7, 40.2, 
28.0, 21.6;  IR (film, cm-1): 3399, 3340, 3305, 3034, 2979, 2924, 2444 (broad), 2055 (broad), 1729, 1597, 1511, 
1455, 1511, 1455, 1359, 1275, 1244, 1170, 1088, 1028, 968, 911, 844, 737; HRMS (ESI) m/z calc’d for 
C33H39N2O8S [M+H]+: 623.2427, found 623.2423; [α]D26 = +9.3° (c = 1.0, CHCl3). 
2-methylpent-4-enoic acid [(-)-15a]:  This acid was obtained using the Meyers alkylation.68 
 1H NMR (500 MHz, CDCl3) δ 5.77 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H), 5.09 (md, 17.0 Hz, 
1H), 5.06 (md, 10.0 Hz, 1H), 2.57 (6x,  J = 7.5 Hz, 1H), 2.45 (m, 1H), 2.21 (m, 1H), 1.19 (d, J = 7.0, 3H). [α]D25 = -
9.6° (c = 1.0, CHCl3). Literature value: [α]D = -10.3° (c = 1.0, CHCl3). 
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(S)-tert-butyl 2-((R)-2-methylpent-4-enamido)-3-phenylpropanoate [(+)-15b]: Acid (+)-15a (50.4 mg, 0.44 
mmol, 1 equiv), L-phenylalanine t-butyl ester•HCl (123.7 mg, 0.48 mmol, 1.1 equiv), PyBOP (249.8 mg, 0.48 
mmol, 1.1 equiv), and a stir bar were added sequentially to a 25 mL round bottom flask.  CHCl3 was added (9.0 
mL), followed by dropwise addition of iPr2NEt (0.19 mL, 1.1 mmol, 2.5 equiv).  The solution became clear after 
addition of the base, and was stirred 1 hr at room temperature.  The mixture was washed with 10% aq. citric acid (2 
x 3 mL), NaHCO3 (3 mL), and dried over MgSO4.  Filtration through celite, followed by evaporation of the solvent 
at reduced pressure (35°C, 20 torr) furnished a thick yellow oil.  Purificaton by flash chromatography (10% 
EtOAc/hexanes) gave pale yellow, crystalline solids (126.9 mg, 0.4 mmol, 91% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.25 (m, 3H), 7.16 (d, J = 8.5 Hz, 2H), 5.92 (bd, J = 7.0 Hz, 1H), 5.67 (ddd, 
J = 14.5, 10.0, 7.0 Hz, 1H), 5.03 (d, J = 15.0 Hz, 1H), 4.99 (d, J = 11.0 Hz, 1H), 4.77 (app q, J = 7.5 Hz, 1H), 3.08 
(d, 6.0 Hz, 2H), 2.35 (dt, J = 14.0, 5.5 Hz, 1H), 2.26 (m, 7.0 Hz, 1H), 2.11 (dt, J = 14.0, 6.5 Hz, 1H), 1.41 (s, 9H), 
1.12 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 174.8, 170.6, 136.0, 135.5, 129.3, 128.0, 126.6, 116.6, 
82.0, 52.9, 40.8, 38.0, 37.9, 27.7, 16.9; IR (film, cm-1): 3270 (broad), 3083, 3030, 2978, 2929, 1731, 1642, 1562, 
1498, 1455, 1392, 1367, 1324, 1282, 1260, 1156, 1033, 980, 917, 848, 700; HRMS (ESI) m/z calc’d for 
C19H27NO3Na [M+Na]+: 340.1889, found 340.1906; [α]D25 = +55.4° (c = 1.0, CHCl3). 
 (S)-tert-butyl 2- ((R,E)-5-(benzyloxycarbonylamine)-2-methylpent-3-enamido)-3-phenylpropanoate 
[(+)-15]: α-olefin (+)-15b (98.2 mg, 97% pure, 0.3 mmol, 1.0 equiv) was reacted with benzyl-N-tosylcarbamate 
(183.2 mg, 0.6 mmol, 2.0 equiv) following the standard procedure.  The workup could be performed in ether or ethyl 
acetate, with no difference in yield.  Flash chromatography (25% EtOAc/hexanes) afforded the linear-(E) carbamate 
(no branched or linear (Z) product was detected was by 1H NMR) as a brown oil (93.8 mg, 0.15 mmol, 50% yield) 
contaminated with the linear acetate product (10.1 mg, 0.027 mmol, 9% yield); run 2 (90.6 mg, 0.146 mmol, 49% 
yield of N-tosylcarbamate, 10% yield of linear OAc).  Average yield: 50%.   
 Carbamate: 1H NMR (500 MHz, CDCl3) δ 7.70 (d, J = 8.5 Hz, 2H), 7.11-7.33 (m, 14H), 6.05 (bd, J = 7.5 
Hz, 1H), 5.77 (dd, J = 15.5, 8.0 Hz 1H), 5.68 (dt, J = 15.0, 6.5 Hz, 1H), 5.07 (s, 2H), 4.71 (m, 1H), 4.44 (m, 2H), 
2.95-3.09 (m, 3H), 2.40 (s, 3H), 1.40 (s, 9H), 1.20 (d, J = 7.5 Hz, 3H); Diagnostic linear acetate peaks: 5.99 (bd, J = 
8.0 Hz, 1H), 4.52 (d, J = 5.5 Hz, 2H), 2.07 (s, 3H) 1.23 (d, J = 7.0 Hz, 3H); HRMS (ESI) m/z calc’d for C34H41N-
2O7S [M+H]+: 621.2634, found 621.2634. 
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 A mixture of N-tosylcarbamate (+)-15 and acetate (538.8 mg, 0.73 mmol, 1.0 equiv, 85% pure) was 
subjected to the same reduction procedure used for the synthesis of (+)-12b.  Flash chromatography (40% 
EtOAc/hexanes) provided the deprotected carbamate as a colorless oil (337.0 mg, 0.72 mmol, 98% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.19-7.36 (m, 8H), 7.11 (d, J = 7.0 Hz, 2H), 6.06 (bd, J = 6.5 Hz, 1H), 5.57 
(m, 2H), 5.11 (s, 2H), 4.80 (m, 1H), 4.72 (app q, J = 7.0 Hz, 1H), 3.77 (app t, J = 5.0 Hz, 2H), 3.07 (m, 2H), 2.95 
(app p, J = 6.8 Hz, 1H), 1.41 (s, 9H), 1.20 (d, J = 7.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 173.0, 170.7, 156.1, 
136.4, 136.1, 132.2, 129.5, 128.6, 128.5, 128.2, 128.1 (2 peaks), 126.9, 82.3, 66.7, 53.2, 43.9, 42.6, 37.8, 27.9, 16.8; 
IR (film, cm-1): 3323 (broad), 3089, 3031, 2975, 2933, 2869, 1725, 1671, 1519, 1455, 1368, 1251, 1154, 1046, 
1029, 973, 912, 844, 735, 699; HRMS (ESI) m/z calc’d for C27H35N2O5 [M+H]+: 467.2546, found 467.2555; [α]D25 
= +22.3° (c = 1.03, CHCl3). 
Amino Sugar Fragment Synthesis 
(E)-methyl 4-(benzyloxy)-4-(2,2-dimethyl-1,3-dioxolan-4-yl)but-2-enylcarbamate (+)-[12b]: Compound (+)-[12] 
(40.2 mg, 0.082 mmol) was added to 10 mL round bottom flask containing a stir bar.  Dimethoxyethane (1 mL) was 
added via syringe, and the flask cooled to -78°C.  A forest green solution of sodium naphthalide69 was slowly added 
dropwise until the solution color became a light green color that persisted for 2 min.  After an additional 10 min at 
-78°C, the solution was diluted with saturated NH4Cl (4 mL), allowed to warm to room temperature, and diluted 
with ethyl acetate (10 mL).  The layers were separated, and the aqueous layer extracted with ethyl acetate (2 x 10 
mL).  Organic fractions were combined, dried over MgSO4, and evaporated at reduced pressure.  Flash 
chromatography (30% EtOAc/hexanes) led to the isolation of a colorless oil (22.6 mg, 0.067 mmol, 82% yield).   
 1H NMR (400 MHz, CDCl3) δ 7.27 (m, 5H), 5.74 (dt, J = 15.5, 5.5 Hz, 1H), 5.50 (dd, J = 15.6, 8.0 Hz, 
1H), 4.78 (m, 1H), 4.63 (d, J = 12.4 Hz, 1H), 4.47 (d, J = 12.0 Hz, 1H), 4.18 (app t, J = 6.4 Hz, 1H), 3.93 (dd, J = 
8.4, 6.8 Hz, 1H), 3.84 (m, 3H), 3.72 (dd, J = 8.4, 6.4 Hz, 1H), 3.67 (s, 3H), 1.38 (s, 3H), 1.35 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 156.8, 138.2, 132.1, 128.3, 127.7 (2 peaks), 127.5, 109.7, 79.8, 70.4, 65.6, 52.2, 42.2, 26.4. 25.2; IR 
(film, cm-1): 3347 (broad), 3038, 2988, 2929, 2874, 1723, 1532, 1458, 1381, 1371, 1338, 1253, 1214, 1155, 1068, 
976, 853, 778; HRMS (ESI) m/z calc’d for C18H26NO5 [M+H]+: 336.1811, found 336.1803; [α]D24 = +26.2° (c = 
1.07, CHCl3). 
(E)-methyl 4-(benzyloxy)-4-(2,2-dimethyl-1,3-dioxolan-4-yl)but-2-en-1-amine (+)-[12c]: Compound (+)-[12b] 
was transferred to a sealed tube and diluted with 0.25 mL ethanol, 0.75 mL water, and 0.5 mL of 2N NaOH.  The 
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tube was heated to 110°C for 2-4 h, then allowed to cool to room temperature.  The water/ethanol mixture was 
transferred to a 25 mL round bottom flask, the ethanol evaporated, and the mixture diluted with EtOAc (5 mL) and 
brine (2 mL).  The organic layer was separated, and the aqueous layer extracted with EtOAc (3 x 5 mL).  Organic 
layers were combined, dried over MgSO4, filtered, and evaporated to dryness.  The crude oil was purified by flash 
chromatography (10% MeOH/CH2Cl2/1% conc. NH4OH) to afford a pale yellow oil (16.8 mg, 0.061 mmol, 95% 
yield). 
 1H NMR (500 MHz, CDCl3) δ 7.33 (m, 4H), 7.26 (m, 1H), 5.87 (d, J = 15.5, 5.5 Hz, 1H), 5.48 (dd, J = 
15.5, 8.0 Hz, 1H), 4.66 (d, J = 12.5 Hz, 1H), 4.49 (d, J = 12.5 Hz, 1H), 4.20 (q, J = 6.5 Hz, 1H), 3.94 (dd, J = 8.5, 
6.8, 1H), 3.84 (app t, J = 7.5 Hz, 1H), 3.73 (dd, J = 8.5, 6.5 Hz, 1H), 3.35 (bs, 2H), 1.48 (bm, 2H), 1.39 (s, 3H), 1.35 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 138.4, 137.3, 128.3, 127.7, 127.4, 125.7, 109.7, 80.3, 77.6, 70.2, 65.8, 43.5, 
29.7, 26.5, 25.3; IR (film, cm-1): 3367 (broad), 3037, 2992, 2982, 2913, 2866, 1584, 1498, 1455, 1380, 1370, 1330, 
1262, 1215, 1157, 1068, 979, 850, 742, 698; HRMS (ESI) m/z calc’d for C16H24NO3 [M+H]+: 278.1756, found 
278.1756; [α]D24 = +30.7° (c = 1.68, CHCl3). 
15N labeled (E)-methyl 4-(benzyloxy)-4-(2,2-dimethyl-1,3-dioxolan-4-yl)but-2-en-1-
amine (+)-[12f] was synthesized in the same manner as (+)-12c (3 steps, 43% overall 
yield, 99.7 % 15N enrichment by ESI-LRMS) from (+)-12a using the 15N labeled 
methyltosyl carbamate.  
 1H NMR (500 MHz, CDCl3) δ  7.33 (m, 4H), 7.26 (m, 1H), 5.87 (dt, J = 15.3, 5.3 Hz, 1H), 5.47 (dd, J = 
16.0, 8.0 Hz, 1H), 4.66 (d, J = 12.5 Hz, 1H), 4.49 (d, J = 12.5 Hz, 1H), 4.19 (q, J = 6.5 Hz, 1H), 3.94 (dd, J = 8.5, 
7.0 Hz, 1H), 8.40 (app t, J = 7.5 Hz, 1H), 3.73 (dd, J = 8.5, 6.5 Hz, 1H), 3.35 (bs, 2H), 1.39 (s, 3H), 1.36 (s, 3H) 
1.26 (m, 2H, NH2); 13C NMR (125 MHz, CDCl3) δ 138.4, 137.5 (broad), 128.2, 127.7, 127.4, 125.5, 109.7, 80.3, 
77.6, 70.2, 65.8, 43.5, 26.5, 25.3; IR (film, cm-1): 3365 (broad), 3029, 2990, 2914, 2862, 1586, 1497, 1462, 1386, 
1369, 1256, 1216, 1158, 1069 (broad), 974, 856.  HRMS (ESI) m/z calc’d for C16H2415NO3 [M+H]+: 279.1727, 
found 279.1724; [α]D25 = +33.1° (c = 1.60, CHCl3). 
Deoxynegamycin Analogue Synthesis. 
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(R)-2-(trimethylsilyl)ethyl 3-(tert-butoxycarbonylamino)hex-5-enoate [(+)-16a]:  To a 10 mL round bottom flask 
containing a stir bar was added Boc-(R)-3-Amino-5-hexenoic acid (-)-16 (100 mg, 0.44 mmol, 1.0 equiv, PepTech 
Corporation, Burlington, MA) and THF (2.2 mL).  With stirring, triphenylphosphine (288.5 mg, 1.1 mmol, 2.5 
equiv) and trimethylsilylethanol (78.0 mg, 0.095 mL, 0.66 mmol, 1.5 equiv) were added. 
Diisopropylazodicarboxylate (196.0 mg, 0.191 mL, 0.97 mmol, 2.2 equiv) was added dropwise over 2 min, and the 
yellow solution stirred for 1.5 h at room temperature.  Saturated NaHCO3 and 10 mL ether were added, and the 
layers separated.  The water layer was extracted with ether (3 x 10 mL), and all organic layers were combined, dried 
over MgSO4, filtered through celite, and concentrated at reduced pressure (40°C, 25 torr).  The crude orange oil was 
purified by flash chromatography (15% EtOAc/hexanes) to give a colorless oil (139.5 mg, 0.42 mmol, 96% yield). 
 1H NMR (400 MHz, CDCl3) δ 5.75 (m, 1H), 5.10 (m, 1H), 5.07 (app s, 1H), 5.01 (bd, J = 4.0 Hz, 1H), 4.16 
(m, 2H), 3.98 (m, 1H), 2.49 (d, J = 5.6 Hz, 1H), 2.30 (m, 2H), 1.42 (s, 9H), 0.98 (m, 2H), 0.03 (s, 9H); 13C NMR: 
(100 MHz, CDCl3) δ 171.8, 155.2, 134.1, 118.2, 79.2, 62.8, 47.1, 38.8, 38.4, 28.3, 17.3, -1.5; IR (film, cm-1): 3439 
(broad), 3372 (broad), 3080, 2978, 2955, 2902, 1721, 1653, 1502, 1439, 1391, 1366, 1300, 1251, 1173, 1111, 1046, 
1026, 992, 918, 860, 838, 763, 695; HRMS (ESI) m/z calc’d for C16H31NNaO4Si [M+Na]+: 352.1920, found 
352.1912; [α]D26 = +4.1° (c = 1.0, CHCl3). 
 
(S,E)-2-(trimethylsilyl)ethyl 6-(N-(benzyloxycarbonyl)-4-methylphenylsulfonamido)-3-(tert-
butoxycarbonylamino)hex-4-enoate [(+)-17]: Following the standard allylic amination procedure, (+)-16a (98.9 
mg, 0.3 mmol, 1.0 equiv) was reacted with benzyl N-tosylcarbamate (183.2 mg, 0.6 mmol, 2.0 equiv), and the 
workup was performed with ether.  Flash chromatography (15%->25% EtOAc/hexanes) afforded a the product as a 
yellow-orange oil (103.1 mg, 0.16 mmol, 54% yield) that was contaminated with a small amount of the acetate 
product (13.6 mg, 0.035 mmol, 12% yield).   Further purification could be carried out by flash chromatography (7% 
THF/PhMe), or material containing the linear acetate could be subjected directly to the next step. Run 1 (103.1 mg, 
0.16 mmol, 54% yield); run 2 (371.1 mg, 0.66 mmol, 53% yield, 1.24 mmol scale). The branched and Z olefin 
isomers were not observed by 1H NMR for both experiments. 
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1H NMR (500 MHz, CDCl3) δ 7.70 (d, J = 8.5 Hz, 2H), 7.32 (m, 3H), 7.19 (m, 4H), 5.75 (m, 2H), 6.17 (m, 
1H), 5.08 (s, 2H), 4.45 (d, J = 5.0 Hz, 2H), 4.17 (m, 2H), 2.53 (app qd, J = 16.0, 5.7 Hz, 2H), 2.40 (s, 3H), 1.44 (s, 
9H), 0.98 (m, 2H), 0.03 (s, 9H). 
 
(S,E)-2-(trimethylsilyl)ethyl 6-(benzyloxycarbonylamino)-3-(tert-butoxycarbonylamino)hex-4-enoate [(+)-
17a]: Compound 17 (67.1mg, 0.106 mmol, 1.0 equiv) was reacted in an analogous procedure to that used for the 
synthesis of 12b.  Flash chromatography (15%->25% EtOAc/hexanes) afforded a light yellow oil (45.4 mg, 0.095 
mmol, 89% yield).   
 1H NMR (500 MHz, CDCl3) δ 7.28-7.37 (m, 5H), 5.63 (m, 2H), 5.21 (bs, 1H), 5.09 (s, 2H), 4.83 (m, 2H), 
4.48 (bs, 1H), 4.15 (m, 2H), 3.79 (m, 2H), 2.54 (m, 2H), 1.42 (s, 9H), 0.97 (m, 2H), 0.03 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 171.2, 156.1, 154.9, 136.4, 131.3, 128.5 (2 peaks), 128.1, 127.4, 70.5, 66.7, 62.9, 48.3, 42.3, 39.4, 
28.3, 17.3, -1.6; IR (film, cm-1): 3350 (broad), 3064, 3035, 2955 (broad), 1720 (broad), 1538, 1455, 1391, 1367, 
1252, 1173, 1045, 969, 939, 859, 837, 776, 755, 736, 696.  HRMS (ESI) m/z calc’d for C24H38N2O6SiNa [M+Na]+: 
501.2397, found 501.2393; [α]D25 = +2.7° (c = 1.02, CHCl3). 
 
 A sample of 17a (52.4 mg, 0.13 mmol, 1.0 equiv) in a 25 mL round bottom flask was dissolved in THF (1.5 
mL), and  tetrabutylammonium fluoride (0.26 mL, 1M in THF) was added dropwise.  The yellow solution was 
stirred for 2 h, and the solvent was removed under reduced pressure.  The remaining yellow oil was taken up in 10 
mL EtOAc and 10 mL 1M HCl.  The organic layer was separated, and the aqueous layer washed again with 10 mL 
EtOAc.  Both organic fractions were combined, washed with 1M HCl (10 mL) and brine (10 mL) prior to drying 
over MgSO4.  Celite filtration and evaporation at reduced pressure (25 torr, 40°C) provided the crude acid.  Further 
purification by flash chromatography (60% EtOAc/hexanes/1% AcOH) led to the isolation of a colorless oil (38.9 
mg, 0.13 mmol, 99% yield). 
 (S,E)-tert-butyl 2-(2-(6-(benzyloxycarbonylamino)-3-(tert-butoxycarbonylamino)hex-4-enoyl)-1-
methylhydrazinyl)acetate [(+)-17b]:  The oil mentioned above (46.7 mg, 0.12 mmol, 1.0 equiv) was added to a 5 
mL round bottom flask, and dissolved in DMF.  The solution was cooled to 0 °C, and O-(7-azabenzotriazole-1-yl)-
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N,N,N,N-tetramethyluronium hexafluorophosphate (“HATU”, 51.5 mg, 0.135 mmol, 1.1 equiv) was added, and 
stirring continued for 10 min. tert-Butyl 2-(1-methylhydrazinyl)acetate (39.4 mg, 0.246 mg, 2.0 equiv) was added 
via syringe, followed by diisopropylethylamine (0.062 mL, 0.357 mmol, 2.9 equiv, dropwise).  The yellow solution 
was allowed to warm to room temperature, and stirred for 17 h.  The reaction was quenched by dilution with EtOAc 
(20 mL).  The organic layer was washed with 1M HCl (2 x 5 mL), 5% NaHCO3 (1 x 5 mL), and brine (10 mL).  
After drying with MgSO4 and filtration through celite, the solvent was removed under reduced pressure (25 torr, 
30°C).  Flash chromatography (2% MeOH/EtOAc) afforded a waxy, white solid (37.3 mg, 0.72 mmol, 58% yield).   
 1H NMR (400 MHz, CDCl3, 1.1:1 mixture of rotomers) major: δ 7.93 (bs, 1H), 7.32 (m, 5H), 5.65 (m, 1H), 
5.60 (m, 1H), 5.43 (m, 1H), 5.11 (s, 1H), 5.07 (s, 2H), 4.43 (bs, 1H), 3.76 (m, 2H), 3.32-3.55 (m, 2H), 2.26-2.66 (m, 
2H), 2.67 (s, 3H), 1.44 (s, 9H), 1.40 (s, 9H); diagnostic minor: δ 5.08 (s, 2H), 4.89 (bs, 1H), 2.67 (s, 3H), 1.45 (s, 
9H), 1.41 (s, 9H); 13C NMR (100 MHz, CDCl3) major: δ 170.5, 169.0, 156.3, 155.3, 136.5, 131.2, 128.5, 128.0 (2 
peaks), 127.7, 82.7, 79.7, 66.7, 59.1, 49.2, 44.5, 42.3, 39.6, 28.3, 28.1; diagnostic minor: δ 174.0, 169.1, 156.2, 
155.2, 132.4, 126.8, 82.4, 79.3, 59.6, 45.1, 36.4, 28.4, 28.1; IR (film, cm-1): 3340 (broad), 3008, 2974, 2930, 1704, 
1521, 1455, 1393, 1368, 1248, 1162, 1050, 971, 844, 753; HRMS (ESI) m/z calc’d for C26H41N4O7 [M+H]+: 
521.2961, found 521.2975; [α]D26 = +4.2° (c = 1.31, CHCl3). 
 
(S,E)-6-(2-(carboxymethyl)-2-methylhydrazinyl)-6-oxohex-2-ene-1,4-diaminium bromide [(+)-19a]: A 5 mL 
round bottom flask containing a stir bar was charged with 17b (12.0 mg, , capped with a septum, and placed in an 
ice bath under N2.  A solution of 30% HBr in AcOH (0.5 mL, Fluka) was added via syringe, and the reaction was 
allowed to warm to room temperature.  After ~1 h, the starting material had dissolved, and the reaction was stirred 
an additional 7 h.  The stir bar was removed, ether was added (~2 mL), and trituration (10 x 2 mL, ether) with ether 
allowed purification of the hydrobromide salt.  Evaporation of the remaining ether at reduced pressure (1 torr) 
furnished a white solid (7.5 mg, 0.019 mmol, 83% yield).   
 1H NMR (400 MHz, D2O) δ 5.99 (1H, m), 5.90 (dd, J = 15.8, 7.0 Hz, 1H), 4.24 (m, 1H), 3.66 (m, 2H), 3.64 
(m, 2H), 2.67 (m, 3H), 2.65 (bs, 2H); 13C NMR (100 MHz, D2O) major rotomer: δ 172.7, 168.9, 130.5, 128.6, 58.9, 
49.8, 44.8, 40.5, 36.1; HRMS (ESI) m/z calc’d for C9H19N4O3 [M+H]+:231.1457, found 231.1451; [α]D25 = +0.4° (c 
= 2.33, D2O). 
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Mechanism Experiments 
 
Spectroscopic evidence for Pd π-allyl species in stoichiometric studies.  To a ½ dram vial was added Pd(bis-
sulfoxide)OAc2 catalyst (50.2 mg, 0.1 mmol, 1.0 equiv), methyl N-tosylcarbamate (45.9 mg, 0.2 mmol, 2.0 equiv), 
and a stir bar.  A stock solution of 1-decene (14.2 mg, 0.1 mmol, 1.0 equiv) and nitrobenzene (0.04 mmol, 0.4 equiv, 
internal standard) in THF-d8 (0.30 mL) was added via syringe. The vial was capped and placed in an oil bath for 4 h 
at 45°C, after which a 0.05 mL aliquot was removed, filtered through glass wool, and diluted to 0.5 with THF-d6.  
1H NMR analysis indicated ~66% conversion of the starting material, and the presence of peaks consistent with a Pd 
π-allyl species.70   
 1H NMR (500 MHz, THF-d8) δ 5.40 (broad s, 1H), 3.4-3.8 (broad m, 2H), 2.60 (broad s, 1H, overlapped). 
 
 Trapping of the Pd π-allyl species as the chloride dimer.  To a ½ dram vial was added Pd(bis-
sulfoxide)OAc2 catalyst (50.2 mg, 0.1 mmol, 1.0 equiv), methyl N-tosylcarbamate (45.9 mg, 0.2 mmol, 2.0 equiv), 
and a stir bar.  A separate ½ dram vial was charged with n-decene (14.2 mg, 0.1 mmol, 1.0 equiv), and transferred 
with THF (0.15 mL) to the vial containing all of the solid reactants.  This vial was then capped and heated at 45°C 
for 4 h, after which a solution of tetrabutylammonium chloride (111 mg, 0.4 mmol, 4.0 equiv) in acetone (0.5 mL) 
was added.  The vial was heated an additional 1 h at 45°C, filtered through a celite plug, and evaporated to yield a 
yellow residue.  Flash chromatography (gradient hexanes->2%->5% EtOAc/hexanes) afforded the chloride dimer as 
a yellow oil (18.3 mg, 0.033 mmol, 66% yield).  
 1H NMR (400 MHz, CDCl3) δ 5.26 (app dt, J = 12.0, 6.4 Hz, 2H), 3.86 (m, 4H), 2.82 (d, J =12.0 Hz), 1.46-
1.21 (m, 28H), 0.88 (t, J = 6.8 Hz, 6H).  This data was in agreement with the literature.20  
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 Functionalization studies.  A 1 dram vial was charged with methyl N-tosylcarbamate (457.4 mg, 2.0 
mmol, 20 equiv), Cr(salen)Cl (37.8 mg, 0.06 mmol, 0.6 equiv), benzoquinone (215.7 mg, 2.0 mmol, 20 equiv), a stir 
bar, and TBME (1.5 mL).  The vial was capped, stirred at 45°C for 1 h, and the vials were allowed to cool to room 
temperature (10 min). π-allylPd acetate dimer20 (30.4 mg, 0.05 mmol, 0.5 equiv) was added, and the mixture was 
heated for an additional 1 h at 45°C.  The vial was cooled to room temperature, diluted to 20 mL with ether, and 
washed with 5% aq. K2CO3 (8x5 mL).  The combined aqueous layers were back extracted with ether (3x25 mL), the 
organic layers combined, dried over MgSO4, and evaporated at reduced pressure.  Nitrobenzene was added (4.11 
µL, weight recorded) as an internal standard, and the 1H NMR spectrum in CDCl3 was examined.  The ratio between 
the ortho protons of PhNO2 and the allylic N-CH2 protons was used to determine yield.  L/B and E/Z ratios were 
obtained by GC.  Linear acetate products (27% yield) were also detected in this fashion. The branched allylic acetate 
product was observed, although overlap of diagnostic peaks prevented a quantitative determination of yield. 
 No amount of the product was detected by GC analysis of the crude reaction mixture when either BQ 
or Cr(salen)Cl was omitted from the reaction conditions. 
 
Branched acetate subjected to the reaction conditions.  Independently synthesized branched acetate product (19.8 
mg, 0.1 mmol, 1.0 equiv) was subjected to the standard reaction conditions.  After 72 h, the vial was spiked with 
PhNO2 (4.11 µL, weight recorded), diluted with CDCl3 (1 mL) and homogenized by vortex stirring. A 0.4 mL 
aliquot of this solution was filtered through glass wool, diluted to 0.7 mL with CDCl3, and analyzed by 1H NMR. 
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The ratio between the ortho protons of PhNO2 and the allylic N-CH2 protons was used to determine yield.  L/B and 
E/Z ratios were obtained by GC.  It was noted that the branched allylic acetate product isomerized to the linear 
allylic acetate product, producing a 1:1 ratio after 72 h. 
 
In an analogous experiment, safrole (16.2 mg, 0.1 mmol, 1.0 equiv) was added in addition to the branched acetate 
substrate.  Branched acetate isomerization led to a 9:1 ratio of branched to linear allyl acetate product, although a 
yield could not be determined due to overlap of 1H NMR peaks. 
Standard conditions using 2,6-dimethylbenzoquinone.  Under the standard optimized conditions, BQ was 
replaced with 2,6-dimethylbenzoquinone (81.9 mg, 0.6 mmol, 2.0 equiv), and all other aspects of the reaction were 
unchanged.  Run 1 (11.2 mg, 0.30 mmol, 10% yield [8:1 L/B, 22:1 E/Z]); run 2 (9.0 mg, 0.24 mmol, 8% yield [7:1 
L/B, 22:1 E/Z]).  Average: 9% yield, 8:1 L/B, 22:1 E/Z. 
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CHAPTER 2: A CATALYTIC, BRØNSTED BASE STRATEGY FOR INTERMOLECULAR ALLYLIC 
C—H AMINATION71  
2.1 INTRODUCTION 
Although the Cr(salen)Cl catalyzed allylic C—H amination successfully delivered synthetically useful 
amounts of product (see Chapter 1), several challenges still remained.  For example, some substrate classes were 
prone to isomerization of the olefin starting material, Lewis basic functional groups occasionally led to lower yields, 
and acetate side-products were always observed with the Cr(salen)Cl additive.  To address these challenges we re-
evaluated the activation strategies that had been succesfully employed for Pd(0)-catalyzed allylic amination (Figure 
2.1).  Strongly coordinating (compared to sulfoxides) ligands such as phosphines have been frequently employed for 
Pd(0)-catalyzed aminations,72 and may promote functionalization via cationic intermediates.73   
Figure 2.1. Activation modes for the functionalization of Pd π-allyl intermediates with nitrogen nucleophiles. 
 
This type of activation can be defined as an “electrophile” activation approach.  Alternatively, many Pd(0) 
allylic amination methods use deprotonated nucleophiles,74 especially in cases where the amine is not particularly 
basic (pKa < 25); exogenous stoichiometric base can also be added.75  This type of activation can be defined as a 
“nucleophile” activation approach.  Cr(salen)Cl’s proposed role as a Lewis acid (binding to quinone, which is bound 
to the Pd π-allyl,76 Figure 2.1) would place it in the category of an electrophile activation.  We hypothesized that 
deprotonation of the N-tosylcarbamate nucleophile is important for functionalization (usually deprotonated by 
acetate anion brought in by the Pd catalyst); therefore, increasing the amount of deprotonated nucleophile in solution 
should accelerate the reaction. The addition of a catalytic amount of base could potentially increase the amount of 
deprotonated nucleophile, activating the nucleophile.  Additionally, several other C—H activation methods have 
benefited from the addition of catalytic bases.77  Ultimately it was hoped that a substitute for Cr(salen)Cl could 
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reduce many of the aformentioned problems with the linear allylic amination reaction, while maintaining high 
selectivities for the linear product.78 
 
2.2 RESULTS AND DISCUSSION 
A series of bases in catalytic quantities were evaluated for their ability to promote allylic amination.  While bases 
such as pyridine and primary amine bases gave low product yields (Table 2.1, entries 3-5), tertiary and hindered 
secondary amine bases led to improved yields of allylic amination products, with selectivities comparable to the 
Cr(salen)Cl conditions (Table 2.1, entries 6-8, vs. entry 2).  During addition of the base to a solution of the 
nucleophile, a visible precipitate forms.  This suggests the formation of a salt between the N-tosylcarbamate and the 
amine base.  However, super-stoichiometric use of the preformed salt led to low yields of product (Table 2.1, entry 
9).  Further exploring the effect of base concentration, a series of different amounts of DIPEA 
(diisopropylethylamine) were screened (Figure 2.1, 0-200 mol%).  Although a mimimum amount of base is clearly 
necessary (>2 mol%), higher amounts of base (>25 mol%) gave low yields of product .  Presumably this drop in 
yield is due to either binding of the amine base with palladium, or a lack of available protons to drive the quinone-
mediated reoxidiation of palladium. 
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Table 2.1. Exogenous, catalytic base additives for direct C—H amination. 
 
entry additive yield(%)a L:Bb E:Zc 
1 none 1d - - 
2 (S,S)-Cr(salen)Cl  2 50 11:1 19:1 
3 pyridine 9 12:1 14:1 
4 2,6-di-tert-butylpyridine - - - 
5 N-isopropylamine - - - 
6 N,N-diisopropylamine 66 12:1 15:1 
7 triethylamine 60 14:1 15:1 
8 N,N-diisopropylethylamine 66 11:1 17:1 
9 MeOC(O)NTsH-DIPEAe 9 6:1 10:1 
aisolated yield of linear product. blinear/branched ratio determined by HPLC of crude reaction mixture. cdetermined by 1H NMR after 
chromatography. d 1H NMR yield by comparison with internal standard. e 2.0 equiv. of the pre-formed salt was used instead of MeOC(O)NHTs. 
Next, the DIPEA-catalyzed amination scope was compared with the previously reported Cr(salen)Cl conditions 
(Table 2.2).  For isomerization prone substrates, the DIPEA conditions delivered higher overall yields (Table 2.2, 
entries 1-6).  Notably, aryl triflates are unreactive towards this chemistry, making it orthogonal to Pd(0) methods 
(Table 2.2, entry 4).  Cr(salen)Cl is a well known catalyst for asymmetric epoxide ring opening,79 rendering our 
Cr(salen)Cl amination conditions incompatible with terminal epoxide substrates (Table 2.2, entries 6-8).  However, 
the DIPEA conditions gave acceptable yields of amination products with the epoxide intact.  These products could 
potentially be elaborated by ring opening to generate motifs found in beta-blocker80 and cystic fibrosis drugs (Table 
2.2, entry 6).81  The new DIPEA conditions also gave higher yields (than Cr) for other complex substrates and 
nucleophiles (Table 2.2, entries 10-14). 
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Figure 2.2. Effect of DIPEA concentration on reactivity for linear allylic C—H amination. 
 
In practical terms, this method represents a useful means of obtaining allylic amine products.  The nitrogen 
nucleophiles can be easily synthesized on >100g scale, and are bench stable reagents (Figure 2.3, A).  Additionally, 
the two groups on the nitrogen can be orthogonally removed using either mild base or one electron reduction (Figure 
2.3, B).  By employing both methods, the free allylic amine can be unveiled for further elaboration.  Alternatively, 
reduction of the carbamate can produce allylic methyl amines. 
C—H activation methods can be particularly powerful when applied to late stages of synthetic sequences.  One 
application is to generate diversity by elaborating known pharmacophores.  To this end, we examined the amination 
of 3182 to generate 32, which had been previously used to generate steroid-antibiotic hybrids for anti-cancer research 
(Figure 2.4, A).83  As expected, 32 was generated efficiently using the DIPEA reaction conditions.  More 
impressively, completely unprotected 33 was also a viable substrate for the improved allylic amination.  Consistent 
with Table 2.2, Cr(salen)Cl conditions led to lower yields of product (34% yield).  Cedrene-derived 35 also provided 
the allylic amine in good yield (80% yield, Figure 2.4, B).  These are relatively rare examples of unprotected alcohol 
tolerance for a C—H amination reaction.  This method has also been utilized by our group for the diversification of 
the β-lactam pharmacophore.84 
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Table 2.2. Scope and comparison of the Brønsted base vs. Lewis acid promoted allylic C—H amination. 
 
 isolated yield entry 
 allylic amination product  DIPEAa Cr(salen)Cl 
1 
 
22  61%b 37%c 
2 23 R = CHO 77% 76% 
3  24 R = CN 79% 59% 
4 25 R = H 81% 53% 
5 
 
26 R = Tf 89% 36% 
6 
 
(-)-27  54% <1% 
7  (+)-28  48%e <1% 
8 
 
(-)-29  64% <1% 
9 
 
(+)-30  59% 45% 
10 
 
(+)-12  76% 63%d 
11 
12 
13 
14 
 
 
4a 
4b 
4c 
4d 
R = Me 
R = Bn 
R = t-Bu 
R = Fm 
84% 
87% 
69%f 
55%f 
53%d 
65%d 
40%d 
40%d 
aAverage of at least two runs at 0.3 mmol.  Products were isolated as one regio- and olefin isomer (1H NMR).  b18:1 E/Z.  c13:1 E/Z.  dReported 
in Chapter 1.  e48 h reaction time.  f10 mol% DIPEA, CCl4 solvent, 24 h reaction time;  Fm = 9-fluorenylmethyl. 
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Figure 2.3. Versatility of the N-tosyl carbamate functional group. 
 
a) K2CO3, MeOH, 25°C, 3.5 h; (b) Na-C10H8, -78°C, DME, 10 min; (c) NaOH, H2O/EtOH, 110°C, 4 h; (d) LiAlH4, THF, reflux, 5 h. 	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Figure 2.4. Late-stage oxidation of natural product derivatives via direct C—H allylic amination. 
 
(a) 1 (10 mol%), DIPEA (6 mol%), TsNHCO2Me (2.0 equiv.), BQ (2.0 equiv.), 0.66 M TBME, 45°C, 72h. 
 The proposed catalytic cycle for the DIPEA system is show in Figure 2.5, A.  Deprotonation of the N-
tosylcarbamate by DIPEA leads to a salt, which is capable of delivering the nucleophile to the Pd π-allyl 
intermediate.  Either acetate or N-tosylcarbamate that was previously associated with the Pd can form a new acetate 
salt B (which subsequently exchanges anions with nucleophile to form acetic acid and A), or directly regenerate A, 
respectively.   
	  50	  
Figure 2.5. Proposed catalytic cycle for Brønsted base-catalyzed, linear allylic C—H amination. 
 
The higher acidity of N-tosylcarbamates (pKa = 3.585) should drive the formation of acetic acid.  Addition 
of an exogenous acetate source (tetra-n-butylammonium acetate) led to nearly identical product yields and 
selectivities as the amine base system (Figure 2.5, B).  With both the Cr(salen)Cl and the Brønsted base amination 
conditions, it is now possible to examine key similarities and differences in the reaction mechanisms.  For example, 
we had previously proposed on the basis of stochiometric studies that activation of the Pd π-allyl electrophile occurs 
via interaction with Cr-BQ complex (see Chapter 1).  In order to test the role of quinones in both reactions (Cr and 
DIPEA) under catalytic conditions, we evaluated a series of 1,4-quinones with different methyl substituents.  If 
binding of the quinone to one or both metals (Pd & Cr) is important for functionalization, lower product yields 
should be obtained.  For the Brønsted base system, quinone is thought to only act as a oxidant for Pd and should be 
relatively insensitive to substitution on the quinone.  Consistent with these hypotheses, addition of one or two 
methyl groups to the same olefin of the quinone leads to a significant drop in yield for the Cr conditions; blocking 
both olefins leads to only low reactivity (Table 2.3, entries 3-6).  In contrast, the Brønsted base-catalyzed conditions 
are unaffected by methyl group substitutions, further establishing that catalytic base likely activates the nucleophile.  
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Finally, the Cr(salen)Cl conditions are sensitive to lower concentrations of BQ while the DIPEA conditions give 
identical yields using only one equivalent of BQ (Table 2.3, entry 2).  However, this data does not rule out the 
possibility that BQ acts to promote the formation of an active Cr species (which may activate the nucleophile). 
Table 2.3.  Effect of quinone sterics on Lewis acid vs. Brønsted base C—H amination systems 
 
 DIPEA Cr(salen)Cl  2 
Entry Quinone Yield(%)a Yield(%)a 
1 66 50 
2 
 
 67b  28b 
3 
 
71 35 
4 
 
60 39 
5 
 
60 11 
6 
 
75 7 
aAverage isolated yield of linear product after at least two runs at 0.3 mmol. bBQ (1.0 equiv.) was used. 
 
2.3 CONCLUSION 
The use of sub-stoichiometric amounts of Brønsted base as a nucleophile activator has resulted in a substantial 
improvement to the intermolecular allylic C—H amination reaction.  Higher yields are obtained using the DIPEA 
system, and the substrate scope encompasses a wide range of functional groups such as epoxides and alcohols.  This 
has enabled the diversification of numerous pharmacophores with the allyl amine group.  Finally, the Brønsted 
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system has allowed a closer examination of quinone’s role in the Lewis-acid catalyzed mechanism, further 
supporting the hypothesis of a BQ-Cr(salen)Cl interaction that promotes functionalization. 
 
2.4 EXPERIMENTAL SECTION 
General Information: The following commercially obtained reagents for the allylic amination reaction were used 
as received: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (Aldrich or Strem); N,N-diisopropylethylamine (DIPEA, 
Aldrich), (+)-(S,S)-Cr(salen)Cl (Strem Chemicals), tert-butyl methyl ether (TBME, anhydrous, Aldrich). Dry 
Solvents tetrahydrofuran (THF), methylene chloride (CH2Cl2), and diethyl ether (Et2O), were purified prior to use by 
passage through a bed of activated alumina (Glass Contour, Laguna Beach, California). All allylic amination 
reactions were run under air with no precautions taken to exclude moisture. All other reactions were run over a 
stream of N2 gas with dry solvent in flame-dried glassware unless otherwise stated.  Solvents were removed by 
rotatory evaporation at  ca. 40 torr, unless otherwise stated.  All products were filtered through a glass wool plug 
prior to obtaining a final weight.  Thin-layer chromatography (TLC) was conducted with E. Merck silica gel 60 
F254 precoated plates (0.25 mm) and visualized with UV, potassium permanganate, ceric ammonium molybdate, 
and ninhydrin staining.  Flash column chromatography was performed as described by Still et al.86 using EM reagent 
silica gel 60 (230-400 mesh).  CDCl3 used to analyze compounds containing epoxide or aldehyde functionality was 
filtered through basic alumina immediately prior to use.  1H NMR spectra were recorded on a Varian Unity-400 (400 
MHz) or Varian Unity-500 (500 MHz) spectrometer and are reported in ppm using solvent as an internal standard 
(CHCl3 at 7.26 ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p = quintet, m = multiplet, b = 
broad, app = apparent; coupling constant(s) in Hz; integration.  Proton-decoupled 13C NMR spectra were recorded 
on a Varian Unity-400 (100 MHz) or Varian Unity-500 (125 MHz) spectrometer and are reported in ppm using 
solvent as an internal standard (CDCl3 at 77.0 ppm). 19F NMR spectra were recorded on a Varian Unity-400 (376 
MHz) spectrometer and are reported in ppm using CFCl3 as an external standard (0.00 ppm).  IR spectra were 
recorded as thin films on NaCl plates on a Mattson Galaxy Series FTIR 5000 and are reported in frequency of 
absorption (cm-1). High-resolution mass spectra were obtained at the University of Illinois Mass Spectrometry 
Laboratory. Optical rotations were measured using a 1 mL cell with a 1 dm path length or a 0.2 mL cell with a 10 
mm path length on a Jasco P-1020 polarimeter. Optical rotations were obtained with a sodium lamp and are reported 
as follows: [α]λT°C (c = g/100 mL, solvent).  Melting points are uncorrected. 
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Catalytic Base Exploration 
Standard Procedure for Table 2.1, liquid additives.  A 1 dram vial was charged with 1-decene (42.1 mg, 0.3 
mmol, 1.0 equiv), followed by t-butyl methyl ether (0.450 mL).  1,2-Bis(phenylsulfinyl)ethane palladium(II) acetate 
(15.1 mg, 0.03 mmol, 0.10 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), methyl tosylcarbamate (137.6 mg, 
0.6 mmol, 2.0 equiv), and a stir bar were then sequentially added.  Liquid additive (0.018 mmol, 0.06 equiv) was 
added via syringe.  The vial was fitted with a Teflon cap, and heated to 45°C (with magnetic stirring) in an oil bath 
for 72 h.  The vial was removed, allowed to cool to room temperature, and thoroughly rinsed into a 125 mL 
separatory funnel with ether (ca. 30 mL).  The organic phase was washed with 5% aq. K2CO3 (6 x 10 mL), and the 
aqueous rinses back-extracted with ether (2 x 30 mL).  The combined organic extracts were dried over MgSO4, 
filtered through a 1:1 mixture of Celite/silica gel, and evaporated to dryness (ca. 30-40°C., 30 torr).  The crude 
product was purified by flash chromatograph on silica gel (7% EtOAc/hexanes), and evaporated to dryness.  Yields 
are reported as the amount of linear product (E and Z isomers). 
HPLC analysis of L/B ratio.  Immediately before workup, the vial was sampled by removing ~5 µL solvent.  This 
small sample was dissolved in a mixture of ether/water (1 mL), mixed by vortex stirring, and the organic layer 
transferred to a new vial.  Ether was removed by passing a gentle stream of nitrogen over the vial (2 min), followed 
by addition of 2 mL acetonitrile. HPLC analysis (Agilent© Eclipse XDB-C8, 35°C, 35% H2O/MeCN, 1.5 mL/min) 
was used to determine the linear/branched ratio, tR = 13.5 (linear E & Z), 12.8 min (branched), reported as the 
average of two injections. Linear products possessing E and Z configuration were not separated by this method.   
Procedure for Table 2.1, solid additives.  Reactions with solid additives were run in an analogous way as above by 
adding the solid additive (0.018 mmol, 0.06 equiv) immediately after the palladium catalyst. 
Table 2.1, Entry 1: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), benzoquinone 
(64.9 mg, 0.6 mmol, 2.0 equiv), and methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following 
the standard procedure.  Product yield was determined by comparison to an internal standard (nitrobenzene).  Run 1: 
(1.2% yield); run 2: (1.2% yield); run 3: (1.8% yield).  E/Z and L/B were not determined. Average yield: 1%. 
Table 2.1, Entry 2: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), (+)-(S,S)-
Cr(salen)Cl (11.4 mg, 0.018 mmol, 0.06 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl 
tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (57.3 mg, 
0.156 mmol, 52% yield linear product [11:1 L/B, 21:1 E/Z]); run 2: (52.9 mg, 0.144 mmol, 48% yield [10:1 L/B, 
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17:1 E/Z]).  Average yield: 50% [11:1 L/B, 19:1 E/Z].  Allylic acetate products were also isolated as a yellow oil. 
Run 1 (4.7 mg, 0.0237 mmol, 8% yield [2:1 L/B, 12:1 E/Z]; run 2 (7.3 mg, 0.0368 mmol, 12% yield, [1.5:1 L/B, 
14:1 E/Z]).  Average allylic acetate yield: 10% [2:1 L/B, 13:1 E/Z]. 
Table 2.1, Entry 3: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), pyridine (1.45 µL, 
0.018 mmol, 0.06 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl tosylcarbamate (137.6 mg, 0.6 
mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (11.0 mg, 0.030 mmol, 10% yield [12:1 L/B, 
14:1 E/Z]); run 2: (8.8 mg, 0.0239 mmol, 8% yield [12:1 L/B, 13:1 E/Z]).  Average yield: 9% [12:1 L/B, 14:1 
E/Z]. 
Table 2.1, Entry 4: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), di-tert-
butylpyridine (1.67 µL, 0.018 mmol, 0.06 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl 
tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (no product 
detected by HPLC); run 2: (no product detected by HPLC).  
Table 2.1, Entry 5: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N-isopropylamine 
(2.07 µL, 0.018 mmol, 0.06 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl tosylcarbamate 
(137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (no product detected by 
HPLC); run 2: (no product detected by HPLC).  
Table 2.1, Entry 6: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylamine (2.54 µL, 0.018 mmol, 0.06 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl 
tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (69.6 mg, 
0.189 mmol, 63% yield [11:1 L/B, 16:1 E/Z]); run 2: (75.4 mg, 0.205 mmol, 68% yield [13:1 L/B, 14:1 E/Z]).  
Average yield: 66% [12:1 L/B, 15:1 E/Z]. 
Table 2.1, Entry 7: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), triethylamine (2.51 
µL, 0.018 mmol, 0.06 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl tosylcarbamate (137.6 mg, 
0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (67.0 mg, 0.182 mmol, 61% yield [14:1 
L/B, 15:1 E/Z]); run 2: (64.9 mg, 0.177 mmol, 59% yield [14:1 L/B, 15:1 E/Z]).  Average yield: 60% [14:1 L/B, 
15:1 E/Z]. 
Table 2.1, Entry 8: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (3.14 µL, 0.018 mmol, 0.06 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and 
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methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (73.6 
mg, 0.200 mmol, 67% yield [11:1 L/B, 15:1 E/Z]); run 2: (73.0 mg, 0.199 mmol, 66% yield [11:1 L/B, 19:1 E/Z]); 
Average yield: 66% [11:1 L/B, 17:1 E/Z]. 
Table 2.1, Entry 9: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), 
N,N-diisopropylethylammonium methyl tosylcarbamate [215.1 mg, 0.6 mmol, 2.0 equiv, transferred with TBME (2 
x 0.150 mL), added last], benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), were used following the standard 
procedure, except that the initial volume of solvent added with the starting material was 0.150 mL to accommodate 
the DIPEAH-MeOCONTs transfer volume.  Run 1: (7.8 mg, 0.0212 mmol, 7% yield [6:1 L/B, 8:1 E/Z]); run 2: 
(10.6 mg, 0.0288 mmol, 10% yield [7:1 L/B, 11:1 E/Z]).  Average yield: 9% [7:1 L/B, 10:1 E/Z]. 
N,N-diisopropylethylammonium methyltosylcarbamate.  To a flame-dried 15 mL flask with Teflon stir bar was 
added N,N-diisopropylethylamine (0.52 mL, 3.0 mmol, 1.0 equiv) and then cooled to 0°C. A solution of methyl 
tosylcarbamate (687.8 mg, 3.0 mmol, 1.0 equiv) in dichloromethane (1.5 mL) under N2 was then transferred 
dropwise via syringe to the amine base with vigorous stirring.  After the addition was completed, the reaction slowly 
warmed to room temperature over 4 h.  Solvent was removed by rotatory evaporation (30°C, 20 torr) to yield a pale 
yellow, viscous oil.   
Figure 2.2. Exploration of Catalytic DIPEA Loadings.  Base loadings at 25 mol% and higher became highly 
viscous, and required vigorous stirring to achieve reproducible results.  
Alternate Procedure for Difficult Stirring Conditions.  A 3.0 mL conical Reacti-Vial© (Thermo Scientific, 
Rockford, IL) was charged with 1-decene (42.1 mg, 0.3 mmol, 1.0 equiv), followed by t-butyl methyl ether (0.450 
mL).  1,2-Bis(phenylsulfinyl)ethane palladium(II) acetate (15.1 mg, 0.03 mmol, 0.10 equiv), benzoquinone (64.9 
mg, 0.6 mmol, 2.0 equiv), methyltosyl carbamate (137.6 mg, 0.6 mmol, 2.0 equiv), and a spin-vane were then 
sequentially added.  Under vigorous magnetic stirring, DIPEA was added dropwise via syringe at a rate of 1 drop/10 
sec.  A black, insoluble residue quickly forms on the sides of the vial.  The vial was fitted with an open cap 
containing a Teflon septum, and heated to 45°C (with magnetic stirring) in an oil bath for 72 h.  The vial was 
removed, allowed to cool to room temperature, and thoroughly rinsed into a 125 mL separatory funnel with acetone 
(2 x 0.5 mL) and ether (ca. 30 mL).  The organic phase was washed with 5% aq. K2CO3 (6 x 10 mL), and the 
aqueous rinses back-extracted with ether (2 x 30 mL).  The combined organic extracts were dried over MgSO4, 
filtered through a 1:1 mixture of Celite/silica gel, and evaporated to dryness (ca. 30-40°C., 30 torr).  The crude 
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product was purified by flash chromatography on silica gel (7% EtOAc/hexanes, load column with CH2Cl2), and 
evaporated to dryness.  Yields are reported as the amount of linear product (E and Z isomers). 
Figure 2.2 (0 mol%): See Table 2.1, entry 1. 
Figure 2.2 (1 mol%): Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (10.0 µL, 0.003 mmol, 0.010 equiv, 0.3M stock solution in TBME), benzoquinone (64.9 mg, 
0.6 mmol, 2.0 equiv), methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv), and 0.440 mL TBME were used 
following the standard procedure.  Yields were determined by comparison with an internal standard (nitrobenzene).  
Run 1: (1.8% yield,); run 2: (3.7% yield), run 3: (2.0% yield).  Average yield: 3%. 
Figure 2.2 (3 mol%): Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (1.57 µL, 0.009 mmol, 0.030 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and 
methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (65.0 
mg, 0.177 mmol, 59% yield); run 2: (68.4 mg, 0.186 mmol, 62% yield); run 3: (56.0 mg, 0.152 mmol, 51% yield).  
Average yield: 57%. 
Figure 2.2 (6 mol%): Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (3.14 µL, 0.018 mmol, 0.060 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and 
methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (73.6 
mg, 0.200 mmol, 67% yield; run 2: (73.0 mg, 0.199 mmol, 66% yield]); run 3: (71.6 mg, 0.195 mmol, 65% yield.  
Average yield: 66%. 
 Figure 2.2 (10 mol%): Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (5.23 µL, 0.3 mmol, 0.10 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl 
tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (66.1 mg, 
0.180 mmol, 60% yield); run 2: (72.6 mg, 0.198 mmol, 66% yield); run 3: (75.0 mg, 0.204 mmol, 68%).  Average 
yield: 65%. 
Figure 2.2 (25 mol%): Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (13.1 µL, 0.075 mmol, 0.25 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and 
methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the alternate procedure.  Run 1: (30.6 
mg, 0.0833 mmol, 28% yield); run 2: (31.4 mg, 0.0854 mmol, 28% yield); run 3 (27.3 mg, 0.0743 mmol, 25% 
yield); run 4 (28.3 mg, 0.0770 mmol, 26% yield).  Average yield: 27%.  
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Figure 2.2 (50 mol%): Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (26.1 µL, 0.15 mmol, 0.50 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl 
tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the alternate procedure. Run 1: (22.7 mg, 
0.0618 mmol, 21% yield); run 2: (21.6 mg, 0.0588 mmol, 20% yield); run 3 (23.0 mg, 0.0626 mmol, 21% yield); 
run 4 (22.7 mg, 0.0618 mmol, 21% yield).  Average yield: 21%.  
Figure 2.2 (100 mol%): Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (52.3 µL, 0.3 mmol, 1.0 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl 
tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the alternate procedure.  Run 1: (9.2 mg, 
0.0250 mmol, 8% yield); run 2: (12.5 mg, 0.0340 mmol, 11% yield), run 3: (12.7 mg, 0.0346 mmol, 12% yield); run 
4: (12.4 mg, 0.0337 mmol, 11% yield).  Average yield: 11%.  
Figure 2.2 (200 mol%): Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (104.5 µL, 0.6 mmol, 2.0 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl 
tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the alternate procedure.  Run 1: (9.7 mg, 
0.0264 mmol, 9% yield); run 2: (8.6 mg, 0.0234 mmol, 8% yield); run 3: (10.4 mg, 0.0283 mmol, 9% yield); run 4: 
(8.7 mg, 0.0237 mmol, 8% yield).  Average yield: 9%.  
Substrate Scope 
General DIPEA Procedure.  A 1 dram vial was charged with olefin (0.3 mmol, 1.0 equiv), followed by t-butyl 
methyl ether (0.450 mL).  1,2-Bis(phenylsulfinyl)ethane palladium(II) acetate (15.1 mg, 0.03 mmol, 0.10 equiv), 
benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv), and a stir 
bar were then sequentially added.  N,N-Diisopropylethylamine (3.14 µL, 0.018 mmol, 0.06 equiv) was added via 
autopipet (or syringe), and the reaction mixture instantly became cloudy.  The vial was fitted with a Teflon cap, and 
heated to 45°C (with magnetic stirring) in an oil bath for 72 h.  The vial was removed, allowed to cool to room 
temperature, and vigorously rinsed into a 125 mL separatory funnel with ether (ca. 30 mL).  The organic phase was 
washed with 5% aq. K2CO3 (6 x 10 mL), and the aqueous rinses back-extracted with ether (2 x 30 mL).  The 
combined organic extracts were dried over MgSO4, filtered through a 1:1 mixture of Celite/silica gel, and 
evaporated to dryness (ca. 30-40°C, 30 torr).  The crude product was purified by flash chromatography on silica gel, 
and evaporated to dryness.   
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Comparison to Cr-catalyzed reaction conditions.  Reactions with Cr were run in an analogous way as above by 
substituting (+)-Cr(salen)Cl (11.4 mg, 0.018 mmol, 0.06 equiv, Strem) for DIPEA.  This reagent was added 
immediately after the palladium catalyst. 
 (E)-methyl 6-(N-(methoxycarbonyl)-4-methylphenylsulfonamido)hex-4-
enoate[22]: Methyl hex-5-enoate (38.5 mg, 0.3 mmol, 1.0 equiv, Aldrich) was 
reacted following the general procedure.  Column chromatography (30% EtOAc/hexanes) yielded the product as a 
pale yellow oil.  Linear/branched ratio was >20:1 after chromatography.  Run 1 (66.1 mg, 0.186 mmol, 62% yield, 
18:1 E/Z); run 2 (64.0 mg, 0.180 mmol, 60% yield, 17:1 E/Z). Average yield: 61%, 18:1 E/Z.  Cr conditions: 
Linear/branched ratio was >20:1 after chromatography, (39.5 mg, 0.111 mmol, 37% yield, 13:1 E/Z).  
 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.5 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 5.76 (dt, J = 15.5, 6.5 Hz, 
1H), 5.57 (dt, J = 15.5, 6.3 Hz, 1H), 4.38 (d, J = 6.5 Hz, 2H), 3.67 (s, 3H), 3.66 (s, 3H), 2.42 (s, 3H), 2.35-2.41 (m, 
4H); 13C NMR: (125 MHz, CDCl3) δ 173.2, 152.6, 144.5, 136.4, 133.2, 129.2, 128.4, 125.6, 53.7, 51.5, 48.3, 33.3, 
27.3, 21.6; IR (film, cm-1): 3000, 2955, 2926, 2850, 1732, 1597, 1494, 1441, 1356, 1324, 1266, 1240, 1166, 1128, 
1089, 1037, 1018, 972, 906, 874, 816, 768, 677; HRMS (ESI) m/z calc’d for C16H22NO6S [M+H]+: 356.1168, found 
356.1154. 
 (E)-methyl 3-(4-formylphenyl)allyl(tosyl)carbamate [23]: p-Allylbenzaldehyde (43.9 mg, 0.3 mmol, 1.0 equiv) 
was reacted according to the standard procedure.  Flash chromatography (30% 
EtOAc/hexanes) afforded off-white crystals.  Run 1 (88.5 mg, 0.237 mmol, 79% 
yield); run 2 (84.1 mg, 0.225 mmol, 75% yield). Only the linear E product was 
observed by 1H NMR.  Average yield: 77%.  Cr conditions: Only the linear E product was observed by 1H NMR.  
Run 1 (81.7 mg, 0.219 mmol, 73% yield); run 2 (88.5 mg, 0.237 mmol, 79% yield); Average yield 76%. 
1H NMR (500 MHz, CDCl3) δ 9.99 (s, 1H), 7.84 (d, J = 8.0 Hz, 2H), 7.83 (d, J = 7.5 Hz, 2H), 7.53 (d, J = 
8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 6.72 (d, J = 16.0 Hz, 1H), 6.41 (dt, J = 15.8, 6.3 Hz, 1H), 4.65 (dd, J = 6.5, 1.0 
Hz, 2H), 3.73 (s, 3H), 2.43 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 191.7, 152.6, 144.8, 142.2, 136.2, 135.7, 132.6, 
130.1, 129.4, 128.5, 127.7, 127.1, 54.0, 48.6, 21.6; IR (film, cm-1): 3039, 2954, 2920, 2861, 2832, 2745, 1739, 1699, 
1603, 1569, 1443, 1360, 1309, 1280, 1231, 1213, 1089, 969, 912, 879, 815, 757, 676; HRMS (ESI) m/z calc’d for 
C19H20NO5S [M+H]+: 374.1062, found 374.1059. 
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 (E)-methyl 3-(4-cyanophenyl)allyl(tosyl)carbamate[24]:  p-Allylbenzonitrile87 
(43.0 mg, 0.3 mmol, 1.0 equiv) was reacted according to the standard procedure.  
Column chromatography (35% EtOAc/hexanes) led to the isolation of white 
crystals.  Run 1 (89.2 mg, 0.241 mmol, 80% yield); run 2 (86.1 mg, 0.232 mmol, 78 % yield). Only the linear E 
product was observed by 1H NMR.  Average yield: 79%. Cr conditions: Only the linear E product was observed by 
1H NMR.  Run 1 (67.0 mg, 0.181 mmol, 60% yield); run 2 (64.6 mg, 0.175, 58% yield); Average yield: 59%. 
 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.0 Hz, 2H), 7.61 (d, J = 8.5 Hz, 2H), 7.46 (d, J = 8.5 Hz, 2H), 
7.30 (d, J = 8.0 Hz, 2H), 6.67 (d, J = 16.0 Hz, 1H), 6.38 (dt, J = 16.0, 6.3 Hz, 1H), 4.63 (dd, J = 6.5, 1.0 Hz, 2H), 
3.72 (s, 3H), 2.43 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 152.6, 144.9, 140.7, 136.2, 132.4, 131.9, 129.4, 128.4, 
128.0, 127.0, 118.8, 111.2, 54.0, 48.5, 21.6; IR (film, cm-1): 3042, 2957, 2226, 1737, 1605, 1495, 1443, 1360, 1318, 
1277, 1231, 1169, 1130, 1089, 1018, 971, 912, 881, 815, 768, 733, 676; HRMS (ESI) m/z calc’d for C19H19N2O4S 
[M+H]+: 371.1066, found 371.1065. 
 (E)-methyl 2-hydroxy-3-methoxy-5-(3-(N-(methoxycarbonyl)-4-methylphenylsulfonamido)prop-1-
enyl)benzoate[25]: Methyl 5-allyl-3-methoxy-salicylate (66.7 mg, 0.3 
mmol, 1.0 equiv, Aldrich) was reacted following the general procedure.  
Column chromatography (30% EtOAc/hexanes) yielded the product as a white 
solid.  Run 1 (104.8 mg, 0.233 mmol, 78% yield); run 2 (112.0 mg, 0.249 mmol, 83% yield).  Only the linear E 
product was observed by 1H NMR.  Average yield: 81%.  Cr Conditions: Only the linear E product was observed 
by 1H NMR.  Run 1 (53.4 mg, 0.119 mmol, 40% yield).   
 1H NMR (500 MHz, CDCl3) δ 11.01 (s, 1H), 7.79 (d, J = 8.0 Hz, 2H), 7.40 (s, 1H), 7.24 (d, J = 8.0 Hz, 
2H), 7.04 (s, 1H), 6.55 (d, J = 16.0 Hz, 1H), 6.10 (dt, J = 15.5, 6.5 Hz, 1H), 4.57 (d, J = 6.5 Hz, 2H), 3.93 (s, 3H), 
3.88 (s, 3H), 3.69 (s, 3H), 2.38 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 170.5, 152.6, 151.9, 148.6, 144.6, 136.3, 
133.0, 129.2, 128.4, 127.1, 122.4, 119.7, 113.7, 112.2, 56.1, 53.9, 52.4, 48.7, 21.5; IR (film, cm-1): 3066 (broad), 
2957, 1737, 1678, 1597, 1482, 1444, 1363, 1291, 1273, 1242, 1203, 1170, 1088, 1070, 964, 874, 794, 754, 669; 
HRMS (ESI) m/z calc’d for C21H24NO8S [M+H]+: 450.1223, found 450.1212. 
(E)-methyl 
3-methoxy-5-(3-(N-(methoxycarbonyl)-4-methylphenylsulfonamido)prop-
1-enyl)-2-(trifluoromethylsulfonyloxy)benzoate[26]: Methyl 5-allyl-3-
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methoxy-2-(trifluoromethylsulfonyloxy)benzoate (106.3 mg, 0.3 mmol, 1.0 equiv) was reacted following the general 
procedure.  Column chromatography (35% EtOAc/hexanes) yielded the product as an orange oil.  Run 1 (155.3 mg, 
0.267 mmol, 89% yield); run 2 (154.1 mg, 0.265 mmol, 88% yield). Only the linear E product was observed by 1H 
NMR.  Average yield: 89%.  Cr Conditions: Only the linear E product was observed by 1H NMR.  Run 1 (62.4 mg, 
0.107 mmol, 36% yield).  The β-methyl styrene product resulting from olefin isomerization was also isolated as 
colorless needles (33.3 mg, 0.0940 mmol, 31% yield).  Olefin geometry (E/Z ratio) was not determined. 
 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.5 Hz, 2H), 7.54 (d, J = 2.0 Hz, 1H), 7.29 (d, J = 8.5 Hz, 2H), 
7.16 (d, J = 2.0 Hz, 1H), 6.62 (d, J = 16.0 Hz, 1H), 6.32 (dt, J = 15.8, 6.0 Hz, 1H), 4.61 (d, J = 6.0 Hz, 2H), 3.93 (s, 
3H), 3.92 (s, 3H), 3.71 (s, 3H), 2.41 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 164.2, 152.5, 151.7, 144.9, 136.9, 
136.7, 136.1, 131.2, 129.4, 128.3, 127.4, 125.4, 121.1, 118.6 (q, J = 319.6 Hz), 114.2, 56.3, 54.0, 52.6, 48.4, 21.5; 
19F NMR: (470 MHz, CFCl3) δ -73.9 (s, 3F); IR (film, cm-1): 3021, 2955, 1744, 1594, 1422, 1363, 1333, 1275, 
1217, 1171, 1135, 1088, 1066, 968, 904, 879, 815, 736; HRMS (ESI) m/z calc’d for C22H23NO10S2F3 [M+H]+: 
582.0715, found 582.0696. 
methyl 3-methoxy-5-(prop-1-enyl)-2-(trifluoromethylsulfonyloxy)benzoate[9a]: E/Z 
ratio was not determined. 
  1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 2.0 Hz, 1H), 7.12 (d, J = 2.5 Hz, 1H), 
6.31-6.41 (m, 2H), 3.95 (s, 3H), 3.93 (s, 3H), 1.93 (d, J = 5.0 Hz, 3H); 19F NMR: (376 MHz, CFCl3) δ -74.0 (s, 3F); 
IR (film, cm-1): 3024, 2962, 2922, 2854, 1732, 1657, 1591, 1423, 1345, 1303, 1280, 1260, 1247, 1214, 1137, 1067, 
1009, 963, 874, 781, 713; HRMS (ESI) m/z calc’d for C13H13O6F3NaS [M+Na]+: 377.0290, found 377.0283.  
(S)-2-((4-allylphenoxy)methyl)oxirane [(-)-27a]: A 50 mL round bottom flask with 
stir bar was charged with p-allylphenol88 (500 mg, 3.7 mmol, 1.0 equiv) and DMF (7 
mL).  The flask was cooled to 0°C, and NaH (156.5 mg, 3.9 mmol, 1.05 equiv, 60% 
by weight in mineral oil) was added portionwise.  After stirring for 1 h at 0°C (H2 evolution ceased), (S)-oxiran-2-
ylmethyl 4-methylbenzenesulfonate (2.35 g, 10.3 mmol, 2.78 equiv, Aldrich) dissolved in DMF (3.5 mL, 1 x 1 mL 
rinse) was cannulated into the flask.  The reaction mixture was then allowed to warm to room temperature, and 
stirred for 13 h.  The reaction was quenched by cooling to 0°C, and adding sat. NH4Cl (5 mL).  After transferring to 
a separatory funnel and diluting with EtOAc (100 mL), the organic layer was washed twice with H2O, dried 30 min 
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over Na2SO4, and the solvent evaporated at 25°C.  Column chromatography (15% EtOAc/hexanes) afforded the pure 
product as a colorless oil (557.2 mg, 2.93 mmol, 79% yield).   
 1H NMR (500 MHz, CDCl3) δ 7.10 (d, J = 9.0 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 5.90-5.99 (m, 1H), 5.03-
5.08 (m, 2H), 4.19 (dd, J = 11.0, 3.0 Hz, 1H), 3.95 (dd, J = 11.0, 6.0 Hz, 1H), 3.32-3.37  (m, 3H), 2.90 (dd, J = 4.8, 
4.3 Hz, 1H), 2.75 (dd, J = 5.0, 2.5 Hz, 1H); 13C NMR: (125 MHz, CDCl3) δ 156.8, 137.7, 132.6, 129.5, 115.4, 
114.5, 68.7, 50.1, 44.6, 39.2; IR (film, cm-1): 3070, 3003, 2971, 2924, 1639, 1611, 1584, 1511, 1454, 1432, 1299, 
1242, 1178, 1037, 994, 916, 846, 829; HRMS (CI, CH4) m/z calc’d for C12H15O [M+H]+: 191.1072, found 191.1071; 
[α]D26 = -0.24° (c = 1.02, CHCl3). 
 (S,E)-methyl 3-(4-(oxiran-2-ylmethoxy)phenyl)allyl(tosyl)carbamate[(-)-27]:  Compound (-)-27a (57.1 mg, 0.3 
mmol, 1.0 equiv) was reacted following the general procedure.  Column 
chromatography (30% EtOAc/hexanes) yielded the product as a pale 
orange oil.  Run 1 (65.3 mg, 0.157 mmol, 52% yield); run 2 (75.0 mg, 
0.180 mmol, 60% yield), run 3 (63.5 mg, 0.152 mmol, 51% yield). Only the linear E product was observed by 1H 
NMR.  Average yield: 54%. Cr conditions: no product could be detected by 1H NMR of the crude reaction mixture. 
 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.0 Hz, 2H), 7.31 (d, J = 8.5 Hz, 2H), 7.26 (d, J = 8.0 Hz, 2H), 
6.88 (d, J = 9.0 Hz, 2H), 6.62 (d, J = 15.5 Hz, 1H), 6.10 (dt, J = 15.8, 6.6 Hz, 1H), 4.59 (d, J = 5.5 Hz, 2H), 4.24 
(dd, J = 11.0, 3.0 Hz, 1H), 3.95 (dd, J = 11.0, 5.5 Hz, 1H), 3.71 (s, 3H), 3.37-3.34 (m, 1H), 2.91 (dd, J = 5.0, 4.0 Hz, 
1H), 2.76 (dd, J = 5.0, 3.0 Hz, 1H), 2.41 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 158.3, 152.7, 144.5, 136.4, 133.5, 
129.5, 129.3, 128.5, 127.8, 121.7, 114.6, 68.7, 53.8, 50.0, 48.9, 44.6, 21.6; IR (film, cm-1): 3440 (broad), 3038, 
3008, 2961, 2930, 2877, 1735, 1652, 1607, 1513, 1446, 1362, 1248, 1166, 1126, 1089, 1034, 968, 911, 815, 733, 
675; HRMS (ESI) m/z calc’d for C21H23NO6SNa [M+Na]+: 440.1144, found 440.1137. [α]D22 = -0.26° (c = 1.0, 
CHCl3). 
(R,E)-methyl 4-(oxiran-2-yl)but-2-enyl(tosyl)carbamate [(+)-28]:  
(-)-(S)-2-(but-3-enyl)oxirane89 (29.4 mg, 0.3 mmol, 1.0 equiv, >99% ee) was reacted 
according to the standard procedure, except that Na2SO4 was used to dry the organic 
layers following the workup.  Column chromatography provided the product as a colorless oil. 48 h reaction time: 
run 1 (48.1 mg, 0.148 mmol, 49% yield); run 2 (45.8 mg, 0.141 mmol, 47% yield); 24 h reaction time (42.3 mg, 
0.130 mmol, 43% yield); 72 h reaction time (48.2 mg, 0.148 mmol, 49% yield).  Linear/branched and E/Z isomer 
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ratios were >20:1 by 1H NMR.  Average yield (48 h reaction time) 48%. Cr conditions: no product could be 
detected by 1H NMR of the crude reaction mixture. 
 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 5.80 (dt, J = 15.5, 7.0 Hz, 
1H), 5.68 (dt, J = 15.5, 6.0 Hz, 1H), 4.43 (d, J = 6.0 Hz, 2H), 3.68 (s, 3H), 3.02-2.98 (m, 1H), 2.77 (dd, J = 5.0, 4.0 
Hz, 1H), 2.52 (dd, J = 5.0, 3.0 Hz, 1H), 2.43 (s, 3H), 2.30-2.35 (m, 2H); 13C NMR (500 MHz, CDCl3) δ 152.6, 
144.6, 136.4, 129.6, 129.3, 128.5, 127.6, 53.8, 51.0, 48.4, 46.5 34.9, 21.6; IR (film, cm-1): 2961, 2924, 1732, 1653, 
1597, 1443, 1355, 1307, 1272, 1237, 1168, 1128, 1090, 974; HRMS (ESI) m/z calc’d for C15H20NO5S [M+H]+: 
326.1062, found 326.1051; [α]D22 = +0.04° (c = 1.09, CHCl3). 
 (S)-1-((R)-2-methyloxiran-2-yl)pent-4-en-1-ol [(+)-29a]: This procedure was adapted from a 
similar report in the literature.90  A 50 mL round bottom flask with stir bar was charged with (±)-
2-methylhepta-1,6-dien-3-ol91 (504.8 mg, 4.0 mmol, 1.0 equiv), 4Å molecular sieves (500 mg), (+)-diisopropyl 
tartrate (276 µL, 1.32 mmol, 0.33 equiv, via syringe equipped with a 16 gauge needle), and CH2Cl2 (16 mL).  The 
reaction mixture was then cooled to -10°C, and Ti(O-i-Pr)4 (234 µL, 0.8 mmol, 0.2 equiv) was added dropwise via 
syringe with stirring for 1 h.  The solution was then cooled to -35 °C, and tert-butyl hydrogen peroxide (327 µL, 1.8 
mmol, 0.45 equiv, 5.5 M in decane) was added dropwise to the white slurry.  After 11 h, 5% aq. HCl (4.4 mL) was 
added, and the reaction mixture was warmed to room temperature.  The mixture was filtered through a fritted funnel 
filled with celite, and transferred to a separatory funnel with CH2Cl2 (20 mL).  The organic layer was washed with 
water (2 x 10 mL), filtering through a fritted glass funnel each time to clear the emulsion.  The organic layer was 
then dried over Na2SO4 (1 h), decanted, and concentrated by rotatory evaporation at 0°C.  Flash chromatography 
(30% ether/pentane) afforded the epoxide as a single diastereomer (85.3 mg, 0.6 mmol, 15% yield).  A small sample 
was removed for Mosher ester analysis (vida infra). 
 1H NMR (500 MHz, CDCl3) δ 5.83 (ddt, J = 16.8, 10.3, 7.0 Hz, 1H), 5.05 (dd, J = 17.0, 1.5 Hz, 1H), 4.98 
(d, J = 10.5 Hz, 1H), 3.65 (app d, J = 9.0 Hz, 1H), 2.89 (d, J = 5.0 Hz, 1H), 2.60 (d, J = 4.5 Hz, 1H), 2.25-2.32 (m, 
1H), 2.13-2.21 (m, 2H), 1.67-1.75 (m, 1H), 1.45-1.53 (m, 1H), 1.33 (s, 3H); 13C NMR: (125 MHz, CDCl3) δ 138.2, 
114.9, 71.0, 59.1, 50.2, 32.1, 29.8, 18.0; IR (film, cm-1): 3446 (broad), 3077, 2981, 2930, 2860, 1722, 1641, 1391, 
1391, 1273, 1235, 1101, 1066, 994, 911, 816; HRMS (CI, CH4) m/z calc’d for C8H15O2 [M+H]+: 143.10721, found 
143.10715; [α]D23 = +6.0° (c = 0.42, CHCl3). 
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Determination of enantiomeric purity by Mosher ester analysis.92  The epoxy alcohol described above (10.7 mg, 
0.08 mmol, 1.0 equiv) was placed in a 1 dram vial, and diluted with CH2Cl2 (0.5 mL).  Triethylamine (50 µL, 0.37 
mmol, 4.6 equiv), N,N-dimethylaminopyridine (4.0 mg, 0.037 mmol, 0.46 equiv), and (+)-α-
methoxytrifluorophenylacetyl chloride (30 µL, 0.16 mmol, 2.0 equiv) were sequentially added.  The reaction vial 
was fitted with a Teflon cap and refluxed until the reaction was deemed complete by TLC analysis (20 min).  The 
orange solution was treated with (N,N-dimethylamino)propylamine (~0.2 mL) to consume excess acid chloride, and 
the solvent removed by blowing with N2.  The thick orange oil was dissolved in 5% EtOAc/hexanes, and passed 
through a pipet filled with silica gel.  The colorless solution was concentrated to dryness and analyzed by 1H NMR.  
A racemic standard was also synthesized for comparison using V(O)(acac)2/t-BuOOH.93  Average ratio of integral 
values corresponds to a 96% ee. 
1H NMR (500 MHz, CDCl3, diagnostic signals) Major diastereomer: δ 4.77 (dd, J = 8.0 Hz, 5.0 Hz, 1H), 
2.79 (d, J = 5.0 Hz, 1H), 2.55 (d, J = 5.0 Hz, 1H).  Minor diastereomer: δ 4.89 (dd, J = 9.0, 4.0 Hz, 1H), 2.82 (d, J = 
5.0 Hz, 1H), 2.59 (d, J = 5.0 Hz, 1H).   
(S,E)-5-(N-(methoxycarbonyl)-4-methylphenylsulfonamido)-1-((R)-2-methyloxiran-2-yl)pent-3-enyl acetate[(-
)-29b]: Epoxy alcohol (+)-29a (142 mg, 1.0 mmol, 1.0 equiv) was added to a 25 mL round bottom flask with stir 
bar, and dissolved in CH2Cl2 (10 mL). Triethylamine (0.560 mL, 4.0 mmol, 4.0 equiv) and acetic anhydride (0.189 
mL, 2.0 mmol, 2.0 equiv) were added via syringe, and the reaction stirred 3.5 hr at room temperature. Evaporation 
of the reactionsolvent, followed by column chromatography (10% EtOAc/hexanes) provided the epoxy acetate as a 
colorless oil (131.0 mg, 0.711 mmol, 71% yield). 
1H NMR (500 MHz, CDCl3) δ 5.79 (ddt, J = 16.8, 10.3, 6.6 Hz, 1H), 5.02 (app dq, J = 15.5, 1.5 Hz, 1H), 
4.98 (app dq, J = 10.0, 1.5 Hz, 1H), 4.61 (dd, J = 8.5, 5.0 Hz, 1H), 2.80 (d, J = 5.5 Hz, 1H), 2.58 (d, J = 5.0 Hz, 1H), 
2.03-2.17 (m, 2H), 2.07 (s, 3H), 1.73-1.78 (m, 2H), 1.31 (s, 3H); 13C NMR: (125 MHz, CDCl3) δ 170.3, 137.4, 
115.3, 75.0, 56.3, 53.2, 29.6 (2 peaks), 21.0, 16.7; IR (film, cm-1): 3080, 2924, 2854, 1738, 1642, 1457, 1373, 1234, 
1066, 1029, 955, 911; HRMS (CI, CH4) m/z calc’d for C10H16O3Na [M+Na]+: 207.0997, found 207.0990; [α]D23 = -
8.6° (c = 1.08, CHCl3). 
 (S,E)-4-(N-(methoxycarbonyl)-4-methylphenylsulfonamido)-1-((R)-2-
methyloxiran-2-yl)but-2-enyl acetate [(-)-29]: Epoxy acetate (-)-29b (55.3 mg, 0.3 
mmol, 1.0 equiv) was reacted following the general procedure.  Column chromatography (30% EtOAc/hexanes) 
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yielded the product as a colorless oil.  Run 1 (82.4 mg, 0.200 mmol, 67% yield; run 2 (73.7 mg, 0.179 mmol, 60% 
yield).  Linear/branched and E/Z ratios were >20:1 by 1H NMR.  Average yield: 64%.  Cr conditions: no product 
could be detected by 1H NMR of the crude reaction mixture. 
 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.5 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 5.61-5.73 (m, 2H), 4.67 
(dd, J = 9.0, 4.0 Hz, 1H), 4.33-4.41 (m, 2H), 3.67 (s, 3H), 2.80 (d, J = 5.0 Hz, 1H), 2.57 (d, J = 4.5 Hz, 1H), 2.42 (s, 
3H), 2.35-2.47 (m, 2H), 2.03 (s, 3H), 1.31 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 170.1, 152.6, 144.6, 136.4, 129.7, 
129.3, 128.4, 127.9, 74.3, 56.2, 53.8, 53.1, 48.4, 33.4, 21.6, 20.9, 16.9; IR (film, cm-1): 2971, 2909, 2850, 1736, 
1595, 1514, 1447, 1358, 1234, 1169, 1090, 972, 814, 756; HRMS (ESI) m/z calc’d for C19H26NO7S [M+H]+: 
412.1430, found 412.1430; [α]D22 = -3.7° (c = 1.14, CHCl3). 
(S)-4,8-dimethylnona-1,7-diene[(-)-30a]:  A 500 mL round bottom flask was charged with triphenylphosphonium 
methyl iodide (15.7 g, 38.9 mmol, 2.0 equiv), THF (187 mL), and a stir bar.  The flask was cooled to 0°C with 
stirring, and potassium tert-butoxide (4.36 g, 38.9 mmol, 2.0 equiv) was added portionwise as the slurry turned 
bright yellow.  After 30 minutes at 0°C,  (-)-(S)-citronellal (3.53 mL, 19.45 mmol, 1.0 equiv, Aldrich, [α]D23 = 
-15.0°, neat) was added dropwise via syringe into the reaction mixture.  After stirring an additional 30 min at 0°C, 
36 mL sat. aqueous NH4Cl was added dropwise, and the solution warmed to room temperature.  The reaction 
mixture was diluted with diethyl ether (300 mL) and extracted with ether (2 x 300 mL).  The combined ether layers 
were then washed with water (1 x 500 mL) and brine (1 x 500 mL) before drying over Na2SO4 (with stirring, 1 h).  
Decantation of ether, followed by solvent removal at 0°C produced the crude product as a pale yellow oil.  This was 
filtered through a pad of silica gel with pentane to afford a colorless oil (2.8173 g, 18.52 
mmol, 95% yield).   
 1H NMR (500 MHz, CDCl3) δ 5.78 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H), 5.09-5.12 (m, 1H), 4.97-5.02 (m, 2H), 
1.87-2.10 (m, 4H), 1.69 (s, 3H), 1.61 (s, 3H), 1.48-1.54 (m, 1H), 1.32-1.39 (m, 1H), 1.11-1.18 (m, 1H), 0.88 (d, J = 
7.0 Hz, 3H); 13C NMR: (125 MHz, CDCl3) δ 137.7, 131.1, 124.8, 115.5, 41.3, 36.6, 32.4, 25.7, 25.6, 19.3, 17.6; IR 
(film, cm-1): 3076, 2967, 2914, 1873, 2856, 2729 (weak), 1825 (weak), 1641, 1454, 1440, 1377, 993, 911; HRMS 
(CI, CH4) m/z calc’d for C11H20 [M]+: 152.15650, found 152.15632; [α]D26 = -2.3° (neat). 
(3R,6S)-2,6-dimethylnon-8-ene-2,3-diol[(+)-30b]: To a 500 mL round bottom flask 
was added ADmix-β (6.44 g, Aldrich), diene (-)-30a (1.0 g, 6.57 mmol, 1.0 equiv), 
methane sulfonamide (812 mg, 8.54 mmol, 1.3 equiv), tert-butanol (81 mL), water (64 mL), and a stir bar.  The 
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mixture was stirred for 64 h at room temperature, followed by quenching with solid Na2SO3 (8.1 g), and stirring an 
additional 30 min until the yellow color faded.  After removal of tert-butanol by rotatory evaporation (45°C), 
followed by dilution with water (480 mL) and extraction with ethyl acetate (3 x 200 mL), the combined organic 
layers were dried with MgSO4.  The solids were filtered and discarded, and the filtrate evaporated to yield the 
product as a colorless oil (930 mg, 5.0 mmol, 76% yield). 
 1H NMR (500 MHz, CDCl3) δ 5.77 (ddt, J = 17.3, 10.5, 7.1 Hz, 1H), 4.97-5.01 (m, 2H), 3.32 (d, J  = 8.5 
Hz, 1H), 2.26 (bs, 1H), 2.06-2.12 (m, 2H), 1.87-1.93 (m, 1H), 1.60-1.67 (m, 1H), 1.49-1.55 (m, 2H), 1.20 (s, 3H), 
1.15 (s, 3H), 1.11-1.29 (m, 2H), 0.89 (d, J = 6.5 Hz, 3H); 13C NMR: (125 MHz, CDCl3) δ 137.4, 115.7, 79.0, 73.2, 
41.1, 33.7, 32.9, 29.1, 26.5, 23.1, 19.5; IR (film, cm-1): 3400 (broad), 3075, 2975, 2955, 2926, 2871, 1640, 1461, 
1439, 1378, 1281, 1228, 1166, 1071, 993, 910, 779; HRMS (ESI) m/z calc’d for C11H22O2Na [M+Na]+: 209.1517, 
found 209.1511; [α]D22 = +1.76° (c = 2.0, CHCl3). 
Determination of Diastereoselectivity.  Analysis of Mosher esters by HPLC (Agilent© Eclipse XDB-C8, 35% 
H2O/MeCN, 1.0 mL/min @ 30°C, tR =  7.82, 8.18 min).  Major diastereomer (8.18 min), 31:1 dr.  The absolute 
configuration of the resulting diol was assigned by analogy.94 
(R)-2,2-dimethyl-3-((S)-3-methylhex-5-enyl)oxirane[(-)-30c]: Diol (+)-30b (552.9 mg, 
3.0 mmol, 1.0 equiv) was added to a 100 mL round bottom flask with a stir bar, followed 
by CH2Cl2 (27.3 mL), and pyridine (1.5 mL, 18.6 mmol, 6.2 equiv).  The reaction flask solution was cooled to 0°C, 
and methanesulfonyl chloride (0.465 mL, 6.0 mmol, 2.0 equiv, freshly distilled) was added dropwise, turning the 
solution yellow.  The reaction warmed to room temperature and stirred an additional 12 h, before being quenched 
with N,N-(dimethylamino)propylamine (0.42 mL, 3.3 mmol, 1.1 equiv).  The now heterogeneous yellow solution 
was allowed to stir for 10 min, then decanted into a separatory funnel.    The solution was washed with 10% aqueous 
CuSO4 (6 x 20 mL) and sat. NaHCO3 (1 x 60 mL) before drying over Na2SO4.  Decantation of the drying agent and 
removal of solvents left the crude mono mesylate as a colorless liquid; this material was sufficiently pure for the 
next step. 
 1H NMR (500 MHz, CDCl3, diagnostic peaks) δ 5.72-5.81 (m, 1H), 4.98-5.02 (m, 2H), 4.54 (dd, J = 10.0, 
2.5 Hz, 1H), 3.11 (s, 3H), 2.05-2.10 (m, 1H), 2.02 (bs, 1H), 1.89-1.95 (m, 1H), 1.50-1.71 (m, 2H), 1.26 (s, 3H), 1.24 
(s, 3H), 0.91 (d, J = 6.5 Hz, 3H). 
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 The mesylate obtained above was dissolved in methanol (15 mL), and stirred with solid K2CO3 (450 mg, 
3.3 mmol, 1.1 equiv) for 4 h at room temperature.  The reaction mixture was then slowly poured into ice cold sat. 
aqueous NH4Cl (150 mL), and allowed to stand until vigorous bubbling subsided.  The solution was extracted with 
ethyl ether (3 x 100 mL), dried over Na2SO4, and evaporated to dryness at 20°C.  Flash chromatography (5% 
EtOAc/hexanes) isolated the epoxide as a colorless liquid (300.0 mg, 1.78 mmol, 60% yield for 2 steps).  
 1H NMR (500 MHz, CDCl3) δ 5.77 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H), 5.00 (d, J = 17.0 Hz, 1H), 4.99 (d, J = 
10.0 Hz, 1H), 2.69 (app t, J = 6.3 Hz, 1H), 2.06-2.11 (m, 1H), 1.89-1.95 (m, 1H), 1.26-1.62 (m, 5H), 1.30 (s, 3H), 
1.26 (s, 3H), 0.89 (d, J = 6.5 Hz, 3H); 13C NMR: (125 MHz, CDCl3) δ 137.2, 115.8, 64.6, 58.3, 41.1, 33.0, 32.6, 
26.5, 24.9, 19.4, 18.7; IR (film, cm-1): 3077, 2997, 2959, 2924, 2873, 1640, 1461, 1378, 1332. 1249, 1122, 994, 910, 
869, 793, 738, 679; HRMS (CI, CH4) m/z calc’d for C11H21O [M+H]+: 169.15925, found 169.15947; [α]D22 = -1.3° 
(c = 1.08, CHCl3). 
methyl (R,E)-6-((S)-3,3-dimethyloxiran-2-yl)-4-methylhex-2-
enyl(tosyl)carbamate[(+)-30]: 
Epoxide (-)-30c (50.5 mg, 0.3 mmol, 1.0 equiv) was reacted following the general procedure.  Column 
chromatography (15% EtOAc/hexanes) yielded the product as a colorless oil.  Run 1 (70.8 mg, 0.179 mmol, 60% 
yield); run 2 (69.1 mg, 0.175 mmol, 58% yield).  No branched products were observed, and the E/Z ratio was >20:1 
by 1H NMR.  Average yield: 59%.  Cr conditions: No branched products were observed, and the E/Z ratio was 
>20:1 by 1H NMR.  Run 1 (53.1 mg, 0.134 mmol, 45% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8.5 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 5.65 (dd, J = 15.5, 7.5 Hz, 
1H), 5.51 (dt, J = 15.3, 6.5 Hz, 1H), 4.41 (d, J = 6.0 Hz, 2H), 3.69 (s, 3H), 2.68-2.70 (m, 1H), 2.43 (s, 3H), 2.17-
2.21 (m, 1H), 1.35-1.54 (m, 4H), 1.30 (s, 3H), 1.24 (s, 3H), 1.03 (d, J = 7.0 Hz, 3H); 13C NMR: (125 MHz, CDCl3) 
δ 152.6, 144.5, 140.7, 136.4, 129.2, 128.4, 123.2, 64.4, 58.2, 53.7, 48.5, 36.3, 33.3, 26.7, 24.8, 21.6, 20.3, 18.6; IR 
(film, cm-1): 2956, 2926, 2874, 1737, 1597, 1444, 1360, 1325, 1291, 1271, 1239, 1186, 1170, 1121, 1090, 973, 875, 
814, 769, 756, 676; HRMS (ESI) m/z calc’d for C20H30NO5S [M+H]+: 396.1845, found 396.1830; [α]D23 = +0.5° (c 
= 1.08, CHCl3). 
 methyl (R,E)-4-(benzyloxy)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-
enyl(tosyl)carbamate [(+)-12]: (R)-4-((R)-1-(benzyloxy)but-3-enyl)-2,2-dimethyl-
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1,3-dioxolane95 (78.7 mg, 0.3 mmol, 1.0 equiv) was reacted according to the standard procedure. Flash 
chromatography (30% EtOAc/hexanes) afforded the product as a pale orange oil.  Run 1 (105.8 mg, 0.216 mmol, 
72% yield); run 2 (116.8 mg, 0.239 mmol, 80% yield). Only the linear E product was observed by 1H NMR.  
Average yield: 76%.   
1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8.0 Hz, 2H), 7.26-7.33 (m, 7H), 5.86 (dt, J = 15.5, 5.0 Hz, 1H), 5.66 
(dd, J = 15.5, 7.5 Hz, 1H), 4.66 (d, J = 12.0 Hz, 1H), 4.48 (m, 3H), 4.20 (q, J = 6.5 Hz, 1H), 3.94 (dd, J = 8.5, 6.5 
Hz, 1H), 3.88 (app t, J = 7.0 Hz, 1H), 3.72 (dd, J = 8.5, 6.5 Hz, 1H), 3.69 (3H, s), 2.42 (s, 3H), 1.38 (s, 3H), 1.35 (s, 
3H); 13C NMR (125 MHz, CDCl3) 152.5, 144.7, 138.0, 136.2, 130.3, 129.9, 129.3, 128.4, 128.3, 127.7, 127.5, 
109.7, 79.5, 77.4, 70.3, 65.6, 53.9, 47.9, 26.4, 25.3, 21.6; IR (film, cm-1): 2993, 2924, 2869, 1738, 1598, 1496, 1444, 
1365, 1248, 1220, 1171, 1090, 1072, 968; LRMS (FD+)  368.2(100), 230.1(90.8), 212.2(19.8), 198.2 (12.7), 155.1 
(47.3); [α]D26 = +15.8° (c = 1.0, CHCl3). 
Nucleophile Scope 
Table 2.2, entry 11: Allyl cyclohexane (38.8 mg, 96% pure, 0.3 mmol, 1.0 equiv) and 
methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv, vide infra) were reacted 
following the general procedure.  Purification by flash chromatography (7% 
EtOAc/hexanes) produced a light orange oil.  Run 1 (88.4 mg, 0.252 mmol, 84% yield); run 2 (84.9 mg, 0.242 
mmol, 81% yield); run 3 (88.2 mg, 0.251 mmol, 84% yield). Average yield: 83%. The linear (Z) and branched 
products were not observed by 1H NMR.  Spectroscopic data for the amination product matched that which was 
reported previously.96 
Table 2.2, entry 12: Allyl cyclohexane (38.8 mg, 96% pure, 0.3 mmol, 1.0 equiv) and 
benzyl tosylcarbamate (183.2 mg, 0.6 mmol, 2.0 equiv, vide infra) were reacted following 
the general procedure.  Purification by flash chromatography (5% EtOAc/hexanes) produced a light orange oil.  Run 
1 (109.0 mg, 0.255 mmol, 85% yield); run 2 (111.4 mg, 0.261 mmol, 87% yield); run 3 (113.2 mg, 0.265 mmol, 
88% yield). Average yield: 87%. The linear (Z) and branched products were not observed by 1H NMR.  
Spectroscopic data for the amination product matched that which was reported previously.12 
Table 2.2, entry 13: Allyl cyclohexane (38.8 mg, 96% pure, 0.3 mmol, 1.0 equiv), 
BocNHTs (162.8 mg, 0.6 mmol, 2.0 equiv, Aldrich), and DIPEA (5.2 µL, 0.03 mmol, 0.1 
equiv, via syringe) were reacted according to the general procedure, using carbon tetrachloride as solvent.  Flash 
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chromatography (5% EtOAc/hexanes) isolated a colorless oil.  Run 1 (81.9 mg, 0.208 mmol, 69% yield); run 2 (81.5 
mg, 0.207 mmol, 69% yield); run 3 (84.1 mg, 0.214 mmol, 71% yield); run 4 (84.3 mg, 0.214 mmol, 71% yield); 
run 5 (79.0 mg, 0.200 mmol, 67% yield). Average yield: 69%. Cr conditions: run 1 (7.6 mg, 0.0193 mmol, 6% 
yield), run 2 (14.1 mg, 0.0358 mmol, 12% yield); run 3 (9.6 mg, 0.0244 mmol, 8% yield).  Average yield with Cr: 
9%. The linear (Z) and branched products were not observed by 1H NMR.  Spectroscopic data for the amination 
product matched that which was reported previously.12 
Table 2.2, entry 14: Allyl cyclohexane (38.8 mg, 96% pure, 0.3 mmol, 1.0 equiv) and 
FmocNHTs (236.1 mg, 0.6 mmol, 2.0 equiv, vide infra) were reacted according to the 
modified procedure for difficult stirring, using carbon tetrachloride as solvent.  Flash chromatography (7% 
EtOAc/hexanes) isolated a light yellow oil.  Run 1 (87.0 mg, 0.169 mmol, 56% yield); run 2 (82.5 mg, 0.160 mmol, 
53% yield). Average yield: 55%.  Cr conditions: run 1 (27.1 mg, 0.0526 mmol, 18% yield); run 2 (22.6 mg, 0.0438 
mmol, 15% yield); run 3 (22.7 mg, 0.0440 mmol, 15% yield).  Average yield with Cr: 16%.  The linear (Z) and 
branched products were not observed by 1H NMR.  Spectroscopic data matched that which was reported 
previously.12 
Methyl N-nosylcarbamate.   To a flame-dried 10 mL round bottom flask with stir bar under N2 
was added p-nitrobenzenesulfonylisocyanate97 (342.3 mg, 1.5 mmol, 1.0 equiv) and THF (2.0 mL).  
After cooling the solution to 0°C, methanol (2.0 mL) was added dropwise over 3 min.  The reaction 
was then allowed to warm to 20°C, and stirred for 10 h.  After removal of solvents, the crude product solidified as 
off-white plates (374.0 mg, 1.437 mmol, 96% yield). 
 1H NMR (400 MHz, CDCl3) δ 8.41 (d, J = 8.8 Hz, 2H), 8.27 (d, J = 9.2 Hz, 2H), 7.42 (bs, 1H), 3.74 (s, 
3H); 13C NMR: (125 MHz, CD3CN) δ 152.1, 151.9, 145.1, 130.5, 125.3, 54.3; IR (film, cm-1): 1608, 1533, 1452, 
1315, 1240, 1163, 1113, 1012, 950, 881, 852, 795, 771, 741; LRMS (EI, 70 eV) 227.9(2), 227.9 (12), 212.0(2), 
202.0(7), 186.0(44), 122.0(26), 78.0(83), 63.0(100). 
(E)-methyl 3-cyclohexylallyl(4-nitrophenylsulfonyl)carbamate: Allyl cyclohexane 
(38.8 mg, 96% pure, 0.3 mmol, 1.0 equiv) and methyl nosylcarbamate (137.6 mg, 0.6 
mmol, 2.0 equiv) were reacted following the general procedure.  Purification by flash chromatography (15% 
EtOAc/hexanes) produced off-white crystalline solids (17.8 mg, 0.0465 mmol, 16% yield).  Cr conditions: (43.6 mg, 
0.0.114 mmol, 38% yield).  10% DIPEA/CCl4 conditions: run 1 (29.2 mg, 0.0763 mmol, 25% yield); run 2 (25.1 
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mg, 0.0656 mmol, 22% yield).  Average yield (10% DIPEA/CCl4 conditions): 24%.  The linear (Z) and branched 
products were not observed by 1H NMR.   
1H NMR (500 MHz, CDCl3) δ 8.34 (d, J = 9.0 Hz, 2H), 8.15 (d, J = 9.0 Hz, 2H), 5.78 (dd, J = 15.5, 6.5 Hz, 
1H), 5.44 (dt, J = 15.5, 6.5 Hz, 1H), 4.43 (d, J = 6.5 Hz, 2H), 3.72 (s, 3H), 1.96-2.02 (m, 1H), 1.66-1.76 (m, 5H), 
1.04-1.32 (m, 5); 13C NMR: (125 MHz, CDCl3) δ 152.3, 150.4, 144.9, 142.6, 130.0, 123.8, 121.1, 54.1, 49.0, 40.3, 
32.6, 26.0, 25.9; IR (film, cm-1): 2927, 2854, 1743, 1537, 1446, 1402, 1377, 1348, 1315, 1259, 1240, 1178, 1128, 
1090, 1012, 976; HRMS (ESI) m/z calc’d for C17H22N2O6NaS [M+Na]+: 405.1096, found 405.1094. 
 Methyl tosylcarbamate.  To a 1 L flame-dried round bottom flask with septum was added dry 
methanol (500 mL) and a stir bar.  The flask was cooled in an ice bath cooled at 0°C, and 
p-toluenesulfonylisocyanate (100 mL, 0.657 mol, 1.0 equiv) was added dropwise via syringe with stirring.  The 
reaction was then allowed to warm to room temperature.  After stirring 2 h, removal of the solvent in vacuo 
produced a colorless syrup that crystallized spontaneously.  The solids were then triturated with pentane (2 x 50 mL) 
and ether (1 x 50 mL), followed by drying under high vacuum (0.5 torr) to yield white plates (141 g, 615 mmol, 
94% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 8.5 Hz, 2H), 7.86 (bs, 1H), 7.34 (d, J = 8.0 Hz, 2H), 3.69 (s, 
3H), 2.44 (s, 3H); mp 103-105 °C [lit.98 106-107 °C].  This procedure was adapted from Uehara, et. al.,99 and the 
data is in agreement with that reported previously. 
Benzyl tosylcarbamate: To a 1 L round bottom flask was added benzyl alcohol (9.9 mL, 
95.0 mmol, 1.0 equiv), dichloromethane (200 mL), and a stir bar.  The mixture was cooled to 
0°C with an ice bath, p-toluenesulfonylisocyanate (15.2 mL, 99.8 mmol, 1.05 equiv) was 
added dropwise, and the reaction stirred for 2 h at 20°C.  After removal of solvent under reduced pressure, the 
product was crystallized as white plates from 5:1 ether/CH2Cl2. 
 1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 8.5 Hz, 2H), 7.44 (bs, 1H), 7.34 (m, 3H), 7.30 (d, J = 8.0 Hz, 
2H), 7.25 (m, 2H), 5.09 (s, 3H), 2.44 (s, 3H); mp 94-95 °C [lit. 103.5-104 °C]. This data is in agreement with that 
reported previously.100 
(9H-fluoren-9-yl)methyl tosylcarbamate: This compound was prepared in the same 
manner as benzyltosyl carbamate. 
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 1H NMR (500 MHz, acetone-d6) δ 7.87 (d, J = 8.5 Hz, 2H), 7.84 (d, J = 7.5 Hz, 2H), 7.63 (d, J = 7.5 Hz, 
2H), 7.42 (d, J = 8.0 Hz, 2H), 7.39 (t, J = 7.5 Hz, 2H), 7.26 (t, J = 7.5 Hz, 2H), 4.37 (d, J = 7.5 Hz, 2H), 4.19 (t, J = 
6.5 Hz, 1H), 2.43 (s, 3H); mp 170-172 °C [lit. 170-171 °C]. This data is in agreement with that reported 
previously.101 
N-((R,E)-4-(benzyloxy)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-enyl)-4-
methylbenzenesulfonamide [(+)-12a]: Compound (+)-12 (43.7 mg, 0.0893 mmol, 1.0 
equiv) was added to a 10 mL flame-dried tear-drop flask with spin-vane stir bar.  MeOH 
(1.3 mL) was added, followed by K2CO3 (23.4 mg, 0.169, 1.9 equiv), and the reaction was vigorously stirred for 
6.75 h at 25°C.  The reaction was then quenched with NH4Cl (1 mL), and diluted with EtOAc (10 mL).  The 
aqueous layer was extracted with EtOAc (2 x 10 mL), and the organic layers were combined, dried over MgSO4, 
filtered through Celite, and evaporated under reduced pressure.  The crude colorless oil (39.0 mg, 0.0904 mmol, 
>99% yield) required no additional purification. 
1H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 8.5 Hz, 2H), 7.27-7.34 (m, 7H), 5.66 (dt, J = 15.7, 5.6 Hz, 1H), 5.48 
(dd, J = 15.0, 7.8 Hz, 1H), 4.55 (d, J = 12.0 Hz, 1H), 4.52 (bs, 1H), 4.41 (d, J = 12.0 Hz, 1H), 4.11 (app q, J = 6.3 
Hz, 1H), 3.87 (dd, J = 8.8, 6.8 Hz, 1H), 3.78 (app t, J = 7.0 Hz, 1H), 3.66 (dd, J = 8.5, 6.5 Hz, 1H), 3.53-3.63 (m, 
2H), 2.41 (s, 3H), 1.36 (s, 3H), 1.33 (s, 3H); 13C NMR: (125 MHz, CDCl3) δ 143.9, 138.4, 137.1, 130.4, 130.0, 
129.9, 128.6, 128.0, 127.8, 127.4, 109.9, 79.8, 77.4, 70.9, 65.8, 44.9, 26.7, 25.5, 21.8; IR (film, cm-1): 3434 (broad), 
1639, 1496, 1454, 1369, 1323, 1308, 1290, 1259, 1215, 1159, 1093; HRMS (ESI) m/z calc’d for C23H30NO5S 
[M+H]+: 432.1845, found 432.1855; [α]D25 = +29.5° (c = 2.67, CHCl3). 
 (E)-methyl 4-(benzyloxy)-4-(2,2-dimethyl-1,3-dioxolan-4-yl)but-2-
enylcarbamate [(+)-12c]: Compound (+)-12 (40.2 mg, 0.082 mmol) was added to 
10 mL round bottom flask containing a stir bar.  Dimethoxyethane (1 mL) was 
added via syringe, and the flask cooled to -78°C.  A dark, forest green solution of sodium naphthalide102 was slowly 
added dropwise (via syringe) until the solution became a light forest green color that persisted for 2 min (Note: trace 
amounts of benzoquinone/dihydroquinone in the starting material can cause a “false” blue-green color that should 
not be confused with the endpoint.  This color will eventually fade to light yellow upon addition of more reducing 
reagent).  After an additional 10 min at -78°C, the solution was diluted with saturated NH4Cl (4 mL), allowed to 
warm to room temperature, and diluted with ethyl acetate (10 mL).  The layers were separated, and the aqueous 
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layer extracted with ethyl acetate (2 x 10 mL).  Organic fractions were combined, dried over MgSO4, and evaporated 
at reduced pressure.  Flash chromatography (30% EtOAc/hexanes) led to the isolation of a colorless oil (22.6 mg, 
0.067 mmol, 82% yield).   
 1H NMR (400 MHz, CDCl3) δ 7.23-7.33 (m, 5H), 5.74 (dt, J = 15.5, 5.5 Hz, 1H), 5.50 (dd, J = 15.6, 8.0 
Hz, 1H), 4.80 (bs, 1H), 4.63 (d, J = 12.4 Hz, 1H), 4.47 (d, J = 12.0 Hz, 1H), 4.18 (app t, J = 6.4 Hz, 1H), 3.93 (dd, J 
= 8.4, 6.8 Hz, 1H), 3.82-3.85 (m, 3H), 3.72 (dd, J = 8.4, 6.4 Hz, 1H), 3.67 (s, 3H), 1.38 (s, 3H), 1.35 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 156.8, 138.2, 132.1, 128.3, 127.7 (2 peaks), 127.5, 109.7, 79.8, 77.4, 70.4, 65.6, 52.2, 
42.2, 26.4. 25.2; IR (film, cm-1): 3347 (broad), 3038, 2988, 2929, 2874, 1723, 1532, 1458, 1381, 1371, 1338, 1253, 
1214, 1155, 1068, 976, 853, 778; HRMS (ESI) m/z calc’d for C18H26NO5 [M+H]+: 336.1811, found 336.1803; [α]D24 
= +26.2° (c = 1.07, CHCl3). 
 (E)-methyl 4-(benzyloxy)-4-(2,2-dimethyl-1,3-dioxolan-4-yl)but-2-en-1-amine [(+)-
12b]: Compound (+)-[12c] (22.6 mg, 0.067 mmol, 1.0 equiv) was transferred to a sealed 
tube and diluted with 0.25 mL ethanol, 0.75 mL water, and 0.5 mL of 2N NaOH.  The tube 
was heated to 110°C for 2-4 h, then allowed to cool to room temperature.  The water/ethanol mixture was 
transferred to a 25 mL round bottom flask, the ethanol evaporated, and the mixture diluted with EtOAc (5 mL) and 
brine (2 mL).  The organic layer was separated, and the aqueous layer extracted with EtOAc (3 x 5 mL).  Organic 
layers were combined, dried over MgSO4, filtered, and evaporated to dryness.  The crude oil was purified by flash 
chromatography (10% MeOH/CH2Cl2/1% conc. NH4OH) to afford a pale yellow oil (16.8 mg, 0.061 mmol, 95% 
yield). 
 1H NMR (500 MHz, CDCl3) δ 7.30-7.35 (m, 4H), 7.24-7.28 (m, 1H), 5.87 (dt, J = 15.5, 5.5 Hz, 1H), 5.48 
(dd, J = 15.5, 8.0 Hz, 1H), 4.66 (d, J = 12.5 Hz, 1H), 4.49 (d, J = 12.5 Hz, 1H), 4.20 (q, J = 6.5 Hz, 1H), 3.94 (dd, J 
= 8.5, 6.8 Hz, 1H), 3.84 (app t, J = 7.5 Hz, 1H), 3.73 (dd, J = 8.5, 6.5 Hz, 1H), 3.35 (bs, 2H), 1.42-1.52 (m, 2H), 
1.39 (s, 3H), 1.35 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 138.4, 137.3, 128.3, 127.7, 127.4, 125.7, 109.7, 80.3, 
77.6, 70.2, 65.8, 43.5, 26.5, 25.3; IR (film, cm-1): 3367 (broad), 3037, 2992, 2982, 2913, 2866, 1584, 1498, 1455, 
1380, 1370, 1330, 1262, 1215, 1157, 1068, 979, 850, 742, 698; HRMS (ESI) m/z calc’d for C16H24NO3 [M+H]+: 
278.1756, found 278.1756; [α]D24 = +30.7° (c = 1.68, CHCl3). 
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 (R,E)-4-(benzyloxy)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-N-methylbut-2-en-1-
amine [(+)-12d]:  To a flame-dried 25 mL round bottom flask containing a stir bar, 
under nitrogen, was added lithium aluminum hydride (15.0 mg, 0.396 mmol, 5.5 equiv) 
and THF (2.0 mL).  The flask was placed in a water bath at 20 °C, and a solution of carbamate (+)-12c (24.2 mg, 
0.0722 mmol, 1.0 equiv) in THF (1.0 mL, with 2 x 1 mL rinses) was added dropwise via cannula.  After the 
bubbling subsided, a reflux condenser was attached and the reaction was heated to reflux for 5 h.  After cooling to 
room temperature, the flask was placed in an ice bath and quenched with water (~0.1 mL), 15% NaOH (0.5 mL), 
and vigorously stirred for 8 hr.  The reaction was then diluted with ether (15 mL) and dried for 1 hr with Na2SO4.  
The resulting solution was filtered through Celite, concentrated under reduced pressure, and purified by flash 
chromatography (7% MeOH/CH2Cl2/1% conc. NH4OH) to yield a colorless oil (10.5 mg, 0.0360 mmol, 50% yield). 
1H NMR (400 MHz, CDCl3) δ 7.24-7.33 (m, 5H), 5.81 (dt, J = 15.6, 6.0 Hz, 1H), 5.50 (dd, J = 15.6, 8.0 Hz, 
1H), 4.66 (d, J = 12.4 Hz, 1H), 4.47 (d, J = 12.4 Hz, 1H), 4.19 (app q, J = 6.7 Hz, 1H), 3.94 (dd, J = 8.4, 6.8 Hz, 
1H), 3.83 (app t, J = 7.2 Hz, 1H), 3.73 (dd, J = 8.6, 6.6 Hz, 1H), 3.24 (d, J = 5.6 Hz, 2H), 2.42 (s, 3H), 1.76 (bs, 1H), 
1.39 (s, 3H), 1.35 (s, 3H); 13C NMR: (100 MHz, CDCl3) δ 138.3, 134.5, 128.3, 127.7, 127.6, 127.4, 109.7, 80.3, 
77.5, 70.1, 65.8, 53.0, 35.9, 26.5, 25.3; IR (film, cm-1): 3394, 2981, 2960, 2931, 2916, 2895, 2877, 2791, 1604, 
1454, 1371, 1259, 1211, 1157, 1065, 977, 852, 739; HRMS (ESI) m/z calc’d for C17H26NO3 [M+H]+: 292.1913, 
found 292.1916; [α]D25 = +26.4° (c = 2.44, CHCl3). 
Natural Product Derivatives 
 Acetylated N-tosylcarbamate derivative of estrone [(+)-32]: Allyl 
estrone acetate (+)-31 (46.8 mg, 0.1 mmol, 1.0 equiv) was reacted 
following the general procedure.  Column chromatography (15% 
EtOAc/hexanes) yielded the product as a colorless oil.  Run 1 (47.7 mg, 0.0686 mmol, 69% yield); run 2 (52.1 mg, 
0.0750 mmol, 75% yield). Only the linear E product was observed by 1H NMR. Average yield: 72%. 
 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8.5 Hz, 2H), 7.31 (d, J = 8.5 Hz, 2H), 7.11 (d, J = 8.5 Hz, 1H), 
6.61 (dd, J = 8.5, 2.5 Hz, 1H), 6.55 (d, 2.5 Hz, 1H), 5.78 (dd, J = 15.3, 8.3 Hz, 1H), 5.53 (dt, J = 15.2, 6.5 Hz, 1H), 
4.71 (d, J = 8.0 Hz, 1H), 4.36-4.44 (m, 2H), 3.70 (s, 3H), 2.80-2.83 (m, 2H), 2.66-2.72 (m, 1H), 2.44 (s, 3H), 2.18-
2.27 (m, 2H), 2.05 (s, 3H), 1.73-1.85 (m, 3H), 1.57-1.61 (m, 1H), 1.33-1.49 (m, 5H), 0.97 (s, 9H), 0.84 (s, 3H), 0.18 
(s, 6H); 13C NMR: (125 MHz, CDCl3) δ 170.8, 153.3, 152.7, 144.5, 137.9, 137.6, 136.5, 132.7, 129.3, 128.5, 126.1, 
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124.0, 119.9, 117.2, 86.1, 53.8, 48.7, 48.5, 44.1, 43.8, 43.7, 38.4, 36.8, 30.3, 29.5, 27.1, 26.0, 25.7, 21.6, 21.1, 18.1, 
12.6, -4.4; IR (film, cm-1): 2943, 2928, 2873, 2860, 1737, 1604, 1495, 1443, 1362, 1286, 1239, 1170, 1129, 1090, 
1034, 956, 840, 756; HRMS (ESI) m/z calc’d for C38H54NO7SSi [M+H]+: 696.3390, found 696.3371; [α]D23 = -0.06° 
(c = 1.02, CHCl3). 
Unprotected steroid derivative [(+)-34]: Allyl estrone alcohol (+)-33103 
(62.5 mg, 0.2 mmol, 1.0 equiv) was reacted following the general procedure.  
Column chromatography (50% EtOAc/hexanes) yielded the product as pale 
yellow solids.  Run 1 (60.0 mg, 0.111 mmol, 56% yield); run 2 (56.9 mg, 
0.105 mmol, 53% yield). Only the linear E product was observed by 1H NMR. The internal olefin product resulting 
from starting material isomerization was also obtained as a white solid (16.7 mg, 0.0534 mmol, 27% yield). 
Average yield: 55%.  Cr conditions: Only the linear E product was observed by 1H NMR. Run 1 (36.7 mg, 0.0681 
mmol, 34% yield, L/B & E/Z >20:1). 
 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.5 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 7.13 (d, J = 9.0 Hz, 1H), 
6.64 (dd, J = 8.5, 2.5 Hz, 1H), 6.57 (d, J = 2.5 Hz, 1H), 5.85 (dd, J = 15.0, 8.5, 1H), 5.60 (dt, J = 15.0, 6.5 Hz, 1H), 
5.59 (bs, 1H), 4.45 (d, J = 6.0 Hz, 2H), 3.69 (s, 3H), 3.42 (d, J = 7.5 Hz, 1H), 2.77-2.82 (m, 2H), 2.45-2.51 (m, 1H), 
2.42 (s, 3H), 2.27-2.30 (m, 1H), 2.14-2.20 (m, 1H), 1.92-1.95 (m, 1H), 1.80-1.83 (m, 1H), 1.71 (app q, J = 12.3 Hz, 
1H), 1.21-1.56 (m, 7H), 0.83 (s, 3H); 13C NMR: (125 MHz, CDCl3) δ 153.6, 152.7, 144.6, 139.1, 138.0, 136.3, 
132.2, 129.3, 128.5, 126.4, 123.8, 115.2, 112.7, 86.8, 53.8, 48.5 (2 peaks), 46.9, 43.9, 43.7, 38.5, 36.6, 30.4, 29.5, 
27.1, 26.1, 21.6 11.7; IR (film, cm-1): 3483, 3020, 2921, 2870, 1729, 1665, 1610, 1598, 1500, 1446, 1358, 1290, 
1216, 1168, 1122, 1089, 1031, 975, 907, 815, 762, 667; HRMS (ESI) m/z calc’d for C30H38NO6S [M+H]+: 540.2420, 
found 540.2444; [α]D26 = +25.7° (c = 2.47, CHCl3). 
(-)-(S)-1-((2R,3aS,4R,6aS)-3a-allyl-1,1,4-trimethyloctahydropentalen-2-yl)ethanol[(-)-35]: This starting material 
was synthesized in 4 steps from (-)-α-cedrene. 
 1H NMR (500 MHz, CDCl3) δ 5.85 (ddt, J = 17.0, 10.1, 7.2 Hz, 1H), 4.97-5.02 (m, 
2H), 3.74-3.79 (m, 1H), 2.01-2.11 (m, 2H), 1.83 (app t, J = 9.3 Hz, 1H), 1.62-1.67 (m, 2H), 
1.52-1.59 (m, 2H), 1.11-1.36 (m, 5H), 1.15 (d, J = 6.5 Hz, 3H), 1.09 (s, 3H), 0.97 (d, J = 7.0 Hz, 3H), 0.94 (s, 3H); 
13C NMR: (125 MHz, CDCl3) δ 137.7, 116.6, 69.4, 60.8, 53.7, 50.7, 46.6, 42.4, 42.0, 39.4, 33.7, 28.8, 26.4, 24.6, 
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24.4, 14.1; IR (film, cm-1):  HRMS (CI, CH4) m/z calc’d for C16H27O [M-H]+: 235.2062, found 235.2064; [α]D25 = -
3.9° (c = 1.22, CHCl3). 
(-)-methyl(E)-3-((2R,3aS,4R,6aS)-2-((S)-1-hydroxyethyl)-1,1,4-
trimethyloctahydropentalen-3a-yl)allyl(tosyl)carbamate[(-)-36]: Alcohol (-)-35 (70.9 mg, 
0.3 mmol, 1.0 equiv) was reacted following the general procedure.  Column chromatography 
(30% EtOAc/hexanes) isolated the product as a thick, colorless oil.  Run 1 (108.7 mg, 0.234 
mmol, 78% yield); run 2 (113.2 mg, 0.244 mmol, 81% yield). Only the linear E product was 
observed by 1H NMR. Average yield: 80%. 
 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.5 Hz, 2H), 7.27 (d, J = 10.0 Hz, 2H), 5.80 (d, J = 16.0 Hz, 
1H), 5.41 (dt, J = 15.5, 6.5 Hz, 1H), 4.41 (d, J = 6.0 Hz, 2H), 3.74-3.80 (m, 1H), 3.66 (s, 3H), 2.41 (s, 3H), 1.90 (app 
t, J = 9.3 Hz, 1H), 1.64-1.71 (m, 2H), 1.51-1.62 (m, 2H), 1.42 (app t, J = 12.3 Hz, 1H), 1.29-1.37 (m, 3H), 1.16 (d, J 
= 6.5 Hz, 3H), 1.07 (3H, s), 1.00-1.11 (m, 1H), 0.83 (s, 3H), 0.79 (d, J = 6.5 Hz, 3H); 13C NMR: (125 MHz, CDCl3) 
δ 152.7, 144.4, 142.7, 136.6, 129.2, 128.3, 119.8, 69.2, 63.1, 53.6, 53.4, 52.9, 49.0, 47.6, 42.4, 38.6, 33.8, 28.7, 25.6, 
24.2, 23.9, 21.5, 15.0; IR (film, cm-1): 3424 (broad), 2951, 1735, 1656, 1599, 1496, 1446, 1366, 1169, 1089, 914, 
870, 813; HRMS (ESI) m/z calc’d for C25H38NO5S [M+H]+: 464.2471, found 464.2452; [α]D25 = -13.3° (c = 1.20, 
CHCl3). 
Mechanism Studies 
Exogenous Acetate Reaction with TBAOAc: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 
equiv), tetra(n-butylammonium) acetate (5.4 mg, 0.018 mmol, 0.06 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 
equiv), and methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  
Run 1: (68.5 mg, 0.186 mmol, 62% yield [11:1 L/B, 22:1 E/Z]); run 2: (69.2 mg, 0.188 mmol, 63% yield [14:1 L/B, 
19:1 E/Z]).  Average yield: 63% [13:1 L/B, 20:1 E/Z]. 
Exogenous Acetate Reaction with (DIPEAH)OAc: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 
mmol, 0.10 equiv), benzoquinone (64.9 mg, 0.6 mmol, 2.0 equiv), and methyl tosylcarbamate (137.6 mg, 0.6 mmol, 
2.0 equiv) were used following the modified procedure for difficult stirring with the following modifications: only 
0.350 mL TBME was added to the vial, and 0.1 mL of a stock solution of DIPEA/AcOH [0.18M; DIPEA (31.35 µL, 
0.18 mmol) and AcOH (10.3 µL, 0.18 mmol) in 1.00 mL of TBME] was added instead of DIPEA.  Run 1: (73.4 mg, 
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0.200 mmol, 67% yield [11:1 L/B, 16:1 E/Z]); run 2: (68.6 mg, 0.187 mmol, 62% yield [11:1 L/B, 14:1 E/Z]).  
Average yield: 65% [11:1 L/B, 15:1 E/Z]. 
Effects of Quinone Substitution 
Table 2.3, Entry 1: See Table 2.1, entries 2 (Cr conditions) & 8 (DIPEA conditions). 
Table 2.3, Entry 2: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (3.14 µL, 0.018 mmol, 0.06 equiv), benzoquinone (32.4 mg, 0.3 mmol, 1.0 equiv), and 
methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (69.7 
mg, 0.190 mmol, 63% yield); run 2: (75.5 mg, 0.205 mmol, 68% yield), run 3: (75.8 mg, 0.206 mmol, 69% yield).  
Average yield: 67%. Cr conditions: Run 1: (31.8 mg, 0.0865 mmol, 29% yield); run 2: (36.0 mg, 0.0980 mmol, 
33% yield), run 3: (28.8 mg, 0.0784 mmol, 26% yield), run 4: (29.0 mg, 0.0789 mmol, 26% yield); run 5 (30.3 mg, 
0.0824 mmol, 27% yield).  Average yield (Cr conditions): 28%. 
Table 2.3, Entry 3: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (3.14 µL, 0.018 mmol, 0.06 equiv), methylbenzoquinone (73.3 mg, 0.6 mmol, 2.0 equiv), and 
methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  Run 1: (78.3 
mg, 0.213 mmol, 71% yield); run 2: (77.2 mg, 0.210 mmol, 70% yield).  Average yield: 71%. Cr conditions: Run 
1: (35.0 mg, 0.0952 mmol, 32% yield); run 2: (40.7 mg, 0.111 mmol, 37% yield).  Average yield (Cr conditions): 
35%. 
Table 2.3, Entry 4: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (3.14 µL, 0.018 mmol, 0.06 equiv), 2,3-dimethylbenzoquinone (81.7 mg, 0.6 mmol, 2.0 
equiv), and methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  
Run 1: (65.0 mg, 0.177 mmol, 59% yield); run 2: (66.0 mg, 0.180 mmol, 60% yield).  Average yield: 60%. Cr 
conditions: Run 1: (44.2 mg, 0.120 mmol, 40% yield); run 2: (42.0 mg, 0.114 mmol, 38% yield).  Average yield 
(Cr conditions): 39%. 
Table 2.3, Entry 5: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (3.14 µL, 0.018 mmol, 0.06 equiv), 2,6-dimethylbenzoquinone (81.7 mg, 0.6 mmol, 2.0 
equiv), and methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  
Run 1: (66.4 mg, 0.181 mmol, 60% yield); run 2: (65.5 mg, 0.178 mmol, 59% yield).  Average yield: 60%. Cr 
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conditions: Run 1: (11.7 mg, 0.0318 mmol, 11% yield); run 2: (11.8 mg, 0.0321 mmol, 11% yield).  Average yield 
(Cr conditions): 11%. 
Table 2.3, Entry 6: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (15.1 mg, 0.03 mmol, 0.10 equiv), N,N-
diisopropylethylamine (3.14 µL, 0.018 mmol, 0.06 equiv), 2,5-dimethylbenzoquinone (81.7 mg, 0.6 mmol, 2.0 
equiv), and methyl tosylcarbamate (137.6 mg, 0.6 mmol, 2.0 equiv) were used following the standard procedure.  
Run 1: (82.4 mg, 0.224 mmol, 75% yield); run 2: (82.2 mg, 0.224 mmol, 75% yield).  Average yield: 75%. Cr 
conditions: Run 1: (9.6 mg, 0.0261 mmol, 9% yield); run 2: (5.9 mg, 0.0161 mmol, 5% yield).  Average yield (Cr 
conditions): 7%. 
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CHAPTER 3: C—H OXIDATION OF NATURAL PRODUCT SCAFFOLDS104 
3.1 INTRODUCTION 
3.1.1 Fe-catalyzed C—H oxidations in Nature 
Previous chapters have discussed allylic amination with palladium; the olefin is essential for activating 
the adjacent C—H bond towards functionalization.  Selective oxidation of unactivated, aliphatic sp3 C—H bonds 
represents a much more challenging problem.105  Despite this, Nature routinely utilizes aliphatic C—H oxidations 
for primary (steroids, fatty acids) and secondary metabolism, as well as removal of xenobiotics.106  These 
reactions occur predominently through the action of heme-containing iron enzymes known as cytochrome P450’s.  
These enzymes operate through a transient high valent, formally FeV oxo intermediate in the porphyrin ligand 
framework (or an FeIV intermediate with partial charge stabilized by the porphyrin ligand, Figure 3.1, A).107   
Figure 3.1. Active oxidants and mechanisms for Fe-catalyzed, aliphatic C—H activation in Nature. 
 
The proposed mechanism involves sequential reduction of molecular oxygen by reductases, followed by 
abstraction of the substrate’s C—H bond (Figure 3.1, B).  This radical intermediate rapidly recombines with the 
Fe-OH to give the hydroxylated product.  Evidence for radical intermediates (such as stereochemical 
scrambling108) has been observed for P450 C—H oxidations.109  Alternatively, high-valent Fe species can be 
stabilized by histidine and carboxylate ligands (Figure 3.1, C); this family of non-heme Fe enzymes is cabable of 
carrying out a wide variety of different oxidations.  Methane oxidation (C—H bond strength = 105 kcal/mol110) 
with methane monooxygenase is perhaps the most well-studied dinuclear non-heme Fe enzyme.111  For 
mononuclear non-heme Fe, the reduction of molecular oxygen is carried out by cofactors such as alpha-
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ketoglutarate, or by the substrate itself (e.g.: isopenicillin N-synthase112) to generate what is hypothesized to be an 
FeIV-oxo intermediate (Figure 3.1, D).  The diversity of bonds formed by non-heme enzymes stems from their 
ability to trap the radical intermediate (formed after C—H abstraction) with atoms other than oxygen (chlorine, 
bromine, sulfur, carbon), or divert these radicals towards desaturation products.113  These examples from Nature 
have inspired the development of small-molecule catalysts capable of unactivated, aliphatic C—H bond 
activation.114 
3.1.2 Directed, aliphatic C—H oxidations 
A number of non-metal, chemical approaches to aliphatic C—H bond functionalization have been 
reported; for example, free radicals produced by the homolytic breakdown of peroxides or other weak bonds (O—
NO, N—Cl, etc.) with light/heat,115 or metal salts (Fenton chemistry)116 are capable of abstracting C—H bonds.  
Although some cases of extraordinary selectivities are known for intermolecular reactions, the unpredictable 
nature of free radical reactions and requirements of excess substrate has limited its general use for synthesis.  
Directing or activating groups are frequently employed to precisely control the location of the radical (Figure 3.2, 
A)117.  Non-radical, non-metal systems have been limited to strained heterocycles such as dioxiranes118 and 
oxaziridines119 or ozone.120   
Figure 3.2. Selected examples of directing groups for C—H activation. 
 
Conversely, metal-catalyzed, aliphatic C—H activation reactions have the possibility to tune both the 
metal and ligands to control reactivity and selectivity. These types of reactions may be loosely organized by the 
types of intermediates that are formed: 1) organometallic intermediates, where a new carbon-metal bond has 
formed, and 2) metal-multiple bond complexes where a formal metal-carbon bond is not formed at the site of C—
H oxidation.  Common directing group aliphatic C—H oxidations that generate organometallic intermediates are 
shown in Figure 3.2, B.121  In fewer cases, undirected C—H activation via organometallic intermediates has been 
demonstrated.122  Inspired by Nature’s arsenal of C—H oxidation catalysts, C—H activation via metal-multiple 
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bond complexes has been more successful in this regard (Figure 3.2, C), with the development of both 
intermolecular and intramolecular systems for amination,123 alkylation,124 oxidation.125   
3.1.3 Biomimetic small-molecule Fe catalysts 
Specifically for aliphatic oxidation, biomimetic iron complexes have been extensively investigated for 
spectroscopic, structural, and reactivity similiarities with their enzymatic counterparts (Figure 3.3).126   
Figure 3.3. Amine ligands used to support high-valent Fe=O chemistry. 
 
Early work by Groves demonstrated the ability of iron porphyrin complexes to oxidize aliphatic C—H 
bonds; however, yields based on substrate were low (<1%).127  Work on iron-catalyzed oxidation became a topic 
of synthetic interest from Barton’s “gif” systems,128 although it was later debated that some of these systems 
proceed via free hydroxyl radicals.129  Work by Que investigated the use of non-heme pyridyl ligands to effect 
aliphatic C—H oxidation, albeit in low yields.130  In 2007, our group reported a non-heme iron catalyst, FePDP 
37, capable of high reactivity (>50% oxidation yields, based on substrate) and predictable site-selectivity that is 
determined by electronics, sterics, stereoelectronics, and (optionally) directing groups (Figure 3.4, A).131  One 
complex substrate example was presented that demonstrated the ability of the catalyst to bind to carboxylic acids 
and direct the oxidation of neighboring C—H bonds. (Figure 3.4, B).  Notably, the corresponding methyl ester 
substrate gave a complex product mixture.  Catalyst 37 could also mimic oxidations performed by P450 enzymes, 
such as the tertiary hydroxylation of the anti-malarial agent artemisinin.132 
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Figure 3.4. FePDP-catalyzed oxidation of unactivated C—H bonds. 
 
EWG = electron-withdrawing group, BG = bulky group, AG = activating group (O, N, cyclopropyl), DG = directing group 
 
3.2 RESULTS AND DISCUSSION 
3.2.1 Oxidation of the picrotoxinin scaffold 
We were interested in exploring carboxylic acid directing groups for FePDP in complex molecule 
synthesis.  Our initial studies with complex carboxylic acid-containing substrates were focused on a family of 
lactone-containing sesquiterpene natural products known as the picrotoxanes.  These compounds have a range of 
biological activities, with picrotoxinin (GABA receptor antagonist) being the most well known.133  Recent 
isolation of structurally related Flakinin A revealed a structure with an alternative lactone configuration134 (Figure 
3.5, A); this compound also demonstrated modest anti-leukemia activity.  In order to rapidly test the ability of the 
carboxylate-directed FePDP reaction to generate these types of lactones, a semi-synthesis from picrotoxinin was 
developed (Figure 3.5, B).  The semi-synthesis began with reduction of the epoxide, followed by global reduction 
of the olefins with Adam’s catalyst.  This compound was then ring-opened under basic conditions to form a 
hydroxy ester, which was subsequently acylated.  The methyl ester could be selectively cleaved under 
microwave/LiCl conditions to reveal the free acid.   
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Figure 3.5. A) Recently isolated picrotoxane natural product containing two lactones.  B) Semi-synthesis of the 
carboxylic acid starting material. 
 
Oxidation of 42 with FePDP 37 led to a highly selective lactonization reaction at the isopropyl group 
(instead of the cyclopentane ring), leading to two different products (Figure 3.6).  In addition to the expected 
lactone 43, hydroxylactone products 44α /44β  were also isolated via a desaturation pathway.  The catalyst  was 
able to control the diastereoselectivity of hydroxylactone formation to a modest extent.  This work underscores the 
ability of 37 to generate two different oxidation patterns on a complex substrate; each product has very different 
physical properties that could be useful for generating diversity in drug libraries.135  Both lactone and 
hydroxylactone products could be conveniently separated by standard column chromatography. 
Figure 3.6. Generating diverse oxidation products using C—H oxidation. 
 
Based on a series of elegant mechanistic experiments, hydroxylactone products are proposed to arise 
from epoxidation of olefin intermediates (ref. 104, Figure 3.7).  Similar to Nature’s desaturases,136 the olefin 
intermediate is generated by a divergent desaturation pathway that is unique to carboxylic acid-containing 
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substrates with FePDP.  Imporantly, oxidation of methyl ester 41 led to no observed lactone products, 
demonstrating that the carboxylic acid can override the low reactivity of a sterically and electronically deactivated 
substrate.  Use of trifluorodimethyldioxirane, an oxidant proposed to proceed through a concerted C—H oxidation 
pathway, led to none of the lactone or hydroxylactone products.137	  
Figure 3.7. Proposed mechanism for the formation of hydroxylactone products (M. Bigi, see ref. 104 ). 
 
3.2.2 Oxidation of the taxane scaffold 
   The first committed step in the biosynthesis of the anti-cancer agent Taxol© (paclitaxel) is the 
cyclization of geranylgeranylpyrophosphate into taxa-4(5)-10(11)-diene during the cyclase phase of terpene 
synthesis.138  This hydrocarbon core is then elaborated to Taxol through a series of P450-mediated C—H 
oxidation reactions and group transfers during a subsequent oxidase/tailoring phase (Figure 3.8).139   
Figure 3.8. Biosynthesis of the anti-cancer agent Taxol from taxadiene involves many enzymatic, P450 mediated 
C—H oxidations. 
 
 Although a substantial amount of work has been devoted to elucidating this biosynthetic pathway, the 
exact order of oxidation steps is still unknown.  This is due to the fact that some of the oxidation enzymes will 
only accept a specific substrate in the sequence, some enzymes are still unidentified, and substantial amounts of 
putative intermediates can be hard to access.  To this end, the high reactivity and analogous mechanism to P450 
enzymes presents the opportunity to use the FePDP catalyst system for biomimetic oxidations, as well as prepare 
potential intermediates and product standards useful for elucidating biosynthetic oxidation pathways.  A better 
understanding of Taxol biosynthesis is essential for metabolic engineering, which is an increasingly powerful 
approach for obtaining medicinal compounds via fermentation.140 
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 Our studies began with oxidation of the C1 position of the taxane core, given that the natural P450 
enzyme for this C—H oxidation is still unknown.  SAR studies have indicated that the C1 hydroxyl group is not 
necessary for Taxol’s microtubule binding ability.141  Interestingly, dimethyldioxirane (DMDO) has been reported 
to stereo- and regio-selectively oxidize the C1 position of taxane frameworks.142  To test the ability of FePDP to 
perform the same oxidation, compound 45 was prepared from taxusin143 via dihydroxylation and carbonate 
formation.  This compound was then subjected to standard FePDP reaction conditions, giving a rearranged A-ring 
nortaxane product 46 (structure verified by x-ray crystallography).  Independently prepared 47 that contained the 
hydroxyl group at C1 did not lead to rearranged products, ruling out a simple Lewis-acid promoted 
ionization/cation rearrangment mechanism with FePDP.144  However, an attempted Barton-McCombie 
deoxygenation at the C1 position was previously reported to lead to nortaxane products.145  Consequently, we 
favor the mechanism shown in Figure 3.9, which involves an initial C—H abstraction to generate radical I-1, 
followed by ring-contraction to I-2, and lastly hydroxyl rebound to form 46.  Although we cannot rule out the 
possibility of I-1 oxidizing to a cation (that subsequently rearranges), the cation must still be formed via a radical 
intermediate.  The use of a novel taxane radical trap represents the first compelling evidence for radical 
intermediates with this class of stereoretentive non-heme Fe catalysts. 
Figure 3.9. Oxidative rearrangment of the taxane core with FePDP, providing evidence of radical intermediates. 
 
 Interestingly, nortaxane products are abundant in Nature146 and possess microtubule binding properties 
necessary for anti-cancer activity.147  Previously, these natural products were proposed to originate from an 
alternative cation rearrangment during the cyclase phase of taxane biosynthesis, although no corresponding 
nortaxane synthase has been identified (Figure 3.10, A).148  With our results using FePDP, we proposed an 
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alternative mechanism involving a P450-mediated, late-stage oxidation/rearrangement that forms nortaxane 
products (Figure 3.10, B).   
Figure 3.10. Biosynthetic hypotheses for nortaxane formation. A) Previously proposed formation of the 
nortaxane core during a divergent cyclase pathway. B) Late-stage P450 mediated oxidation/rearrangment of C-1 
deoxytaxanes to form the nortaxane core. 
 
Oxidation of the C2 position on the taxane core is neccessary for biological activity.149  Despite this, C—
H oxidation of this position has only been reported using the naturally occuring taxane hydroxylase enzyme.150  
We hypothesized that with an adjacent carboxylic acid directing group, we could potentially access C2 
hydroxylated taxanes.  Synthesis of 48 from taxusin and oxidation under the standard reaction conditions led to 
the expected nortaxane product 49; this was consistent with our previous results that showed that the C1 hydrogen 
was the most reactive (Figure 3.11, A).  No lactone formation at C2 was observed.  Exposure of acid 50 to the 
oxidation conditions gave lactone 51 as the major isolable product, forming the new C—O bond with the correct 
diastereoselectivity found in Taxol.  Electrostatic charge calculations of an energy minimized structure of 50 
revealed that the C1 hydrogen is the most sterically accessible, electron rich C—H bond.  However, in the 
presence of the carboxylic acid directing group, oxidation is diverted away from C1 towards C2 (which is among 
the least reactive C—H bonds, electronically).  The diastereoselectivity can be rationalized by the close proximity 
of H-2α with the carboxylic acid.  Consistent with simpler chiral, non-racemic substrates, the reaction efficiency 
was influenced by the choice of catalyst enantiomer; oxidation using (R,R)-37 gave complex product mixtures and 
a lower yield of 51. 
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Figure 3.11. A) Oxidation of C1 is the most favorable pathway in the absence of directing groups. B) The 
carboxylic acid redirects oxidation to C2, diastereoselectively forming the lactone. 
 
3.3 CONCLUSION 
The application of FePDP with carboxylic acid substrates has led to the formation of novel lactone and 
hydroxylactone picrotoxinin derivatives via a common radical intermediate.  The use of a taxane-based radical 
trap has provided evidence for the formation of radical intermediates for this class of stereoretentive iron catalysts, 
and suggested a new biosynthetic hypothesis for the formation of A-ring nortaxane natural products.  Finally, the 
use of carboxylic acid directing groups has successfully installed oxidation at the C2 position of the taxane core, 
which may be useful for the synthesis of new biologically active taxanes. 
 
3.4 EXPERIMENTAL SECTION 
General Information: The following commercially obtained reagents for the C-H lactonization were 
used as received: HPLC grade CH3CN (Fisher Scientific), glacial acetic acid (AcOH, Fisher Scientific), 50 wt.% 
H2O2 solution in water (Aldrich, stored at 4oC). All C-H lactonization reactions were run under air with no 
precautions taken to exclude moisture. All products were filtered through a glass wool plug prior to obtaining a 
final weight. Each antipode of the Fe(PDP) catalyst was prepared as previously described and stored at 4oC.151 All 
other reactions were run under an atmosphere of N2 or Ar gas with dry solvent unless otherwise stated. Dry 
solvents tetrahydrofuran (THF), methylene chloride (CH2Cl2), diethyl ether (Et2O), methanol (MeOH), and 1,4-
dioxane were purified prior to use by passage through a bed of activated alumina (Glass Contour, Laguna Beach, 
California). Achiral gas chromatographic (GC) analyses were performed on an Agilent Technologies 6890N 
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Series instrument equipped with FID detectors using a HP-5 (5%-Phenyl)-methylpolysiloxane column (30m, 
0.32mm, 0.25mm). Chiral GC analysis was performed on an Agilent 5890 Series instrument equipped with FID 
detectors using a J&W cyclodex-β column (30 m, 0.25 mm, 0.25 mm). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with potassium 
permanganate, p-anisaldehyde, bromocresol green, and ceric ammonium molybdate staining. Flash column 
chromatography was performed as described by Still et al.152 using EM reagent silica gel 60 (230-400 mesh). 1H 
NMR spectra were recorded on a Varian Unity-400 (400 MHz), Varian Unity-500 (500 MHz), or a Varian Unity 
Inova 500NB (500 MHz) spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 
7.26 ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p = quintet, m = multiplet, b = broad, 
app = apparent; coupling constant(s) in Hz; integration. Proton-decoupled 13C NMR spectra were recorded on a 
Varian Unity-400 (100 MHz) or Varian Unity-500 (125 MHz) spectrometer and are reported in ppm using solvent 
as an internal standard (CDCl3 at 77.0 ppm). IR spectra were recorded as thin films on NaCl plates on a Mattson 
Galaxy Series FTIR 5000 and are reported in frequency of absorption (cm-1). High-resolution mass spectra were 
obtained at the University of Illinois Mass Spectrometry Laboratory. Optical rotations were measured using a 1 
mL cell with a 50 mm path length on a Perkin-Elmer 341 polarimeter. Optical rotations were obtained with a 
sodium lamp and are reported as follows: [α]λT°C (c = g/100 mL, solvent).  
General Procedures for the Oxidative C-H Lactonization Reaction 
General Procedure A 
C-H oxidation of Carboxylic Acids (0.5 mmol substrate): Into a 40 mL borosilicate vial was added hydrocarbon 
substrate (0.5 mmol, 1.0 equiv.), followed by 5 mol% Fe(PDP) catalyst 37 (23.3 mg, 0.025 mmol, 0.05 equiv.), 
0.75 mL CH3CN, and a magnetic stir bar.  While the resulting deep red solution stirred, a solution of H2O2 (50 
wt% in H2O, 34.6 µL, 0.60 mmol, 1.2 equiv.) in 4.5 mL CH3CN was added over a period of 1 minute (dropwise 
addition for 45 seconds, followed by streamwise addition for 15 seconds), generating an amber brown solution. 
Stirring followed for 10 minutes at ambient temperature, and a solution of 5 mol% 37 (23.3 mg, 0.025 mmol, 0.05 
equiv.) in 0.5 mL CH3CN was added in one burst.  A second solution of H2O2 (50 wt% in H2O, 34.6 µL, 0.60 
mmol, 1.2 equiv.) in 4.5 mL CH3CN was added as before and stirring followed for 10 minutes.  Following this 
stirring period, a second solution of 5 mol% 37 (23.3 mg, 0.025 mmol, 0.05 equiv.) in 0.5 mL CH3CN was added 
in one burst, followed by a third solution of H2O2 (50 wt% in H2O, 34.6 µL, 0.60 mmol, 1.2 equiv.) in 4.5 mL 
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CH3CN.  The reaction stirred a final 10 minutes and was analyzed by TLC.  The crude reaction mixture was 
concentrated in vacuo and purified by flash chromatography using EtOAc/hexanes mixtures, or for reactions 
generating volatile products, Et2O/pentanes mixtures. For 0.30 and 0.10 mmol reactions, the quantities of reagents 
were scaled accordingly. 
General Procedure B 
C-H oxidation of Non-Carboxylic Acids (0.5 mmol substrate): Into a 40 mL borosilicate vial was added 
hydrocarbon substrate (0.5 mmol, 1.0 equiv.), followed by 5 mol% Fe(PDP) catalyst 37 (23.3 mg, 0.025 mmol, 
0.05 equiv.), 0.75 mL CH3CN, 14.3 µL AcOH (0.25 mmol, 0.5 equiv.), and a magnetic stir bar.  While the 
resulting deep red solution stirred, a solution of H2O2 (50 wt% in H2O, 34.6 µL, 0.60 mmol, 1.2 equiv.) in 4.5 mL 
CH3CN was added over a period of 1 minute (dropwise addition for 45 seconds, followed by streamwise addition 
for 15 seconds), generating an amber brown solution.  Stirring followed for 10 minutes at ambient temperature, 
and a solution of 5 mol% 37 (23.3 mg, 0.025 mmol, 0.05 equiv.) and 14.3 µL AcOH (0.25 mmol, 0.5 equiv.) in 
0.5 mL CH3CN was added in one burst.  A second solution of H2O2 (50 wt% in H2O, 34.6 µL, 0.60 mmol, 1.2 
equiv.) in 4.5 mL CH3CN was added as before and stirring followed for 10 minutes.  Following this stirring 
period, a second solution of 5 mol% 37 (23.3 mg, 0.025 mmol, 0.05 equiv.) and 14.3 µL AcOH (0.25 mmol, 0.5 
equiv.) in 0.5 mL CH3CN was added in one burst, followed by a third solution of H2O2 (50 wt% in H2O, 34.6 µL, 
0.60 mmol, 1.2 equiv.) in 4.5 mL CH3CN.  The reaction stirred approx. 16h at ambient temperature to ensure 
complete lactonization of intermediate hydroxyester products and was thereafter concentrated in vacuo and 
purified by flash chromatography using EtOAc/hexanes mixtures, or for reactions generating volatile products, 
Et2O/pentanes mixtures. For 0.30 and 0.10 mmol reactions, the quantities of reagents were scaled accordingly. 
Picrotoxinin Derivative Synthesis and Oxidative C-H Lactonization 
Picrotoxinin-8,9-ene [(+)-38]. To a vigorously stirred solution of solid HgCl2 (1.2 g, 4.42 mmol, 
2.6 equiv.) and Zn dust (12 g, 0.184 mol, 108 equiv.) under argon atmosphere (maintained with a 
rubber septum and balloon) in a 250 mL round bottom flask was added 1M aqueous HCl (30 mL) 
via syringe.  After 15 min, the stirring was stopped, allowing the solution to settle.  The liquid 
was decanted with a syringe, and fresh 1M HCl was added (30 mL), maintaining inert atmosphere.  In a separate 
250 mL Erlenmeyer flask, chromium(III) chloride hexahydrate (19.5 g, 73.2 mmol, 43 equiv.) was dissolved in 30 
mL of 1M HCl.  The septum on the flask containing the Zn(Hg) amalgam was quickly removed and the Cr(III)Cl3 
O
O
O
O
OH
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solution was rapidly added by pouring.  The septum on the flask was replaced, and the reaction purged with an 
argon balloon.  The reaction was stirred for 1 h, changing from dark forest green to a deep blue color (CrCl2).  In a 
separate 250 mL round bottom flask containing a stir bar, 37 (500 mg, 1.71 mmol, 1.0 equiv.) was dissolved in 
acetone (33 mL, degassed for 30 min with argon).  The flask was then purged with argon for 5 min.  All of the 
Cr(II)Cl2 solution was added to the solution of substrate, and the reaction allowed to stir for 15 hrs under argon.  
The reaction was worked up by dilution with CH2Cl2 (150 mL) and water (150 mL).  The organic layer was 
separated, and the aqueous layer extracted twice with CH2Cl2 (2 x 100 mL).  The combined organic layers were 
washed with sat. NaHCO3 (2 x 150 mL), dried with MgSO4, and the slurry filtered through celite.  Evaporation of 
solvents yielded white solids, which were further purified by column chromatography on silica gel (40% ethyl 
acetate/hexane + 5% acetone) to give the diene product as a white solid (275.9 mg, 0.98 mmol, 57% yield). 
  1H NMR (500 MHz, CDCl3) δ 6.39 (dd, J = 2.0, 4.0 Hz, 1H), 5.11 (t, J = 1.5 Hz, 1H), 4.98 (dd, J = 4.5, 
3.5 Hz, 1H), 4.87 (d, J = 1.5 Hz, 1H), 4.69 (d, J = 3.0 Hz, 1H), 3.39 (bs, 1H), 3.35 (dd, J = 18.0, 4.0 Hz, 1H), 3.09 
(dd, J = 18.0, 2.0 Hz, 1H), 2.92 (d, J = 4.5 Hz, 1H), 2.15 (s, 1H), 1.95 (s, 3H), 1.32 (s, 3H); 13C NMR: (125 MHz, 
acetone-d6) δ 175.8, 164.5, 143.8, 141.6, 135.0, 111.8, 83.5, 80.4, 79.0, 54.3, 50.4, 50.2, 50.0, 23.3, 19.8; IR 
(film, cm-1): 3504 (broad), 2980, 2931, 2864, 1784, 1759, 1649, 1454, 1298, 1215, 1171, 1105, 980, 910; HRMS 
(ESI) m/z calc’d for C15H17O5 [M+H]+: 277.1076, found 277.1068; [α]D25 = +133.6° (c = 1.78, EtOH). 
Tetrahydropicrotoxinin [(-)-39].  To 250 mL round bottom flask was added 38 (523.6 mg, 1.9 
mmol, 1.0 equiv.), acetic acid (50 mL), and a stir bar.  Platinum oxide (10 mg) was added, and 
the reaction capped with a rubber septum.  H2 gas was then bubbled through the solution while 
vigorously stirring, until white solids began to form in the flask (4-6 hr).  The hydrogen balloon 
was then removed, and additional platinum oxide catalyst was added (6 mg).  CAUTION: The hydrogen in the 
flask headspace may ignite during catalyst addition.  Keep a watch glass nearby to extinguish.  The reaction 
was stirred an additional 8 hr (with H2 bubbling for 2 h, then stirred with a H2 atmosphere maintained by balloon 
for 6 h), and then diluted with EtOAc (50 mL).  The solution/catalyst mixture was filtered on silica/celite, and the 
solvent removed to yield white solids.  (466.2 mg, 1.58 mmol, 83% yield). 
1H NMR (500 MHz, acetone-d6) δ 4.79 (dd, J = 5.8, 3.8 Hz, 1H), 4.41 (d, J = 3.5 Hz, 1H), 2.90 (t, J = 
10.5 Hz, 1H), 2.75 (d, J = 4.0 Hz, 1H), 2.42 (dd, J = 12.8, 6.8 Hz, 1H), 2.36 (app dt, J = 11.7, 4.9 Hz, 1H), 2.09-
1.94 (m, 4H), 1.57-1.48 (m, 1H), 1.44 (s, 3H), 1.08 (d, J = 6.5 Hz, 3H), 1.02 (d, J = 6.5 Hz, 3H); 13C NMR: (125 
O
O
O
O
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H
 90	  
MHz, acetone-d6) δ 177.4, 176.1, 83.4, 80.2, 79.2, 55.0, 51.9, 51.8, 51.1, 44.1, 26.6, 26.0, 24.8, 22.3, 20.9;  IR 
(film, cm-1): 3504 (broad), 2960, 2926, 2873, 1788, 1745, 1477, 1448, 1389, 1367, 1319, 1228, 1201, 1176, 1126, 
1093, 1012, 970, 920; HRMS (ESI) m/z calc’d for C15H21O5 [M+H]+: 281.1389, found 281.1379; [α]D25 = -36.2° 
(c = 0.57, EtOH). 
Hydroxy methyl ester [(+)-40].  To a 250 mL round bottom flask was added bis-lactone 39 
(466.2 mg, 1.66 mmol, 1.0 equiv.), methanol (75 mL), and a stir bar.  With stirring, 1N 
NaOH (75 mL) was slowly added (exothermic!).  The reaction was stirred for 3 h at room 
temperature, then quenched by dropwise addition of 2M HCl until reaching a pH of 2.  The 
reaction then extracted with ether (3 x 300 mL), dried over MgSO4, filtered through celite, and evaporated to 
produce a crude white powder.  The crude material was further purified by elution through a pad of silica gel (90 x 
60 mm) with 50% EtOAc/hexanes (ca. 3L) to provide the methyl ester as a white solid (446.0 mg, 1.43 mmol, 
86% yield).   
1H NMR (500 MHz, CDCl3) δ 4.45 (d, J = 4.0 Hz, 1H), 3.77 (dd, J = 11.5, 3.5 Hz, 1H), 3.73 (s, 3H), 
2.80 (d, J = 7.0 Hz, 1H), 2.60 (d, J = 12.0 Hz, 1H), 2.18-2.07 (m, 2H), 2.01 (s, 1H), 1.96 (app t, J = 11.8 Hz, 1H), 
1.85 (td, J = 13.9, 6.2 Hz, 1H), 1.77-1.71 (m, 2H), 1.56 (dd, J = 14.0, 5.0 Hz, 1H), 1.31 (s, 3H), 1.13 (d, J = 7.0 
Hz, 3H), 0.99 (d, J = 7.0 Hz, 3H); 13C NMR: (125 MHz, CDCl3) δ 178.8, 172.8, 87.4, 81.4, 69.4, 55.2, 53.9, 51.8, 
51.4, 40.6, 37.4, 29.5, 27.5, 22.6, 19.7, 16.1; IR (film, cm-1): 3462 (broad), 2958, 2879, 1764, 1732, 1643, 1437, 
1367, 1284, 1228, 1196, 1173, 1068, 1011, 980; HRMS (ESI) m/z calc’d for C16H25O6 [M+H]+: 313.1651, found 
313.1646; [α]D25 = +56.5° (c = 1.0, CHCl3). 
Methyl ester acetate [(+)-41].  To a 1-dram screw-top vial was added methyl ester 40 
(200.0 mg, 0.64 mmol, 1.0 equiv.), a stir bar, pyridine (1 mL), and acetic anhydride (1 
mL).  While stirring, N,N-dimethylaminopyridine was added (5.0 mg, 0.041 mmol, 0.06 
equiv.), and the reaction was stirred at room temperature for 8 hr.  The reaction was then 
slowly poured onto a stirring solution of sat. NaHCO3 (ca. 50 mL), and allowed to quench until bubbling stopped 
(10 min).  The mixture was extracted with diethyl ether (3 x 40 mL), and the combined organic layers washed 
with 1N HCl (5 x 10 mL).  After drying the organic layer over MgSO4, filtration through celite, and evaporation 
of the solvent, the crude acetate was isolated as a white solid (194.2 mg, 0.55 mmol, 86% yield).  This material 
required no additional purification. 
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1H NMR (500 MHz, CDCl3) δ 4.95 (dd, J = 11.8, 3.8 Hz, 1H), 4.49 (d, J = 3.5 Hz, 1H), 3.74 (s, 3H), 
2.73 (d, J = 7.5 Hz, 1H), 2.66 (d, J = 12.5 Hz, 1H), 2.31 (td, J = 12.5, 1.0 Hz, 1H), 2.14 (s, 1H), 2.11 (s, 3H), 2.16-
2.06 (m, 2H), 1.86 (td, J = 13.5, 6.0 Hz, 1H), 1.68 (septet, J = 7.0 Hz, 1H), 1.53 (dd, J = 14.0, 5.0 Hz, 1H), 1.33 
(s, 3H), 1.06 (d, J = 7.0 Hz, 3H), 0.83 (d, J = 7.5 Hz, 3H); 13C NMR: (125 MHz, CDCl3) δ 178.9, 172.3, 170.1, 
83.4, 81.1, 70.4, 54.9, 54.1, 52.0, 51.6, 37.8, 37.6, 29.3, 27.4, 22.4, 21.2, 19.5, 16.2; IR (film, cm-1): 3489 (broad), 
2954, 2933, 2879, 1765, 1738, 1730, 1464, 1439, 1369, 1232, 1194, 1173, 1149, 1036, 1011, 980, 951, 903; 
HRMS (ESI) m/z calc’d for C18H27O7 [M+H]+: 355.1757, found 355.1745; [α]D25 = +75.0° (c = 0.9, CHCl3). 
Carboxylic acid [(+)-42]. This procedure was adapted from Wu and coworkers.153 To a 
dry, 10 mL microwave tube containing methyl ester 41 (27.8 mg, 0.079 mmol, 1.0 equiv.) 
was added lithium chloride (200 mg, dried 24 h at 200°C, 0.1 torr) and a stir bar (inside the 
glove box). Dry DMF (0.5 mL) was added while stirring vigorously under an argon 
atmosphere for 10 min; the tube was then quickly closed with a teflon cap, and heated to 160°C (~1.5 min 
ramping time to reach this temperature) in a CEM discover multimode reaction microwave and held at 160°C for 
5 min.  The resulting brown slurry was cooled to 0°C with an ice bath, followed by dilution with ethyl acetate (2 
mL) and 0.1N NaOH (2 mL).  An additional stir bar was added, and the biphasic mixture stirred until all the 
lithium chloride had dissolved (5-10 min).  The layers were separated, and the aqueous phase was washed with 
EtOAc (2 x 2 mL).  While still cold, 1N HCl was added until a pH of 1-2 was obtained (usually evident by a color 
change from pale yellow to near colorless).  The product was then extracted with ethyl acetate (3 x 5 mL); the 
combined organic washings were dried over MgSO4, filtered through celite, and evaporated to yield a waxy solid.  
Purification was carried out by flash chromatography on silica gel (30% acetone/hexanes + 1% AcOH) to isolate 
the carboxylic acid as a fluffy white solid (12.5 mg, 0.0367 mmol, 46% yield) after repeated azeotropic drying 
with benzene. 
1H NMR (500 MHz, CDCl3) δ 4.97 (dd, J = 12.0, 3.0 Hz, 1H), 4.50 (d, J = 3.5 Hz, 1H), 2.76 (d, J = 7.0 
Hz, 1H), 2.67 (d, J = 12.5 Hz, 1H), 2.30 (app t, J = 11.5 Hz, 1H), 2.12 (s, 3H), 2.17-2.06 (m, 2H), 1.90 (td, J = 
13.8, 6.3 Hz, 1H), 1.80 (app t, J = 6.5 Hz, 1H), 1.68-1.65 (m, 1H), 1.60 (bs, 2H), 1.35 (s, 3H), 1.09 (s, 3H), 0.87 
(s, 3H); 13C NMR: (125 MHz, CDCl3) δ 179.4, 177.0, 170.5, 83.7, 81.5, 70.6, 55.1, 54.2, 52.0, 37.9, 37.7, 29.6, 
27.7, 22.7, 21.5, 19.7, 16.3; IR (film, cm-1): 3481 (broad), 2964, 2931, 2877, 1739 (2 peaks), 1726, 1468, 1371, 
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1242, 1173, 1043, 949, 904; HRMS (ESI) m/z calc’d for C17H25O7 [M+H]+: 341.1600, found 341.1602; [α]D25 = 
+120.6° (c = 0.43, CHCl3). 
Lactone [(+)-43]. Following general procedure A, acid 42 (71.4 mg, 0.21 mmol, 1.0 equiv.) 
was reacted with catalyst (S,S)-37.  Analysis of the crude reaction mixture indicated a mixture 
of diastereomers. [Run 1: (1.6:1 d.r.); run 2: (1.5:1 d.r.); average: 1.6:1 d.r. (44α /44β , 1H NMR, 
acetone-d6). Flash chromatography with silica gel (gradient, 20%30%50% 
acetone/hexanes) was used to isolate the lactone product as white crystals [Run 1: (26.1 mg, 0.077 mmol), 37% 
yield; run 2 (74.2 mg scale): (29.1 mg, 0.086 mmol, 39% yield); average: 38% yield], along with a mixture of 
hydroxylactones 44α  and 44β  [Run 1: (29.6 mg, 0.084 mmol, 40% yield); run 2: (29.7 mg, 0.084 mmol, 38% 
yield); average: 39% yield]. The hydroxylactone diastereomers could be separated by MPLC (gradient, 050% 
acetone/hexanes) to obtain pure samples for spectroscopic analysis. 
1H NMR (500 MHz, CDCl3) δ 5.10 (dd, J = 11.8, 3.8 Hz, 1H), 4.62 (d, J = 4.0 Hz, 1H), 2.80 (d, J = 15.0 
Hz, 1H), 2.76 (d, J = 7.5 Hz, 1H), 2.68 (bs, 1H), 2.50 (dd, J = 14.5, 6.5 Hz, 1H), 2.35-2.30 (m, 1H), 2.19 (dd, J = 
12.3, 5.8 Hz, 1H), 2.13 (s, 3H), 1.95 (dd, J = 13.3, 5.3 Hz, 1H), 1.59 (td, J = 13.5, 5.8 Hz, 1H), 1.53 (s, 3H), 1.35 
(s, 3H), 1.34 (s, 3H); 13C NMR: (125 MHz, CDCl3) δ 178.5, 173.7, 170.0, 84.5, 84.2, 79.8, 70.8, 55.0, 54.1, 48.3, 
44.0, 35.3, 28.7, 28.5, 20.7, 20.5, 19.1; IR (film, cm-1): 3489 (broad), 2954, 2922, 2854, 1780, 1739 (2 peaks), 
1464, 1377, 1263, 1240, 1174, 1120, 1072, 1036; HRMS (ESI) m/z calc’d for C17H23O7 [M+H]+: 339.1444, found 
339.1448; [α]D25 = +130.1° (c = 1.22, CHCl3). 
Hydroxylactone [(+)-44α].   1H NMR (500 MHz, CDCl3) δ 5.48 (dd, J = 12.0, 3.5 Hz, 1H), 
4.66 (d, J = 4.0 Hz, 1H), 3.86 (d, J = 12.5 Hz, 1H), 3.72 (d, J = 12.5 Hz, 1H), 3.48 (d, J = 14.5 
Hz, 1H), 2.75 (d, J = 7.5 Hz, 1H), 2.56 (dd, J = 14.5, 12.0 Hz, 1H), 2.38-2.30 (m, 1H), 2.19 
(dd, J = 12.5, 6.0 Hz, 1H), 2.17 (s, 1H), 2.13 (s, 3H), 1.88 (dd, J = 13.3, 5.3 Hz, 1H), 1.58 (td, 
J = 13.5, 6.0 Hz, 1H), 1.43 (s, 3H), 1.35 (s, 3H); 13C NMR: (125 MHz, CDCl3) δ 178.7, 175.0, 170.2, 85.5, 84.4, 
80.2, 70.9, 66.1, 55.2, 54.0, 48.7, 43.6, 34.6, 28.6, 24.3, 20.9, 19.2; IR (film, cm-1): 3473 (broad), 2947, 2929, 
2873, 1763, 1751, 1462, 1379, 1329, 1286, 1236, 1178, 1119, 1066, 1038; HRMS (ESI) m/z calc’d for 
C17H22O8Na [M+Na]+: 377.1212, found 377.1205; [α]D25 = +132.7° (c = 0.32, EtOH). 
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Hydroxylactone [(+)-44β].   1H NMR (500 MHz, CDCl3) δ 5.11 (dd, J = 11.3, 3.8 Hz, 1H), 
4.65 (d, J = 4.0 Hz, 1H), 3.78 (d, J = 12.5 Hz, 1H), 3.58 (d, J = 12.5 Hz, 1H), 2.88 (ABq, Δυ = 
34.9 Hz, Jab = 15.0 Hz, 1H), 2.87 (ABq, Δυ = 22.4 Hz, Jab = 15.0 Hz, 1H), 2.77 (d, J = 7.5 Hz, 
1H), 2.39-2.31 (m, 1H), 2.20 (dd, J = 12.5, 6.0 Hz, 1H), 2.13 (s, 3H), 1.94 (dd, J = 13.5, 6.0 
Hz, 1H), 1.66 (bs, 2H); 1.64 (td, J = 13.5, 6.0 Hz, 1H), 1.37 (s, 3H), 1.32 (s, 3H); 13C NMR: (125 MHz, CDCl3) δ 
178.4, 173.5, 170.0, 86.3, 84.1, 79.9, 70.7, 67.4, 55.1, 54.1, 47.9, 37.4, 35.3, 28.5, 20.8, 19.2, 15.9; IR (film, cm-
1): 3464 (broad), 2929, 2872, 2854, 1765, 1749, 1462, 1377, 1329, 1284, 1236, 1186, 1115, 1070, 1036, 982; 
HRMS (ESI) m/z calc’d for C17H22O8Na [M+Na]+: 377.1212, found 377.1220; [α]D25 = +104.7° (c = 0.47, EtOH). 
Reaction of methyl ester (+)-41.  Methyl ester 41 (70.9 mg, 0.2 mmol, 1.0 equiv.) was reacted 
according to general procedure B with catalyst (S,S)-37. Flash chromatography yielded only recovered starting 
material as a white solid (63.9 mg, 0.18 mmol, 90% recovery).  Reaction of methyl ester 41 (63.0 mg, 0.18 mmol, 
1.0 equiv.) with catalyst (R,R)-37 under identical conditions also provided only starting material (59.8 mg, 0.169 
mmol, 94% recovery). 
Reaction of acid 42 with TFDO.  Acid 42 (95.2 mg, 0.280 mmol, 1.0 equiv.) was added to a brand-new 
50 mL round bottom flask equipped with a magnetic stir bar, and dissolved in CH2Cl2 (17 mL).  The flask was 
cooled to 0°C in an ice bath, and a -78°C solution of TFDO (4.2 mL, 0.42 mmol, 1.5 equiv., 0.1M in 1,1,1-
trifluoroacetone) was added in one portion via liquid nitrogen-cooled Pasteur pipet.  The reaction stirred for 2 h at 
0°C, and was then sealed with a plastic cap and allowed to warm to room temperature for 12 h.  The solvent was 
removed by rotatory evaporation at room temperature, and no lactone or hydroxylactone products were detected 
by crude 1H NMR or TLC comparison with authentic standards.   
Taxane-derivative Oxidation/Rearrangement 
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4α ,20-dihydroxy-taxusin [45a]: To a 250 mL round bottom flask with a stir bar 
under N2 was added taxusin (200 mg, 0.248 mmol, 1.0 equiv.), diethyl ether (45 mL), and pyridine (4 mL).  The 
solution was cooled to 0°C, and a solution of OsO4 (11.4 mL, 1.12 mmol, 2.8 equiv., 0.098 M in THF) was added 
dropwise. The yellow solution gradually changed to an orange color, and the reaction was allowed to warm to 
room temperature.  Stirring was continued for 8 hr, then quenched by dropwise addition of a pre-mixed water (48 
mL), THF (32 mL), pyridine (4.8 mL), NaHSO3 (9.3 g) solution.  The reaction became a dark orange color, and 
was stirred for 2 h at room temperature.  The two layers that formed were transferred to a seperatory funnel, and 
extracted with ethyl acetate (2 x 100 mL).  The combined organic layers were washed with brine (1 x 100 mL), 
dried over MgSO4, filtered through Celite, and evaporated to dryness.  The crude material was subjected to silica 
gel chromatography (50% EtOAc/hexanes) to yield a white solid (205.3 mg, 0.381 mmol, 95% yield). 
1H NMR (500 MHz, CDCl3) δ 5.99 (d, J = 10.6 Hz, 1H), 5.78 (d, J = 10.6 Hz, 1H), 5.63–5.70 (m, 1H), 
5.21 (t, J = 2.8 Hz, 1H), 3.58 (dd, J = 11.6, 1.7 Hz, 1H), 3.44–3.53 (m, 1H), 2.81 (ddd, J = 15.4, 10.8, 8.1 Hz, 1H), 
2.69–2.75 (m, 1H), 2.50 (d, J = 1.4 Hz, 1H), 2.21 (s, 3H), 2.10 (s, 6H), 2.05 (s, 3H), 2.00 (s, 3H), 1.93-1.96 (m, 
1H), 1.76 (ddt, J = 17.9, 15.2, 4.5 Hz, 5H), 1.61-1.64 (m, 2H), 1.58 (s, 3H), 1.12–1.22 (m, 1H), 1.01 (s, 3H), 0.78 
(s, 3H). 
4α ,20-carbonato-taxusin [45]: Diol 45a (120.1 mg, 0.223 mmol, 1.0 equiv.) was 
dissolved in 2.25 mL CH2Cl2 and transferred to a flame-dried 25 mL round bottom 
flask containing a stir bar under N2.  Pyridine (1.1 mL, 13.4 mmol, 60 equiv.) was 
added via syringe, and the solution cooled to -78°C.  A solution of triphosgene 
(49.6 mg, 0.167 mmol, 0.75 equiv., in 2.25 mL CH2Cl2) was added dropwise, causing an immediate precipitation 
of off-white solids.  Stirring was continued for 10 min at -78°C, then the solution was warmed to 20°C for 20 min.  
The reaction was then quenched by addition of sat. NH4Cl (20 mL), diluted with CH2Cl2 (50 mL), and the 
aqueous layer extracted with CH2Cl2 (2 x 50 mL).  The combined organic layers were then washed sequentially 
with 1N HCl (1 x 75 mL), sat. NaHCO3 (1 x 75 mL), and brine (1 x 100 mL).  The organic layer was dried over 
Na2SO4 (20 min), filtered through Celite, and the solvent removed by rotatory evaporation.  Isolation was 
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accomplished by flash chromatography on silica gel (50% EtOAc/hexanes) to provide the product as a off-white 
solid (97.1 mg, 0.172 mmol, 77% yield). 
  1H NMR (500 MHz, CDCl3): δ 6.02 (d, J = 10.5 Hz, 1H), 5.80 (d, J = 11.0 Hz, 1H), 5.71 (m, 1H), 5.17 
(s, 1H), 4.16 (d, J = 9.5 Hz, 1H), 4.04 (d, J = 9.0 Hz, 1H), 2.99 (m, 1H), 2.70-2.76 (m, 1H), 2.21 (s, 3H), 2.09 (s, 
6H), 2.04 (s, 3H), 1.98 (s, 3H), 1.84-1.91 (m, 3H), 1.71 (m, 3H), 1.69-1.61 (m, 1H), 1.57 (s, 3H), 1.36 (d, J = 12.5 
Hz, 1H), 1.06 (s, 3H), 0.68 (s, 3H); 13C NMR (125 MHz, CDCl3):  δ 170.5, 170.4, 169.7, 169.5, 152.9, 137.9, 
135.0, 86.2, 75.7, 72.0, 70.1 (2 peaks), 68.9, 42.4, 39.8, 39.1, 36.3, 31.2, 31.1, 27.1, 26.6, 25.5, 23.2, 21.4, 21.2, 
20.9, 20.7, 18.2, 15.0; LRMS (ESI): 587.3 [M+Na]+. 
 1-hydroxy-4α ,20-carbonato-A-nortaxusin [(-)-46]:  (+)-
4α,20-carbonato-taxusin 45 (53.2 mg, 0.094 mmol, 1.0 equiv.) was reacted with 
(R,R)-Fe(PDP) following general procedure B, except that only one oxidation 
cycle was used.  After silica gel column chromatography (gradient, CH2Cl2  
1%  2%  3% MeOH/CH2Cl2), 46 was isolated as a colorless oil (11.6 mg, 0.020 mmol, 21% yield), along 
with unreacted starting material 45 (15.2 mg, 0.027 mmol, 29% recovery).  X-ray quality crystals of 46 were 
obtained from slow evaporation of CHCl3/acetone. 
1H NMR (500 MHz, CDCl3) δ 6.11 (d, J = 10.5 Hz, 1H), 6.82 (d, J = 10.5 Hz, 1H), 5.58 (t, J = 7.5 Hz, 
1H), 5.26 (t, J = 2.5 Hz, 1H), 4.18 (ABq, Δυ = 3.6 Hz, Jab = 13.0 Hz, 2H), 2.59 (d, J = 8.5 Hz, 1H), 2.42 (dd, J = 
14.3, 7.3 Hz, 1H), 2.30 (bs, 1H), 2.17 (dd, J = 14.0, 8.3 Hz, 1H), 2.12 (s, 3H), 2.06 (s, 3H), 2.03 (s, 3H), 1.99 (s, 
3H), 1.93-1.97 (m, 1H), 1.81 (s, 3H), 1.78-1.83 (m, 1H), 1.71 (dt, J = 13.1, 3.7 Hz, 1H), 1.60-1.64 (m, 2H), 1.35 
(d, J = 13.5 Hz, 1H), 1.29 (s, 3H), 1.16 (s, 3H), 0.79 (s, 3H); 13C NMR: (125 MHz, CDCl3) δ 170.6, 170.1, 169.4, 
168.6, 152.8, 146.0, 137.3, 85.3, 79.1, 76.5, 75.7, 69.2, 69.0, 68.8, 62.9, 42.5, 41.6, 39.0, 27.1, 26.5, 26.1, 24.8, 
23.7, 21.1, 20.8, 20.6 (2 peaks), 17.4, 11.5; IR (film, cm-1): 3556, 2974, 2933, 2873, 2858, 1813, 1745, 1458, 
1439, 1373, 1236, 1144, 1070, 1059, 1030, 962, 910, 754;  HRMS (ESI) m/z calc’d for C29H40O12Na [M+Na]+: 
603.2417, found 603.2416; [α]D25 = -38.7° (c = 1.68, CHCl3). 
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Crystal data and structure refinement for ba53las, (-)-46. 
Identification code  ba53las 
Empirical formula  C29 H40 O12 
Formula weight  580.61 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21  
Unit cell dimensions a = 11.7889(6) Å a= 90°. 
 b = 14.0098(8) Å b= 90°. 
 c = 18.6054(10) Å g = 90°. 
Volume 3072.9(3) Å3 
Z 4 
Density (calculated) 1.255 Mg/m3 
Absorption coefficient 0.097 mm-1 
F(000) 1240 
Crystal size 0.461 x 0.268 x 0.268 mm3 
Theta range for data collection 1.82 to 27.17°. 
Index ranges -15<=h<=15, -18<=k<=17, -23<=l<=23 
Reflections collected 56978 
Independent reflections 3791 [R(int) = 0.0594] 
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Completeness to theta = 27.17° 99.4 %  
Absorption correction Integration 
Max. and min. transmission 0.9877 and 0.9704 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3791 / 231 / 466 
Goodness-of-fit on F2 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0374, wR2 = 0.0906 
R indices (all data) R1 = 0.0507, wR2 = 0.0984 
Absolute structure parameter 0(10) 
Largest diff. peak and hole 0.377 and -0.177 e.Å-3 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for ba53las.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(1) 9484(2) 7970(1) 6484(1) 48(1) 
O(2) 6650(2) 7621(2) 9690(1) 46(1) 
O(3) 4929(2) 7224(2) 9282(1) 57(1) 
O(4) 6494(1) 6588(1) 8794(1) 35(1) 
O(5) 7430(2) 4869(1) 8993(1) 42(1) 
O(6) 5912(3) 4804(3) 9730(2) 58(1) 
C(22) 6421(4) 4523(4) 9210(2) 49(1) 
C(23) 5996(5) 3792(4) 8697(3) 65(2) 
O(6B) 6400(20) 4378(19) 9876(10) 62(5) 
C(22B) 6530(30) 4380(30) 9235(12) 56(4) 
C(23B) 6250(30) 3570(20) 8754(16) 58(6) 
O(7) 11431(1) 6126(1) 7776(1) 35(1) 
O(8) 12059(13) 7479(9) 7237(10) 60(3) 
C(24) 12232(8) 6772(12) 7586(15) 43(2) 
C(25) 13391(8) 6445(15) 7808(12) 66(3) 
O(8B) 12190(20) 7489(12) 7424(15) 54(3) 
C(24B) 12336(12) 6684(19) 7620(30) 45(3) 
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C(25B) 13413(9) 6250(19) 7891(17) 53(4) 
O(9) 10479(1) 5998(1) 6421(1) 32(1) 
O(10) 11206(2) 4517(1) 6427(1) 50(1) 
O(11) 5923(1) 5004(1) 6669(1) 42(1) 
O(12) 4596(15) 5845(11) 6079(10) 59(3) 
C(28) 4880(10) 5133(18) 6394(19) 45(2) 
C(29) 4136(11) 4289(13) 6565(11) 59(3) 
O(12B) 4525(15) 5627(14) 6011(9) 54(3) 
C(28B) 4840(11) 5050(20) 6450(20) 46(2) 
C(29B) 4153(11) 4278(12) 6803(11) 56(3) 
C(1) 7946(2) 6959(2) 6955(1) 25(1) 
C(2) 8092(2) 7355(2) 7735(1) 27(1) 
C(3) 8362(2) 6546(2) 8269(1) 25(1) 
C(4) 7704(2) 6570(2) 8977(1) 30(1) 
C(5) 7913(2) 5650(2) 9403(1) 36(1) 
C(6) 9169(2) 5438(2) 9502(1) 42(1) 
C(7) 9829(2) 5465(2) 8791(1) 36(1) 
C(8) 9657(2) 6412(2) 8393(1) 28(1) 
C(9) 10266(2) 6435(2) 7655(1) 28(1) 
C(10) 9790(2) 5811(2) 7061(1) 25(1) 
C(11) 8568(2) 6006(2) 6855(1) 25(1) 
C(12) 7908(2) 5327(2) 6578(1) 28(1) 
C(13) 6745(2) 5704(2) 6418(1) 31(1) 
C(14) 6691(2) 6630(2) 6842(1) 30(1) 
C(15) 8300(2) 7730(2) 6385(1) 34(1) 
C(16) 8083(3) 7388(2) 5626(1) 50(1) 
C(17) 7676(2) 8670(2) 6513(2) 44(1) 
C(18) 8213(2) 4313(2) 6414(2) 38(1) 
C(19) 10180(2) 7237(2) 8828(1) 36(1) 
C(20) 7800(2) 7462(2) 9451(1) 36(1) 
C(21) 5931(2) 7148(2) 9261(1) 40(1) 
C(26) 11124(2) 5288(2) 6153(1) 37(1) 
C(27) 11705(2) 5597(3) 5478(2) 54(1) 
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"CCDC 794910 contains the supplementary crystallographic data for this paper. These data can be obtained free 
of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif." 
 
 
Hydroxylation of C-1 with TFDO to form 47.  Taxane 45 (122.5 mg, 0.217 mmol, 1.0 equiv.) was 
added to a brand-new 50 mL round bottom flask equipped with a magnetic stir bar, and dissolved in CH2Cl2 (9 
mL).  The flask was cooled to 0°C in an ice bath, and a -78°C solution of TFDO (2.05 mL, 0.245 mmol, 1.13 
equiv., 0.12M in 1,1,1-trifluoroacetone) was added in one portion via liquid nitrogen-cooled Pasteur pipet.  The 
reaction stirred for 7 h at 0°C in the dark, and was then dried by rotatory evaporation at 0°C.  After silica gel 
column chromatography (gradient, 1%3% MeOH/CH2Cl2), 47 was isolated as white solid (37.4 mg, 0.0644 
mmol, 30% yield).  X-ray quality crystals were obtained by slow evaporation of acetone/chloroform. 
1H NMR (500 MHz, CDCl3): δ 6.03 (d, J = 11.0 Hz, 1H), 5.85 (d, J = 10.5 Hz, 1H), 5.83-5.87 (m, 1H), 
5.20 (s, 1H), 4.19 (d, J = 9.0 Hz, 1), 4.06 (d, J = 9.5 Hz, 1H), 2.97 (d, J = 5.5 Hz, 1H), 2.58 (dd, J = 15.0, 10.0 Hz, 
1H), 2.23 (s, 3H), 2.12 (s, 3H), 2.11 (s, 3H), 2.06 (s, 3H), 2.02 (s, 3H), 1.97-2.12 (m, 3H), 1.90-1.92 (m, 1H), 1.70 
(m, 1H), 1.58 (s, 3H), 1.60 (d, J = 6.5 Hz, 1H), 1.45 (d, J = 14.5 Hz, 1H), 1.14 (s, 3H), 0.72 (s, 3H); 13C NMR 
(125 MHz, CDCl3): δ 170.4, 170.3, 169.7, 169.4, 152.7, 139.5, 135.1, 86.0, 75.4, 75.1, 71.6, 70.9, 70.2, 68.9, 
43.4, 42.7, 41.1, 39.4, 36.4, 27.5, 25.5, 23.2, 21.5, 21.4, 21.3, 20.9, 20.7, 18.3, 15.1; LRMS (ESI, M+23): 603.5, 
537.5, 461.4, 360.5, 312.4, 280.3. 
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Crystal data and structure refinement for ba55kas, 47. 
Identification code  ba55kas 
Empirical formula  C31 H42 Cl6 O12 
Formula weight  819.35 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1)  
Unit cell dimensions a = 9.5644(4) Å a= 90°. 
 b = 11.8919(5) Å b= 90°. 
 c = 31.9645(14) Å g = 90°. 
Volume 3635.6(3) Å3 
Z 4 
Density (calculated) 1.497 Mg/m3 
Absorption coefficient 0.533 mm-1 
F(000) 1704 
Crystal size 0.274 x 0.221 x 0.167 mm3 
Theta range for data collection 1.83 to 25.43°. 
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Index ranges -11<=h<=11, -14<=k<=14, -38<=l<=38 
Reflections collected 59930 
Independent reflections 6684 [R(int) = 0.0891] 
Completeness to theta = 25.43° 99.3 %  
Absorption correction Integration 
Max. and min. transmission 0.9449 and 0.9059 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6684 / 54 / 487 
Goodness-of-fit on F2 1.020 
Final R indices [I>2sigma(I)] R1 = 0.0448, wR2 = 0.1025 
R indices (all data) R1 = 0.0689, wR2 = 0.1142 
Absolute structure parameter -0.02(7) 
Largest diff. peak and hole 0.259 and -0.454 e.Å-3 
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Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for ba55kas.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
C(1) 6948(4) 3526(3) 259(1) 18(1) 
C(2) 5503(4) 3913(3) 432(1) 18(1) 
C(3) 5344(4) 4233(3) 901(1) 17(1) 
C(4) 4109(4) 3607(3) 1112(1) 21(1) 
C(5) 4072(4) 3800(3) 1589(1) 22(1) 
C(6) 4081(4) 5037(3) 1703(1) 27(1) 
C(7) 5259(4) 5669(3) 1487(1) 24(1) 
C(8) 5246(4) 5539(3) 1005(1) 20(1) 
C(9) 6466(4) 6232(3) 819(1) 20(1) 
C(10) 7975(4) 5868(3) 903(1) 19(1) 
C(11) 8319(3) 4729(3) 720(1) 16(1) 
C(12) 8690(3) 3882(3) 976(1) 18(1) 
C(13) 8741(4) 2707(3) 788(1) 19(1) 
C(14) 7500(4) 2488(3) 499(1) 21(1) 
C(15) 8071(4) 4476(3) 255(1) 18(1) 
C(16) 7584(4) 5441(3) -36(1) 21(1) 
C(17) 9459(4) 4116(3) 47(1) 22(1) 
C(18) 9014(4) 3993(3) 1437(1) 25(1) 
C(19) 3927(4) 6068(3) 818(1) 27(1) 
C(20) 3138(4) 1857(3) 1066(1) 24(1) 
C(21) 2634(4) 3667(3) 937(1) 24(1) 
C(22) 5167(4) 2284(3) 1951(1) 28(1) 
C(23) 6547(5) 1824(4) 2081(1) 43(1) 
C(24) 6207(4) 8224(3) 720(1) 28(1) 
C(25) 6105(5) 9324(3) 945(1) 40(1) 
C(26) 10108(4) 6896(3) 872(1) 23(1) 
C(27) 10854(4) 7790(3) 637(1) 29(1) 
C(28) 9360(4) 895(3) 1036(1) 25(1) 
C(29) 9529(5) 171(3) 1416(1) 39(1) 
C(30) 1410(13) 2644(7) 2580(3) 65(3) 
C(30B) 1516(12) 2595(8) 2562(3) 49(3) 
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C(31) 3309(5) 9240(3) 1967(1) 38(1) 
O(1) 6717(2) 3123(2) -160(1) 23(1) 
O(2) 4370(2) 2396(2) 1057(1) 21(1) 
O(3) 2080(2) 2576(2) 1030(1) 25(1) 
O(4) 3017(3) 858(2) 1100(1) 31(1) 
O(5) 5313(3) 3299(2) 1766(1) 24(1) 
O(6) 4064(3) 1825(2) 1999(1) 37(1) 
O(7) 6353(3) 7361(2) 992(1) 22(1) 
O(8) 6127(4) 8113(2) 350(1) 49(1) 
O(9) 8822(2) 6744(2) 714(1) 22(1) 
O(10) 10561(3) 6358(2) 1162(1) 36(1) 
O(11) 8749(3) 1884(2) 1128(1) 23(1) 
O(12) 9743(3) 634(2) 691(1) 32(1) 
Cl(1) 1408(5) 4034(3) 2440(1) 38(1) 
Cl(1B) 1547(12) 4023(7) 2483(3) 144(4) 
Cl(2) -72(5) 1928(4) 2442(2) 90(2) 
Cl(2B) 217(16) 1956(7) 2279(6) 183(5) 
Cl(3) 1843(5) 2445(4) 3092(1) 51(2) 
Cl(3B) 1410(20) 2265(11) 3082(2) 182(5) 
Cl(4) 5022(1) 8846(1) 2097(1) 52(1) 
Cl(5) 2480(2) 8126(1) 1705(1) 59(1) 
Cl(6) 2388(2) 9604(1) 2419(1) 61(1) 
________________________________________________________________________________ 
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Reaction of taxusin derivative 47 with Fe(PDP). Independently synthesized 1-hydroxy-4α,20-carbonato-taxusin 
47 (37.4 mg, 0.0644 mmol, 1.0 equiv.) was reacted following general procedure B with (R,R)-37.  After silica gel 
column chromatography (3% MeOH/CH2Cl2), the C13 ketone was isolated as white solid (24.7 mg, 0.0460 mmol, 
71% yield).   
1H NMR (500 MHz, CDCl3): δ 6.08 (d, J = 10.5 Hz, 1H), 5.86 (d, J = 10.5 Hz, 1H), 5.24 (d, J = 3.1 Hz, 
1H), 4.16 (d, J = 9.4 Hz, 1H), 4.08 (d, J = 9.4 Hz, 1H), 3.01 (d, J = 19.5 Hz, 1H), 2.86-2.78 (m, 2H), 2.22 (s, 3H), 
2.17-2.00 (m, 11H), 1.88 (dt, J = 13.1, 3.1 Hz, 1H), 1.79-1.50 (m, 1H),  1.62 (s, 3H), 1.21 (s, 3H), 0.72 (s, 3H). 
Studies with Taxusin-derived Carboxylic Acid 
 
4a-hydro-20-taxusin carboxylic acid [(+)-50]. The alcohol depicted above (171.0 mg, 0.327 mmol, 1 equiv., 
obtained from BH3 hydroboration/oxidation of taxusin154) was added to a 40 mL screw-top scintillation vial 
containing a stir bar, and CH2Cl2 (6.5 mL).  Dess-Martin periodinane (693.5 mg, 1.64 mmol, 5.0 equiv.) was then 
added, followed by a drop of water.  The reaction was stirred at room temperature until complete conversion of 
the starting material was observed by TLC (2 h).  Extended reaction times led to low yields and complex product 
mixtures.  The reaction mixture was then added dropwise to a stirring solution of saturated NaS2O3/NaHCO3 (150 
mL, 5:1 ratio), and stirred at room temperature for 30 min.  The cloudy organic layer was extracted with CH2Cl2 
(3x50 mL); the combined organic layers were washed with brine and dried over Na2SO4 (1 hr).  After decantation, 
the solvent was removed to provide the crude aldehyde, which was used immediately for the next step without 
further purification. 
 1H NMR (500 MHz, CDCl3, diagnostic peaks): δ 9.83 (s, 1H), 6.02 (d, J = 10.5 Hz, 1H), 5.88 (t, J = 15.0 
Hz, 1H), 5.86 (d, J  = 10.5 Hz, 1H), 5.49 (app d, J = 2.0 Hz, 1H), 2.82-2.92 (m, 2H), 2.37 (app d, J = 5.0 Hz, 1H), 
2.26-2.31 (m, 2H). 
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 A 100 mL round bottom flask was charged with the aldehyde from the previous step, 2-methyl-2-butene 
(11.3 mL, 2M solution in THF), tert-butanol (22.5 mL), and a stir bar.  A solution of NaClO2 (930 mg, 10.3 
mmol) and NaH2PO4 (655 mg, 5.5 mmol) in water (16 mL) was prepared in a separate scintillation vial.  Both the 
oxidant vial and the reaction flask were cooled to 0°C with an ice bath. The oxidant solution was then slowly 
added dropwise via pipette to the reaction flask until complete conversion of the starting material was observed by 
TLC (~8 mL).  The reaction flask was then poured into water (70 mL), and extracted with EtOAc (3x50 mL).  The 
combined organic layers were dried over MgSO4, filtered through celite, and evaporated.  The crude product was 
purified by silica flash chromatography (gradient, 20%  30% acetone/hexanes/1% AcOH) to provide the acid 50 
as a foamy white solid (148.4 mg, 0.277 mmol, 85% for 2 steps). 
1H NMR (500 MHz, CDCl3): δ 5.97 (d, J = 11.0 Hz, 1H), 5.86 (t, J = 8.0 Hz, 1H), 5.82 (d, J = 10.5 Hz, 1H), 
5.37 (broad s, 1H), 2.77 (app dt, J = 15.0 Hz, 9.8 Hz, 1H), 2.68 (t, J = 5.8 Hz, 1H), 2.46 (d, J = 5.0 Hz, 1H), 2.18 
(s, 3H), 2.07 (s, 6H), 2.05-2.09 (m, 1H), 2.03 (s, 3H), 1.98 (s, 3H), 1.91-1.99 (m, 2H), 1.81-1.82 (m, 1H), 1.70-
1.72 (m, 2H), 1.56-1.62 (m, 1H), 1.56 (s, 3H), 1.11 (dd, J = 14.8, 7.3 Hz, 1H), 1.07 (s, 3H), 0.79 (s, 3H); 13C 
NMR (125 MHz, CDCl3): δ 178.9, 170.6, 170.3, 170.0, 169.9, 136.7, 135.0, 76.9, 72.5, 70.7, 69.9, 50.9, 42.0, 
40.4, 38.9, 34.0, 32.5 (2 peaks), 31.0, 27.0, 26.7, 22.9, 21.6, 21.4, 20.9, 20.8, 17.0, 14.7; IR (film, cm-1): 3264 
(broad), 3018, 2948, 2875, 1739, 1699, 1456, 1439, 1373, 1243, 1169, 1117, 1022, 972, 929, 755; HRMS (ESI) 
m/z calc’d for C28H40O10Na [M+Na]+: 559.2519, found 559.2516; [α]D26.5 = +97.8° (c = 1.9, CHCl3). 
Taxusilactone [(+)-51]. Acid 50 (73.2 mg, 0.136 mmol, 1.0 equiv.) was reacted 
using the standard procedure with (S,S)-Fe(PDP)(SbF6)2.  Following silica flash 
chromatography (1%  2%  3%  4%  5% MeOH/CH2Cl2), the lactone was 
isolated as a colorless, waxy solid (run 1: 36.9 mg, 0.0690 mmol, 51% yield; run 2: 34.1 mg, 0.0638 mmol, 47% 
yield), along with unreacted starting material (run 1: 16.6 mg, 0.0310, 23% recovery; run 2: 11.5 mg, 0.0214 
mmol, 16% recovery).  Average (S,S catalyst): 49% yield lactone + 20% recovered starting material.   
Using (R,R)-Fe(PDP)(SbF6)2: Run 1(67.4 mg, 0.126 mmol scale): 17.9 mg, 0.0335 mmol, 27% yield); run 2 (73.1 
mg, 0.136 mmol scale): 16.4 mg, 0.0307 mmol, 23% yield).  Average (R,R catalyst): 25% yield lactone.  
Although a small amount of starting material was observed by crude 1H NMR, it was unable to be re-isolated from 
other reaction byproducts.  
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1H NMR (500 MHz, CDCl3): δ 5.94 (d, J = 10.0 Hz, 1H), 5.74-5.77 (m, 1H), 5.63 (d, J = 10.0 Hz, 1H), 
5.31-5.36 (m, 1H), 4.65 (dd, J = 4.8, 2.8 Hz, 1H), 3.33 (dd, J = 13.8, 5.3 Hz, 1H), 2.76 (dd, J = 14.0, 9.5 Hz, 1H), 
2.70 (dt, J = 17.3, 9.2 Hz, 1H), 2.19-2.23 (m, 1H), 2.03-2.11 (m, 1H), 2.15 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H), 2.00 
(s, 3H), 1.96 (s, 3H), 1.80-1.86 (m, 1H), 1.64-1.70 (m, 1H), 1.60 (s, 3H), 1.19-1.51 (m, 2H), 1.11 (s, 3H), 1.01 (s, 
3H); 13C NMR (125 MHz, CDCl3): δ 175.3, 170.2. 170.1, 169.9, 169.7, 139.0, 136.7, 80.7, 77.5, 73.1, 69.3, 66.4, 
42.7, 42.3, 38.8, 37.9, 37.1, 32.6, 28.3, 27.5, 25.6, 25.4, 23.5, 21.2, 21.1, 20.9, 20.7, 15.8;  IR (film, cm-1): 3020, 
2962, 2922, 2859, 1777, 1742, 1467, 1441, 1372, 1238, 1184, 1026, 981, 964, 755.5; HRMS (ESI) m/z calc’d for 
C28H38O10Na [M+Na]+: 557.2363, found 557.2363; [α]D26.5 = +60.2° (c =1.44, CHCl3). 
 
Reaction of lactone 51 with Fe(PDP). Lactone 51 (32.2 mg, 0.06 mmol, 1.0 equiv.) was reacted following 
general procedure B with (R,R)-37.  No new products were visible by 1H NMR analysis of the crude reaction 
mixture.   
 4a-hydro-20-taxusin carboxylic acid methyl ester [(+)-48]. A flame-dried 
10 mL round bottom flask with stir bar was charged with acid 50 (33.2 mg, 0.0619 
mmol, 1.0 equiv.) and dry methanol (0.62 mL) under nitrogen.  The solution was 
cooled to 0°C, and trimethylsilyl diazomethane (2M in Et2O, Aldrich) was added 
dropwise until a yellow color persisted (~ 0.3 mL).  The reaction was stirred at 0°C for 30 min, then carefully 
quenched with 0.15 mL acetic acid (the yellow color immediately disappated, and the solution bubbled).  Removal 
of solvent by rotatory evaporation and purification by silica flash chromatography (20%  30%  40% ethyl 
acetate/hexanes) allowed isolation of the methyl ester as a white foam (24.7 mg, 0.0449 mmol, 72% yield). 
1H NMR (500 MHz, CDCl3): δ 5.99 (d, J = 10.5 Hz, 1H), 5.87 (t, J = 9.5 Hz, 1H), 5.83 (d, J = 10.5 Hz, 1H), 
5.04 (d, J = 2.0 Hz, 1H), 3.64 (s, 3H), 2.78 (app dt, J = 15.0, 9.5 Hz, 1H), 2.68 (t, J = 5.5 Hz, 1H), 2.45 (d, J = 5.5 
Hz, 1H), 2.19 (s, 3H), 2.09 (s, 3H), 2.08 (s, 3H), 2.06-2.11 (m, 1H), 2.04 (s, 3H), 1.99 (s, 3H), 1.91-1.96 (m, 2H), 
1.83-1.84 (m, 1H), 1.71-1.74 (m, 2H), 1.62 (dd, J = 13.8, 4.3 Hz, 1H), 1.58 (s, 3H), 1.13 (dd, J = 14.8, 7.3 Hz, 
1H), 1.09 (s, 3H), 0.74 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 173.6, 170.5, 170.3, 169.9, 169.8, 136.7, 135.1, 
 107	  
77.0 (partial CDCl3 overlap), 72.5, 70.7, 70.2, 51.7, 51.1, 41.8, 40.5, 39.0, 34.0, 32.5 (2 peaks), 31.1, 27.1, 26.9, 
23.0, 21.7, 21.4, 21.0, 20.8, 16.9, 14.8;  IR (film, cm-1): 3016, 2954, 2881, 1739, 1454, 1439, 1371, 1238, 1169, 
1117, 1020, 970, 754; HRMS (ESI) m/z calc’d for C29H42O10Na [M+Na]+: 573.2676, found 573.2678; [α]D26 = 
+75.5° (c = 1.58, CHCl3). 
Nortaxane methyl ester [(-)-49]. Methyl ester (+)-48 (24.7 mg, 0.0449 mmol, 1.0 
equiv.) was reacted according to the standard procedure (with 0.5 equiv. AcOH). No 
peaks corresponding to lactone 51 were observed by crude 1H NMR. Nortaxane 
product 49 was isolated by silica flash chromatography (40% ethyl acetate/hexanes) 
as a colorless oil [run 1: 7.4 mg, 0.0131 mmol, 29% yield; run 2 (32.8 mg starting material, 0.0596 mmol scale): 
9.7 mg, 0.0171 mmol, 29% yield].  
1H NMR (500 MHz, CDCl3): δ 6.09 (d, J = 10.5 Hz, 1H), 5.77 (d, J =10.5 Hz, 1H), 5.54 (t, J = 7.3 Hz, 1H), 
5.36 (app d, J = 2.0 Hz, 1H), 3.66 (s, 3H), 2.54-2.58 (m, 2H), 2.43 (dd, J = 15.0, 8.5 Hz, 1H), 2.32 (dd, J = 8.5, 5.0 
Hz, 1H), 2.07 (s, 3H), 2.02-2.05 (m, 2H), 2.03 (s, 3H), 2.02 (s, 3H), 2.01 (s, 3H), 1.99 (s, 3H), 1.82 (s, 3H), 1.77-
1.78 (m, 1H), 1.55-1.61 (m, 3H), 1.41 (s, 3H), 1.33 (s, 3H), 1.22-1.29 (m, 1H), 0.77 (s, 3H); 13C NMR (125 MHz, 
CDCl3): δ 173.3, 170.5, 170.2, 169.7, 168.7, 144.9, 137.8, 79.4, 77.4, 75.5, 69.9, 69.4, 63.4, 51.6, 49.1, 45.0, 40.8, 
35.7, 33.6, 27.4, 27.1, 24.8, 22.9, 21.1, 21.0, 20.9, 20.7, 15.8, 11.5; IR (film, cm-1): 2949, 1740, 1732, 1462, 1441, 
1372, 1238, 1029, 970, 754; HRMS (ESI) m/z calc’d for C29H42O11Na [M+Na]+: 589.2625, found 589.2620; [α]D25 
= -60.1° (c = 2.26, CHCl3). 
Computational Methods for Analysis of Electronic Structure of (+)-50 
A conformational search was performed using the MMFF force field (‘vacuum’ phase) as implemented in the 
program Spartan ’10. The lowest energy conformer was selected for ab-initio energy minimization using density 
functional theory (B3LYP/6-31G*), providing an energy of 1843.32406 Hartrees. Electrostatic atomic partial 
charges were calculated for all atoms. Of note are the hydrogen atoms attached to C1 and C2 (see Figure S1); as 
revealed below, H1 is significantly more electron-rich than either H2α or H2β (as expected when comparing 3o to 
2o C—H bonds), rendering it the most likely site of oxidation. 
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     Electrostatic Charges from B3LYP/6-31G* 
Hydrogen Atom Electrostatic charge (eV) 
H1 0.015 
H2α 0.153 
H2β 0.126 
Lowest potential energy conformer of (+)-50. 
 
 
Atomic Electrostatic Charges for lowest potential energy conformer of (+)-50. 
 
Atom  Charge 
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H1  0.015 
H2α  0.153 
H2β  0.126 
H3  0.032 
H4  0.120 
H5  0.047 
H6α  0.135 
H6β  0.130 
H7α  0.077 
H7β  0.116 
H9  0.177 
H10  0.079 
H13  0.022 
H14α  0.154 
H14β  0.127 
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